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 This dissertation examines the complex and often uncertain relationship between body weight and 
health in a highly weight-conscious society like the United States, using a mixed methods approach to 
study three key domains in which this ambiguity is evident. The first chapter draws on interviews with 
clinicians to examine the tension between medical definitions of healthy weight used by practitioners, the 
metrics of success they seek to promote among patients, and the broader messaging about weight and 
health in the culture at-large. Notably, practitioners often avoid “diagnosing” childhood obesity and poor 
health in favor of emphasizing a more optimistic “prognosis” emphasizing children’s and families’ 
success in developing healthy beliefs and behaviors that engender long-term success. The second chapter 
questions the assumption of homogeneously poor health among adults with obesity by examining the 
clustering of body size and other measures of health in a large nationally-representative data set. Medical 
research often frames “healthy” and “unhealthy” obesity as a function of random biological differences in 
the population; conversely, my work shows that these phenotypes are socially-patterned on the basis of 
individuals’ socioeconomic status, helping to explain group differences in mortality. Finally, the third 
chapter examines the consequences of individuals’ perceptions of their weight over the life course. Social 
and cultural stereotypes about individuals on the basis of their weight suggest that negative perceptions of 
one’s weight can be psychosocially damaging, leading to many of the harmful outcomes that we associate 
with body weight. This study demonstrates that objective and subjective weight status influence each 
other over time, such that both impact health in adulthood. Critically, these analyses underscore the 
consequences of weight-related stigma as source of poor health that is attributable to social norms about 
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what constitutes a “healthy” and “normal” body. In sum, this dissertation advances a more comprehensive 
approach to the study of and messaging about body weight and health, inclusive of a broader and more 
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CHAPTER 1: INTRODUCTION 
Sociologists representing a broad range of sub-disciplinary areas and interests have come to 
recognize obesity, and weight-related health more broadly, as a growing risk in U.S. society; however, the 
nature of this risk remains highly contested. Many argue that the biophysiological toll of obesity as state 
of impaired health is considerable, and likely to increase in coming decades as a greater proportion of 
adults spend a larger share of their lives exceeding recommended thresholds for a “healthy” weight 
(National Academies of Science, Engineering, and Medicine 2021). There is evidence to suggest that 
obesity’s impact on population health is already implicated in stagnating and/or declining life expectancy 
in the United States (Masters et al. 2018; Olshansky et al. 2005; Preston et al. 2014; Preston et al. 2018). 
Yet others take the position that the psychological and social toll of obesity, as a source of inequality and 
stigma, has inflicted the most harm on millions of adults whose individual experiences of their bodies, 
weight, and health are increasingly circumscribed by clinical and epidemiologic standards for disease and 
unhealthiness (Greenhalgh 2015; Saguy 2012; Shugart 2016). Thus, rather than adhering to these 
unambiguous standards for normal or ideal bodies, there is a push to recognize individuals’ health as a 
multidimensional and holistic construct, with an emphasis on understanding heterogeneity in body weight 
as a contributing rather than deterministic component.  
Indeed, researchers primarily care about body weight and size inasmuch as it purports to convey 
information about other aspects of health, like the types of behaviors a person engages in or their level of 
physiological impairment, to the extent that having a scale or measurement like the body mass index 
(BMI: weight[kg]/height[m]2) facilitates comparisons and rankings (Bowker and Star 1999; Fourcade 
2016; Jutel 2006). These behavioral and disease frameworks are inherently attractive as they convey 
information about what a person is doing or how they are, at present, allowing researchers to make more 
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definitive pronouncements about individuals’ healthiness based on their BMI. However, there is 
increasing recognition of an alternative perspective that bridges clinical and epidemiologic research on 
the limitations of BMI as a health surrogate with a sociological and psychological understanding of body 
size as an axis of inequality. This ‘weight neutral’ framework does not downplay the importance of 
studying body size and health; rather, it downplays the need to directly and unambiguously equate body 
size with health in research, the practice of medicine, and the conceptualization of overweight and 
obesity. Body size is acknowledged as a neutral form of human variation (Saguy 2012), whereby BMI 
reflects both biophysiological and psychosocial mechanisms of risk.  
This framing is integral to maintaining a sociological perspective on the role of body size and 
weight in individuals’ lives and society as a whole. Body size has been problematized and stigmatized as 
an abnormal form of human variation just as other forms of human variation have been considered 
‘undesirable.’ In a highly weight-conscious society where individuals social worth is tied to their 
appearance (Gutin 2021; Jutel and Buetow 2007; Shugart 2016), body size represents another form of 
stratification that influences health. Stigma is a fundamental mechanism underlying health disparities 
(Hatzenbuehler et al. 2013), and body weight is historically one of the first forms of stigma examined by 
sociologists (Cahnman 1968; Maddox et al. 1968). Yet, more than a half-century later, it continues to be a 
“socially acceptable form of bias” due in no small part to the presumption that individuals with medically 
“unacceptable” bodies are a social, economic, and health burden (Puhl and Heuer 2010: 1019). To the 
extent that body weight and size provide some indication of individuals’ physical appearance, they have 
significance as markers of social abnormality and inequality which are independently associated with 
health by way of individuals’ social interactions and experiences. Consequently, there is considerable 
heterogeneity in the mechanisms and explanations underlying how and why body weight and health are 
associated with one another. 
Critically, this uncertainty in our understanding of the relationship between weight and health is 
more than just a function of disciplinary differences in methodology and theoretical grounding, or even 
individual choices in the definition or measurement of disease and health. More fundamentally, it is a 
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reflection of the difficulties in assessing the risk that obesity poses in a medically and socially dynamic 
world, wherein the relationship between one’s weight and health is simultaneously constructed at a 
clinical, epidemiological, and subjective level. Indeed, the co-construction of health and illness across 
multiple social domains is a foundational principle within medical sociology; decades of research have 
examined the social practices underlying the creation of medical knowledge and practice (Conrad and 
Barker 2010; Foucault 1963; Timmermans and Berg 2003), the definition and diagnosis of disease and 
illness (Brown 1995; Jutel 2009; Jutel 2014; Rosenberg 2002), and the significance of individuals’ 
experiences of their health and wellbeing (Brown 1995; Bury 1991; Bury 2013; Hydén 1997; Kleinman 
1988; Parsons 1975; Rosenberg 2002). Yet this comprehensive approach to documenting multiple 
stakeholders and perspectives in the study of health and illness writ-large is rarely applied to the study of 
specific diseases and health conditions (Timmermans and Haas 2008). This is an unfortunate limitation of 
much extant medical sociology, as it “grant[s] health professionals, many health researchers and, 
increasingly, epidemiologists the clinical facts, leaving [social scientists] no choice either to accept 
clinical parameters at face value, tirelessly denounce the ‘construction’ of factual knowledges, or, more 
often, to ignore such factors” in conducting research and making claims about its implications 
(Timmermans and Haas 2008: 662). 
However, the broad repertoire of analytic techniques, data sources, and theoretical frameworks 
employed by sociologists can and should be leveraged towards greater specificity in our research on 
health – especially in the study of body weight. Sociologists’ contributions to the understanding of body 
weight and size – and the broader concept of obesity that they help define – as “clinical facts” is 
contingent upon recognizing what is unique, rather than exclusively generalizable, about their relationship 
with health. Yet, capturing the uniqueness of how body weight is associated with health requires 
knowledge of the many contexts in which body weight is defined as a health risk, such as the perspective 
of clinicians and health practitioners studying obesity and working with patients, the results of 
epidemiological analyses of population health data, and individuals’ subjective experiences and 
perceptions of their weight. Consequently, the overarching goal of this dissertation is to examine these 
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different disciplinary inputs in the framing of body size as a health risk and, in doing so, help resolve 
some of the ambiguity and uncertainty in the study of obesity and weight-related health.  
In brief, the first project examines obesity within a medical/clinical research setting, focusing on 
the challenges of conceptualization and communication in childhood obesity as a diagnosis in clinical 
encounters. Clinicians are tasked with conveying the potential for future harm to patients and families, 
rather than pointing to clear signs that something is already wrong. This is especially difficult given the 
emphasis on certainty and unambiguity in medical care; doctors are looked to as arbiters of healthiness, 
but healthiness takes on many meanings among children and families. However, recent sociological 
research has noted the importance of prognostication in diagnosis and how thinking more critically about 
patients’ future, rather than present, circumstances necessitates a kind of social diagnosis informed by 
multiple stakeholders and knowledge of the many social, rather than medical, aspects of their day-to-day 
lives. This emerging diagnostic model is especially key for clinicians’ success in creating a partnership 
with patients and families, understanding their psychosocial milieu, and identifying an individualized 
model of success rather than continuing to promote universal criteria for defining healthiness. To better 
understand the challenges and nuances of body weight and health in early life, this project draws on semi-
structured interviews with health professionals to examine their strategies for communicating risk and 
defining success in the diagnosis and treatment of childhood obesity.  
The second project examines obesity as an epidemiological measure, documenting the co-
occurrence of obesity (on the basis of body weight and size) with key indicators of cardiometabolic health 
risk within the U.S. adult population over the past three decades. Many critiques of obesity as a “disease” 
take issue with the implicit assumption of homogeneously poor health among adults exceeding clinical 
thresholds for obesity, as both the definition and measurement of obesity is not necessarily a reflection of 
individuals’ underlying physiological state. Yet, biophysiological variation underlying obesity as an 
“unhealthy” condition or a disease can be empirically analyzed by examining its co-occurrence with other 
cardiometabolic health indicators within the population, and in their association with mortality risk. 
Indeed, many studies have identified a “Metabolically Healthy Obesity” phenotype, which represents a 
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substantial proportion of adults with obesity, and the population as a whole. However, past research has 
primarily described these obesity phenotypes as biologically or genetically patterned, ignoring key social 
factors – like educational attainment – that shape individuals’ risk profiles. This study uses data from the 
National Health and Nutrition Examination Survey (1988-2014) linked with follow-up mortality data to 
identify which set of body sizes and cardiometabolic health profiles best characterize the U.S. adult 
population over the past decades, how they are associated with premature mortality risk, and how the 
social patterning of these profiles explains overall educational gradients in mortality risk. 
Finally, the third project examines body weight as a subjective, individual-level construct, 
analyzing the relationship between individuals’ “objective” body weight and their perceptions of their 
weight, and how the two interact with one another in their associations with both physical and mental 
health outcomes. Individuals’ subjective experiences and assessments of their health are commonly-used 
variables in social and health research, with demonstrated utility over and above objective or clinical 
measures. Yet, subjective experiences or (mis)perceptions of weight are primarily framed as an obstacle 
to improving population health, as they may lead individuals to inaccurately assess their weight status and 
engage in unhealthy behaviors. This perspective ignores a large body of research on the deeply 
stigmatizing aspects of being overweight as a unique driving force underlying poor mental and physical 
health among many children, adolescents and adults. The extent to which adults negatively perceive 
themselves and their bodies in relation to their weight (i.e., subjective weight) – in a society where so 
many are devalued and derogated on the basis of their physical appearance – can be psychologically 
damaging and stressful, leading not only to poor mental health, but also to many of the harmful physical 
risk factors typically associated with objective weight. Using five waves of the National Longitudinal 
Study of Adult to Adolescent Health (1994-2019), this study uses structural equation modeling to analyze 
the cumulative effect of both objective and subjective weight on health, while allowing for cross-lagged 
and direct associations between the two. By examining a mix of both physical and mental health 
outcomes, this study is the first to compare the relative impact of objective and subjective weight on 
health throughout the early portion of life course. 
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Though the three projects answer different research questions, focus on different bodies of 
literature, and use different sources of data and methodological approaches, they are united by a shared 
objective of improving the conceptualization, definition, and measurement of body size and obesity in 
sociological, demographic, epidemiologic, and medical research, as well as in informing research 
priorities and interventions for improving population health. Taken together, this dissertation seeks to 
emphasize the value of adequately documenting the different ways that individuals’ weight interacts with 
their health as a function of it being both a physical trait and social identity. Moreover, both perspectives 
on weight inform the actions taken by institutions and individuals to improve the health and quality of life 
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CHAPTER 2: NOT ‘PUTTING A NAME TO IT’: INTEGRATING UNCERTAINTY INTO THE 
DIAGNOSIS AND TREATMENT OF CHILDHOOD OBESITY 
Introduction 
Childhood obesity is consistently singled out as a key public health challenge facing the United 
States. Recent data show that approximately one-in-five youth ages 2-19 have a body mass index (BMI: 
height[m]/weight[kg]2) that is considered “obese” (Fryar et al. 2020). Often described as a “crisis” or a 
“threat,” the sense of urgency is understandable given the emergence of obesity as a major contributor to 
morbidity and mortality (RWJF 2021; WHTFCO 2010), especially as U.S. adults spend an increasing 
proportion of their lives in an ‘unhealthy’ body weight (Lee 2010; NASEM 2021). Indeed, while 
childhood obesity is associated with worse health in early life (CDC 2021), the greater concern is over its 
future implications because youth with obesity are more likely to become adults with obesity (CDC 2021; 
Gordon-Larsen et al. 2010; Ward et al. 2017). Given the social and economic costs stemming from poor 
health and limitations linked to obesity throughout the life course, the Obama administration explicitly 
made “solving the problem of childhood obesity within a generation” a key public health priority 
(WHTFCO 2010). Unfortunately, this ambitious goal has not been achieved and recent evidence suggests 
that any leveling off or decrease in childhood obesity observed over the past decade was illusory (Skinner 
et al. 2018).  
The discrepancy between our ever-increasing knowledge of the etiology and consequences of 
childhood obesity, and our continued inability to address it in any meaningful way, is a source of 
frustration for pediatricians and many other health professionals (Carroll 2020). Diagnosing, discussing, 
and treating weight-related health in a clinical setting represents a distinct set of challenges compared to 
population-level initiatives. In theory, there is considerable certainty on how to address obesity – as 




there is considerable uncertainty in understanding how this knowledge can be translated into actual 
improvements for individuals (Carroll 2020). Due to this uncertainty, the health professionals involved in 
the development and deployment of clinical protocols have been castigated for using obesity as a medical 
diagnosis if “the field of medicine has no safe, reliable means to enable [children and teens] to lose the 
weight and keep it off, and so become ‘well’ and ‘normal’” (Greenhalgh 2015: 281-282). 
Though controversial, diagnoses like “childhood obesity” are a critical organizational tool in 
medicine, imposing certainty by categorizing individuals as healthy or unhealthy (Jutel 2009). Yet weight 
and health are hard to definitively characterize in children. Direct evidence of poor health is rarely 
observed, and in some cases unobservable, beyond the tautological observation that the BMI itself is 
“unhealthy” (Gutin 2018; Sharma and Campbell-Scherer 2017). Youth with obesity are at higher risk for 
developing cardiometabolic comorbidities like hypertension, dyslipidemia, and hyperglycemia (Skinner et 
al. 2015), but the lower absolute prevalence of these conditions in early life suggests that most pediatric 
patients with obesity do not exhibit clear signs of poor health. In the highly time-constrained context of a 
clinical encounter – where a typical visit is less than 20 minutes (Halfon et al. 2011) – practitioners may 
not be able to identify an observable issue caused by weight. Moreover, childhood is an incredibly 
dynamic period in life; weight naturally fluctuates as children grow and the same BMI has different 
interpretations at different ages (CDC 2020). Visual assessments of a child’s weight may not comport 
with clinical definitions of “healthiness,” introducing an added layer of complexity and uncertainty for 
both practitioners and patients (CDC 2014).  
Finally, diagnosis is further complicated by increased recognition that obesity has social 
meanings and consequences that transcend the confines of a clinical encounter. In theory, obesity is an 
objective clinical diagnosis (Jutel 2019); in practice, it is far from neutral with respect to the social 
stigmas surrounding the term (Murray 2009; Saguy 2012; Shugart 2016). Medicine is a powerful and 
authoritative social institution, and many contend that the medicalization of childhood obesity in 
contemporary society perpetuates these harmful social beliefs about what constitutes a healthy and good 




representative of how some aspect of one’s biology or appearance that is superficially ‘abnormal’ 
becomes harmful when subjected to the framework of a biomedical model for health (Jutel and Dew 
2014). There is a societal tendency to “medicalize that which we find morally unacceptable,” such that 
children with obesity become “‘patients who must be cured” and parents are implicated for failing to 
protect their children (Moffat 2010: 5). Thus, just as the diagnostic label of obesity carries meaning in the 
social world outside the clinic, these broader social norms and beliefs about weight and health 
reciprocally influence medical knowledge and patient-provider interactions (Conrad and Barker 2010). 
Current Study 
In describing the inherent diagnostic uncertainty of childhood obesity, I contend that health 
professionals dealing with issues of weight and health in early life are in an unenviable position. That is, 
they are trying to address a legitimate health concern, often before it is clearly observed as a health issue, 
while also being careful to avoid causing new problems in labeling children as “unhealthy.” Striking a 
balance between these goals speaks to sociological research on uncertainty and diagnosis in medicine, and 
how these two concepts intersect. The complex biological and social etiology and sequalae of childhood 
obesity make it a challenging health issue to neatly define and categorize, and thus address in clinical 
settings. I do not challenge the fact that a high BMI can be and often is unhealthy in early life, but instead 
focus on the fact that practitioners’ certainty about this relationship at the individual level of a patient is 
limited. Specifically, this chapter examines how uncertainty influences the diagnostic process, focusing 
on how children’s BMIs are interpreted and used during clinical encounters.   
Through in-depth interviewers with health professionals working with pediatric patients, I 
examine how uncertainty affects communication about risk, the structuration of treatment, and the 
determination of what constitutes a successful outcome. Research on pediatric medicine is instrumental in 
exploring how uncertainty manifests in different clinical settings, and in broadening our understanding of 
how diagnoses differ based on the health issue under examination (Timmermans and Haas 2008). This 
study contributes to a growing body of research building a case for integrating children and youth into 




knowledge in light of their unique health experiences and concerns (Brady et al. 2015; Bray et al. 2014; 
Mayall 1998). Specifically, I focus on uncertainty in the process of diagnosis, by examining the act of 
diagnosis or how practitioners “do diagnosis” on a day-to-day basis (Armstrong and Hilton 2014), which 
remains an understudied topic with respect to pediatric care (Lutz 2019; Timmermans and Stivers 2018). 
The chapter begins with an overview of extant literature on the role of uncertainty in diagnosis 
and its relevance for obesity, emphasizing uncertainty in diagnostic tools and criteria, as well as noting 
how diagnoses have come to encompass individuals’ future health. In using an abductive analytic 
approach to interpret and analyze the interview data (Timmermans and Tavory 2012), this study 
demonstrates how uncertainty can be a defining feature of the diagnostic process rather than treated as 
something to be ignored, avoided, or suppressed (Jutel 2009). I focus on BMI growth charts as a 
diagnostic tool and technique that circumvents the need to explicitly label a child as unhealthy, and thus 
mitigates the need for immediate solutions. Practitioners are less declarative about a diagnosis of obesity 
and shift the clinical narrative towards prognosis and what the future holds for a given patient and family 
– which is inherently uncertain. Moreover, the focus on diagnosis and treatment as a long-term process 
recognizes that individuals’ weight trajectories are often unpredictable – reflecting numerous influences 
outside the realm of medicine. In turn, this acknowledgement of non-clinical uncertainty broadens 
practitioners’ definitions and standards of success across patients and families. Ultimately, I use this 
insight on the beneficial aspects of uncertainty in diagnosis to challenge how we evaluate the success of 
childhood obesity interventions at the population level.  
Theoretical Background   
Clinical Uncertainty 
Uncertainty is a central theme in medical sociology and research on the social construction of 
health and illness, presenting itself in various ways among practitioners and patients (Mackintosh and 
Armstrong 2020). Indeed, uncertainty was the defining feature of clinical care for much of human history, 
as health practitioners and healers practiced medicine with a primitive toolkit for examining the inner 




Schubert 2011). In turn, the push to formalize medicine as a discipline – and thus establish a consistent 
set of standards, guidelines, and protocols to ensure uniform care (Timmermans and Berg 2003) – 
represents a decades-long effort to minimize uncertainty during clinical encounters and provide 
practitioners and patients with accurate and actionable information. A broad exploration of clinical 
uncertainty is beyond the scope of this study; however, the broader effort to mitigate uncertainty in 
medicine has had a profound influence on shaping clinical knowledge and practice as it related to BMI as 
a diagnostic instrument and obesity as a diagnosable condition. 
The “evidence-based movement” (EBM) in medicine is most representative of this battle against 
uncertainty (Fox 2000; Lambert 2006; Timmermans and Angell 2001). Health professionals follow 
established protocols and guidelines based on “best” practices and “gold standards” of measurement 
identified in research (Timmermans and Berg 1997; Timmermans and Berg 2003; Timmermans and 
Kolker 2004; Upshur 2005). To the extent that uncertainty introduces subjectivity into clinical practice, 
EBM thus helps maintain “objectivity” (Cambrosio et al. 2006; Camrosio et al. 2009; Goldenberg 2006; 
Weisz et al. 2007). Clinical cutoffs or guidelines “map the area over which health care providers maintain 
professional sovereignty” (Timmermans and Berg 2003: 93), translating subjective, lay assessments of 
health into objective health standards, measures, and benchmarks. Obesity clearly reflects this push for 
standardization, wherein qualitative and holistic assessments of individuals’ bodies and health were 
replaced by quantitative measures like the BMI (Jutel 2006; Jutel 2009; Jutel 2011), which now serves as 
the basis for obesity as a diagnosis. 
This is not to suggest that evidence-based decision-making or standardization represent negative 
attributes of contemporary medicine. It is uncontroversial to suggest medical practice should be based on 
the best available evidence, while standardization helps organize health care and facilitate communication 
across the many parties involved (Timmermans and Berg 2003). Rather, the concern is defining what 
does and does not count as “best evidence,” as maximizing ‘universality’ through the use of quantifiable 
and objective standards is contingent on minimizing the alleged uncertainty introduced by subjective 




measure (Burkhauser and Cawley 2008; Gutin 2018), but it continues to be the “gold standard” for body 
size (Hu 2008) – and the defining attribute of obesity – because it represents the kind of objective 
measure of health prioritized by contemporary medicine. 
Uncertainty in Diagnostic Tools 
The evidence that informs medical knowledge and practice requires diagnostic tools and 
instruments that allow for the collection and evaluation of ‘objective’ evidence about individuals’ health 
(Armstrong and Hilton 2014; Brown 1995). Namely, they are perceived as the objective and neutral 
counterpart to the subjective and biased assessments that come from practitioners (Schubert 2011). These 
tools and instruments have advanced medical care and saved countless lives, but medical sociologists 
have been careful to note that their perceived objectivity and infallibility – and thus the certainty with 
which they are used – is not necessarily guaranteed (Armstrong and Hilton 2014; Schubert 2011; 
Timmermans and Oh 2010). These tools create additional uncertainty when they are perceived to provide 
incomplete information about the issue at hand, as demonstrated in the case of invasive urodynamic tests 
(Armstrong and Hilton 2014), CT scans (Saunders 2008), or even more cutting-edge methods concerning 
genetic testing (Timmermans 2015; Timmermans et al. 2017). As these studies suggest, the subjective 
clinician is not absent from the diagnostic process, imposing their judgement and knowledge – and 
reacting to patient feedback – in determining how and when to interpret and use these diagnostic tools. 
Uncertainty is inherent to many of the diagnostic tools now regularly used to measure health. 
With the rise of medical screening and the enumeration of ‘risk,’ the consistent measurement and tracking 
of various health metrics is an integral aspect of the clinical encounter. The influence of the ‘risk factor’ 
framework stemming from epidemiologic perspectives on health means that practitioners measure and 
monitor health even when signs of poor health are absent (Armstrong 1995; Armstrong 2012). This is not 
to suggest that medical screening is unimportant, or not integral to the practice of preventive medicine. 
Rather, the issue is that screening creates more uncertainty by expanding our societal notions of risk to 
categorize many seemingly benign behaviors and attributes as risky and unhealthy (Armstrong and 




we use many of the same metrics to both gauge risk and diagnose health, giving rise to “proto-diseases” 
like pre-hypertensive, pre-diabetic, and overweight, rather than obese (Jutel 2006; Rosenberg 2007). The 
use of medical screening is well-intentioned in seeking to reduce uncertainty about individuals’ 
propensity for poor health in the future; however, these screening tools often introduce more uncertainty 
among those deemed “at risk,” leading them to conflate their potential for poor health with a perception 
of their already having poor health (Cupit et al. 2020; Gillespie 2015; Jauho 2019). Thus, many screening 
tools and measures situate individuals in an unsatisfying and uncertain state of diagnostic liminality, 
which creates problems for practitioners trying to communicate meaningful information to their patients 
and articulate a clear course of action (Armstrong 2019; Cupit et al. 2020; Gaspar 2020; Saukko et al. 
2012).  
This hybrid screening and diagnostic framework describes BMI, which “screens” for future risk 
but is also used to “diagnose” obesity. While we may not think of BMI as an instrument in a traditional 
sense like a stethoscope or pulse oximeter (Schubert 2011), it is a measured derived from measured 
height and weight, using a stadiometer and a scale. BMI is automatically calculated and incorporated into 
many patients’ charts, just as one would find with other diagnostic measures like blood pressure, pulse, or 
any lab work. The resulting values provide practitioners with some sense of patient risk, but there is little 
certainty with respect to BMI as a measure of individuals’ current health. BMI provides limited insight on 
body composition, as the biophysiological attribute of concern (Snijder et al. 2006). More importantly, 
there is a lack of consensus as to the diagnosability of obesity as a condition; the definition of obesity is 
being conflated with its measurement based on BMI (Gutin 2018; Nicholls 2013), rather than using a 
definition of obesity as a state of impaired health caused by excess adiposity (Sharma and Campbell-
Scherer 2017). Thus, when used as a diagnostic tool, there is considerable uncertainty as to what BMI 
measures or what broader construct this measure maps onto.  
“Putting a Name to It” 
Despite the uncertainty in BMI as a diagnostic tool, many medical organizations have adopted the 




diagnosable health condition (Bray et al. 2017; Jutel 2014; Kyle et al. 2016). This decision relocates 
obesity further from its causes, such as diet and physical activity, and closer towards the kinds of 
comorbidities and outcomes that fall under the purview of medical care (Chang and Christakis 2012). 
More importantly, disease diagnoses are “non-negotiable” and “make no space for error or uncertainty” in 
defining healthiness (Jutel 2019: 66), and thus serve as a gateway for intervention and reimbursement.   
However, this disease label has encountered pushback among those contending that this certainty 
is misplaced and diagnosing obesity as a disease is hampered by an inability to definitively determine 
“whether abnormal or excessive body fat is actually impairing [a] person's health” (Sharma and 
Campbell-Scherer 2017: 660). Indeed, scrutiny of the decision-making underlying this decision suggests 
that, ironically, the diagnosis does not come from a place of certainty in being able to “scientifically prove 
either that obesity is a disease or that it is not a disease,” but is instead a response to how this uncertainty 
in classification causes problems for practitioners and patients that needs to be resolved. Consequently, 
medical organizations adopted a “utilitarian” position (Allison et al. 2008: 1162) – asking whether obesity 
should be called a disease, rather than whether it is a disease – in recognizing that health conditions 
“come to be considered diseases as the result of a social process when it is assessed to be beneficial to the 
greater good that they be so judged” (p. 1161). The diagnosis is thus a pragmatic concession – or a 
“bureaucratic and an emotional necessity” (Rosenberg 2002: 256) – sanctioning obesity treatment as a 
billable transaction.  
Diagnoses are designed to impose certainty for practitioners, and the medical system at large, but 
this certainty is not without consequence for the patients to whom diagnoses are assigned. Diagnoses 
redefine individuals’ health, with the “diagnostic moment” marking a critical transition from healthy to 
unhealthy (Heritage and Macarthur 2019; Jutel 2014). The label of “obese” can produce “an instantaneous 
– and traumatic change in [individuals’] sense of self” and perceptions of their overall health (Greenhalgh 
2015: 113; Jutel 2014). Though the disease label is used to legitimize obesity as a health issue and remove 
personal blame, this diagnosis cannot be disentangled from the social consequences of labeling 




choices (Greenhalgh 2015; Saguy 2012). Thus, while diagnoses legitimize obesity in medicine, the need 
to impose certainty about good versus bad health has consequences for individuals whose bodies do not 
conform to ideals and norms about who is considered “healthy” and “good” in our society. These 
unintended consequences are anticipated in extant theories in the sociology of diagnosis (Jutel 2009; Jutel 
2019). However, we lack more comprehensive knowledge of how the meanings attached to diagnostic 
labels may impact the diagnostic process itself, influencing how practitioners discuss diagnoses and 
treatment (Heritage and Macarthur 2019).  
Diagnosis as Prognosis 
Recognition of diagnoses as laden with both clinical and social uncertainty has led scholars to 
reconsider how diagnosis – as a process – often transcends the confines of a given clinical encounter. 
Though diagnoses can provide certainty to practitioners and patients in search of a clear name or label for 
a health condition (Jutel 2019), the diagnostic process is often less clear-cut than the guidelines and 
standards promoted under EBM might suggest. Much of contemporary health and medicine is defined by 
conditions that unfold over the course of many years, and thus diagnoses are often made with limited 
insight on a patient’s health trajectory. Moreover, this trajectory is not solely a function of individuals’ 
latent health; it is also affected by many non-medical factors. Recognition of this multi-layered 
uncertainty informs the social diagnosis framework (Brown et al. 2011), which emphasizes the concurrent 
influence of practitioners, patients, and the many individual- and social-level actors and forces shaping 
diagnoses and health. As Brown and colleagues (2011) explain, this comprehensive theory of social 
diagnosis makes “time” as a critical dimension of treatment in bringing these various actors and forces 
together: diagnoses are often less contingent on the past and present experience of a condition as much as 
they “explicitly consider the potentiality of future conditions” and the extent to which this potentiality is 
shaped by social causes and liable to have social consequences (p.941). Thus, the inherent individual-
level biomedical uncertainty about patients’ diagnosis and the trajectory of their condition intersects with 




Temporal uncertainty is critical to more recent work on the sociology of prognosis, which 
examines how health professionals allow for uncertainty in practice and deviate from established 
protocols when faced with unclear prospects for their patients. While the prognosis framework has 
generally been applied to end-of-life circumstances or terminal cases (Christakis 1997), Timmermans and 
Stivers’ (2018) analysis examines prognosis in the context of chronic illness, focusing on the trajectory of 
epilepsy throughout childhood. Critically, their work documents the utility of prognoses as a means by 
which practitioners avoid declarative – and potentially incorrect – conclusions about the severity of a 
condition, and instead emphasize plausible trajectories. Practitioners were unlikely to communicate 
explicit diagnoses to patients and families and would instead “tip their hand” about their expectations 
(Timmermans and Stivers 2018). In turn, this openness about uncertainty helped facilitate a view of 
patients as representing individual cases rather than trying to situate their prognoses in a fixed framework 
of guidelines and protocols; likewise, it helped maintain a collaborative, long-term relationship with 
patients, as is crucial to long-term treatment (Timmermans and Stivers 2018). 
Indeed, the importance of the individual – as more than a clinical entity – is central to the 
prognostic model of clinical practice. Echoing Brown et al.’s (2011) emphasis on accounting for non-
biophysiological factors, Croft et al. (2015) contend that the emphasis on diagnosis in contemporary 
medicine enforces an unnecessarily limited view of patients. Diagnoses reinforce a binary view of health 
and disease, which implicitly categorizes individuals into homogenous groupings based on their having or 
not having a given condition, rather than considering how their condition may interact with various non-
clinical aspects of their life (Croft et al. 2015). By contrast, prognosis “offers an alternative starting point 
with wider incorporation of factors relevant to patient outcomes than diagnosis alone”; namely, the 
framework encourages the collection and integration of information on the totality of a patient’s 
biological, psychological, and social environment, which may convey more certainty about future health 
than data from imprecise diagnostic tools and cutoffs (Croft et al. 2015). In this way, prognoses prioritize 




the information on hand and identifying what outcomes are truly “wanted or needed” for all parties 
involved (Croft et al. 2015). 
Methods 
This study draws on data from a purposeful sample of health professionals seeing children and 
adolescents, as well as their families, in clinical settings. Recruitment was conducted at a large university 
hospital system via email listservs for various departments and working groups, as well as in-person 
recruitment at a research group specifically focused on childhood obesity. The email and presentation 
provide a general overview of the project – i.e., approximately 60-minute interviews focused on the 
diagnosis and treatment of childhood obesity – and offer an incentive for participation. Following this 
initial recruitment, participants were asked to circulate details about the study among their practices, 
departments, and additional organizational listservs (Biernacki and Waldorf 1981). This study was 
exempted by the institutional IRB following a review of the recruitment methods and interview guide 
(#19-2361). 
In total, 28 participants contributed to the study, representing a diverse group of practitioners in 
terms of years of experience and areas of expertise in diagnosing and treating weight and health in young 
populations. Half of participants were general pediatricians (N=14), with five to 30 years of clinical 
experience. Their perspectives were complimented by clinicians and residents in family medicine (N=3), 
behavioral specialists (e.g., adolescent psychology and dieticians) regularly seeing children and 
adolescents with overweight and obesity (N=5), and medical students with clinical experience (N=6). 
Except for three of the medical students and two of the behavioral specialists, all respondents were 
actively engaged in clinical practice during the time of interview, though the proportion of time in clinical 
hours versus other activities varied between 30 and 100%. In general, respondents described working with 
fairly diverse patient populations or, as one pediatrician explained, “one day I see a kiddo whose dad is 
the head of cardiology, and the next day I see someone from a very low-income, under-resourced area.” 
Some respondents also noted that they were bilingual, and probably saw more Hispanic patients and 




Interviews were conducted between January 2020 and March 2021; due to the overlap with the 
COVID-19 pandemic, 24 of 28 interviews were conducted using videoconferencing software, which were 
recorded with the participant’s consent. These semi-structured interviews encouraged an open, but 
focused, conversation about how practitioners approach weight and obesity as a health issue in early life, 
how they communicate on this subject with patient and families, and how treatment is provided and 
monitored (see Appendix). The interview questions were piloted as part of a shorter set of interviews with 
clinicians one year prior to data collection to help better specify questions and identify appropriate 
terminology; any clinicians participating in the earlier stage were not re-interviewed. Interviews ranged 
from 45 minutes to 1.5 hours, depending on participants’ availability. The recorded interviews were 
transcribed and matched to any memos written while they were being conducted.  
The overall analytic approach is informed by the abductive framework outlined by Timmermans 
and Tavory (2012), using a version of flexible coding suggested by Deterding and Waters (2018) for 
researchers using QDA software to conduct abductive analysis of interview data. Extant medical 
sociological theory helped to motivate interview questions on uncertainty in practitioners’ approach to 
diagnosis and treatment; the abductive analysis framework allows for this extant knowledge to serve as 
the basis for identifying key themes in the data, upon which coding iterates and elaborates. However, this 
abductive approach encourages researchers to privilege “observational surprises or puzzles” rather than 
ignore them in favor of predetermined theories (Timmermans and Tavory 2012: 169). In the case of this 
study, reviewing transcripts during both data collection and analysis yielded interesting and recurring 
insights on “trajectories” and “growth” as both a diagnostic tool and mentality in the care of childhood 
obesity – speaking to, but also deviating from, extant theory on diagnosis and uncertainty. Likewise, I 
used an iterative coding scheme based on multiple reviews of transcripts. Initial coding identified broad 
themes consistent with extant theories of diagnosis and uncertainty; these codes were then re-evaluated in 
light of findings specific to childhood obesity, with an eye towards illustrative quotes (Deterding and 





Diagnosing “Growth” Rather Than Weight 
During interviews, practitioners were asked how and why weight is brought up during a clinical 
encounter and prompted to describe typical interactions with patients and families. Most respondents 
explained that taking height and weight is a now standard part of the “flow” of clinical visits, such that 
seeing and reacting to BMI is a very natural. Dietician Patricia casually notes how “BMI just shows up” 
in patient charts, conveniently categorized as “either red or not red” in relation to obesity, at which point 
her concern is making sure to enter the correct diagnostic code and initiating the conversation. Indeed, 
several respondents spoke positively of how automatically BMI is incorporated during the visit. General 
pediatrician Nancy noted that using BMI is a more recent innovation given the advent of electronic 
records, emphasizing that she used to not use BMI “because I'm not going to sit there and a 15-minute 
visit and calculate someone's BMI, because I got too many things to do.” She noted that BMI, and BMI 
growth charts, were a “great tool” as compared to past protocol of asking “what did the kid look like” and 
“going through what their diet and habits were.” Likewise, general pediatrician William appreciated how 
getting BMI into electronic health records “just puts it in front of us” to start the conversation with 
families. Along these lines, adolescent medicine specialist Elliott described how he “might sort of edge 
into it a little bit more peripherally” in starting a visit by “just go[ing] through the numbers” – and 
bringing up weight alongside height or blood pressure – before talking about patient experiences. 
Despite these conveniences, practitioners expressed apprehension about how these numbers shape 
the clinical encounter. Medical student Sandra noted that seeing and talking about BMI felt “almost like a 
reflex”; while having the conversation is important, she felt “forced to think about weight” and worried 
how it made it “easy to write off all of the problems” a patient has with obesity. Similarly, general 
pediatrician Erika explained that “get[ting] everyone to a healthy BMI” is often the only framework she 
has during clinical encounters, and BMI is “the only tool” available to make decisions. Both Sandra and 
Erika explain how the ubiquity of BMI in clinical settings does not always square with the fact that 




with a diagnosis may not be productive. Sandra described a patient with back pain who has been 
repeatedly told to lose weight as the solution; yet imaging found no signs of something being physically 
wrong that were attributable to weight. Sandra maintained that a healthier weight would benefit the 
patient, but it was important to recognize that this “was not the solution [the patient] was looking for” or 
the “solution that would work for her at the point she was at”: rather than focusing on weight, Sandra 
retrospectively felt that it would have been better to acknowledge the patients’ specific concern. Erika 
also noted how the parents she interacts with probably feel like “all [doctors] want to talk about is my 
kid’s weight,” ignoring families’ other concerns. Erika wondered if she and other pediatricians are part of 
the problem in bringing up weight at every visit, which makes patients feel like “if their weight is not 
within the healthy zone of a BMI, someone's going to tell them about it, and someone's going to shame 
them about it.” 
The latter point presented a conundrum for many respondents: the evidence practitioners are 
presented with instantaneously informs them of whether a patient is healthy or not based on BMI, but 
they have good reason to withhold a diagnosis from patients and families. When probed on how they use 
the diagnosis of “obesity” during clinical interactions, all but two of the respondents reported ever using 
that word – or the label of “obese” – in talking to patients and families. The two respondents who did use 
the term worked more with patients and families seeking treatment for severe long-term obesity, wherein 
bariatric surgery or medicine might be the next option. Otherwise, some of the longer-practicing 
practitioners mentioned it being a term they used early on but no longer employed.  
Specifically, respondents did not see the utility of using obesity as a diagnosis given the inability 
to clearly state something is wrong with patients. Medical student Kimberly did not disagree that it was 
wrong to describe obesity as a disease but acknowledged that using the term was not very helpful because 
she could not definitively say “what that means for my patient right now” in the sense that “clinically, I 
can’t tell anyone here’s why it’s bad.” Family medicine resident Jonathan also did not think the diagnosis 




instantly” and thus not “an imminent threat”; thus, he was reliant on the patient to know when to discuss 
weight.  
However, the primary motivation for avoiding a diagnosis and not mentioning obesity was 
recognition that the medicalized language surrounding weight can be harmful and counterproductive, with 
“obese” being a harmful label in a clinical setting. According to general pediatrician Frederick: 
[M]ost people who are obese know they're obese. And they get so many negative 
messages about their obesity. And they know, or have heard over and over again, that 
there's an epidemic of obesity that is out of control and problem. [They] probably heard 
from other clinicians before about their obesity and may have attempted to achieve some 
improvements in their BMI and it had failed. And now here comes another condition. All 
right, tell me what I already know. 
 
Frederick explained that the diagnosis and label was an obstacle to maintaining a positive atmosphere in 
clinical settings. This sentiment was echoed by other practitioners noting how important it is to keep 
patients and families “engaged” when it comes to weight. William observed that families interpret obesity 
in unpredictable ways; in some cases it might be helpful, but he is concerned that the term “ostracizes 
people or turns them off” and “maybe erodes trust” when it runs counter to patients’ and families’ 
experiences. Pediatrician Nancy summarized this conundrum in recognizing the need to talk about weight 
but worrying how to do this “without causing another issue?” Nancy tried to balance the harmful 
connotations of obesity by reinforcing all the positive aspects of a child’s appearance because she thought 
“most of them look in the mirror, and they don’t see that happy stuff at all.” Elliott has a similar mentality 
when it comes to “articulat[ing] the positive truth” of a patient’s health. As a doctor, it is his 
responsibility to tell adolescents the truth, but to “do it in a way that they understand” – which involves 
telling them the “full truth, both the good and the less good” when it comes to all the things going right. 
Thus, practitioners tried to be cognizant of BMI as a number that provided objectivity and 
evidentiary basis to care, but that needed to be contextualized among patients’ other attributes. This was 
observed in their framing of obesity as a diagnostic “code” – in a bureaucratic sense – rather than 
something that provides greater understanding for the patient and family. General pediatrician Cassandra 




given the emphasis on “coding for as many diagnoses that exist as possible.” She drew a comparison to 
riding a motorcycle as a situation where “your lack of helmet wearing isn’t a disease” in the sense that 
disease better communicates the risk compared to simply having a discussion with patients. General 
practitioner Joseph avoided using the term obesity in clinical encounters, but on the rare occasion where 
he was asked by families he was careful to explain that it is “not an adjective,” but just a diagnostic 
formality. 
More broadly, this distinction between practicality and clinical utility in diagnosis was seen in 
respondents’ perceptions of how much information BMI provides about patients. Practitioners 
acknowledged BMI as a limited measure, highlighting different sources of uncertainty in the measure and 
how it maps onto health. Some practitioners, such as William, recognized BMI as, at best, a screening 
tool, knowing that lab work was unlikely to show clear evidence of insulin resistance or more serious 
concerns. In working with young patients, William viewed his role as “preventative,” noting how they are 
“still, hopefully in the front end of [health] and there may be things smoldering” like a high BMI. The 
measure is not sufficient to describe underlying health and thus William acknowledged that “I don't have 
a diagnosis. You’re not treating anything, you're, you're just heightening your antenna for prevention.” 
Kimberly shared these concerns, wanting a more “meaningful” definition of obesity that is “not just a 
number” because number definitions are “what we like” in medicine. The emphasis on identifying a 
diagnostic threshold that corresponds with this number represents yet another source of uncertainty for 
William, as well as Cassandra, both of whom felt that “nothing magical happens when you go from the 
84th to the 85th or 94th to the 95th percentile [for BMI])” (William) or that a “BMI of 32 is that much better 
or worse than a BMI of 30” (Cassandra). This combination of measurement and diagnostic uncertainty 
motivated Erika’s highly-critical position on BMI, leading her to question whether BMI “means anything 
at all?” Namely, she described an evolution in thought on BMI, transitioning from an unquestioning 
position influenced by her medical training to a skeptical perspective on BMI as a “made up thing” based 
on both personal professional experience of its discordance with individuals’ perceptions of themselves as 




somewhere” when it comes to BMI and obesity; thus, while she continued to use the measure, it is “now 
more as a signal rather than a final label.” 
Indeed, many respondents expressed this sentiment – feeling that they had no choice but to 
continue using BMI given a lack of alternate measures and due to its centrality in bureaucracy. However, 
rather than fixate on its limitations, practitioners were strategic in reorienting their use of BMI as a 
measure of growth and development as opposed to a diagnostic measure of health. Practitioners explained 
how BMI is situated on a growth curve relative to both the individual child and other children of their age, 
which is then shown to parents and families as an indicator of a child’s overall trajectory. In turn, the 
emphasis on future outcomes allowed practitioners to convey the appropriate level of concern without 
causing harm and disengagement. Erika explicitly used this strategy to circumvent the problems with 
obesity as a label and diagnosis: 
I do talk about growth at every well child visit that I have. I will talk about BMI. And the 
way I talk about it is more that BMI is a general indicator of your weight and your height 
together. So I'm not focused on your weight as a number because I get a lot of things 
about like, how much should we weigh? But that's not where we're going… Like, let's 
talk about BMI more in the context of like proportionality of your weight. But that's kind 
of how I'll approach it is just and then I'll say not I will never say like, we want your kid 
to lose weight… And to attain a healthier weight. I'll often tell them, depending on how 
old they are, how much growth potential they have, you know, if you could just keep 
your weight the same and grow taller, we're gonna even this out! 
 
Other practitioners noted how this growth perspective on BMI helped shift the nature of the clinical 
encounter from disease and diagnosis – and a focus on the child and their health at present – to a gentler 
language of concern and worry about deviation from these trends. For instance, Nancy described the 
diagnostic utility of growth curves: 
I always pointed out the growth charts and I always talked about how we got a pattern 
here that can lead to trouble. And I always point out from the very beginning: this does 
not show me what you look like. This doesn't tell me anything about you. This is just a 
pattern. 
 
Likewise, general pediatrician Olivia noted that growth and development are the defining aspect of 
pediatric medicine and provided a natural opportunity to discuss any concerns. Olivia looked at the 




families that discordant trends for these two measures might be a cause for worry with respect to having a 
healthy weight. 
From a diagnostic perspective, situating BMI in this longitudinal, growth context also shifts the 
focus to potentiality and prognosis (Brown et al. 2011; Croft et al. 2015; Timmermans and Stivers 2018), 
encouraging practitioners to set aside the obese/non-obese diagnostic binary in favor of a more holistic 
perspective on future health. Joseph described how a future-oriented mentality influenced his diagnostic 
approach, given the uncertainty in what BMI means at a given point in time: 
Even if I have a kid who's at the 50th percentile for their BMI, but their intake is largely 
soda and unhealthy foods, I tend to spend a lot of time talking about future cardiovascular 
health and stuff. As opposed to, you know, only worrying about what their BMI looks 
like, or who's at the 84th percentile for BMI. But if they were at the 30th a year ago, and 
the 50th six months ago, I know that even though they're not even in an overweight 
category... if the appointment is three days later, they would be. So, it's not so much I 
have a different framework for obesity, specifically, in my head, but in terms of patients 
who I am more worried about and spend more time talking about nutrition and activity 
with, it’s people who habits are leaning towards unhealthy or people who's who are 
moving in the wrong direction. 
 
Later in the interview, Joseph described how his own children followed a non-standard trajectory of 
sharply increasing BMIs before suddenly falling into a healthier range. This recognition of looking 
beyond point-in-time estimates was echoed by pediatrician Tina, who is not “100% convinced that all of 
us belong on the same growth curve,” which makes it difficult to understand what a certain BMI means at 
a given point, or how to characterize a brief period of increased or decreased weight due to the complex 
interplay of genetics, the environment, and a host of other factors that practitioners cannot account for. 
Practitioners were not ignoring the health implications of an obese BMI; rather, they emphasized 
patterns and trends to signal concern about the child or adolescent patient as a hypothetical future adult 
patient – extending the BMI and health trajectory beyond early life. Practitioners’ prioritized prognosis 
and raised concern without diagnosing and labeling the child at present. Talking about other health 
conditions or diseases associated with obesity in adulthood provided practitioners with yet another 
strategy to acknowledge the lack of certainty in what obesity means as a diagnosis, and what BMI signals 




and Kathryn both used growth curves to initiate a conversation about maintaining a healthy lifestyle that 
helps children avoid “going down the road” (Kathryn) or “pathway” (Nancy) of higher risks for heart 
disease and hypertension. Joseph openly told parents that he “can’t look into a patient’s future,” but the 
fact that a child seems pretty healthy at the moment doesn’t mean he can “predict… what their heart is 
gonna be like 50 or 60 years from now.” He acknowledged that this could go either way, and that even a 
child with a high BMI can be fine, so his goal “isn't to make your weight X, Y, or Z in 2021 or 2022” but 
“to have you having healthy habits grow up… that are going to keep you healthier and alive longer.” As 
Elliott explained, clinicians are on a long-term trajectory with patients, and this relationship requires 
acting in a way that maintain this relationship. In talking about weight, Elliott adopted a neutral position 
in explaining that his goal is to work together with patients to make sure they are “not held back by any 
health issue” in the future, rather than providing a diagnosis and “tell[ing] them you have a disease.” 
Delaying diagnosis to maintain the patient-provider relationship 
 The emphasis on maintaining a working relationship with patients and families was a recurring 
theme throughout the interviews. Simply assessing a patient’s BMI was insufficient; practitioners also 
needed to ‘diagnose’ a child’s and family’s level of emotional and cognitive readiness to provide the best 
possible care. Rather than being prescriptive in their advice and course of treatment, respondents 
expressed a desire to “meet patients where they are” (Joseph) on this long-term trajectory of weight and 
health. In turn, clinical encounters focused on understanding and responding to ‘where’ the patients and 
families are rather than reacting to where the BMI is and what actions need to be taken. Nancy described 
this aspect of her clinical duties as “detective work” where a visit might start with patients and families 
telling you “everything is perfect, and then you start asking some questions and things start coming out… 
and suddenly you’re in the game.” Nancy knows there are no guarantees or certainties in how these 
conversations go, mentioning how a lot of the challenge is to “just try and fine tune it as you’re talking” 
in figuring out what children’s and parent’s concerns are and how to address them. Patricia explicitly said 
that it is “super boring to reflect upon the fact that that’s happening” in simply seeing that a child has 




decision is often based on incomplete information; Elliott explained that a patient might be a “10 out of 
10 on importance” in understanding the importance of losing weight, but a “2 out of 10 on confidence” 
and thus the priority becomes giving them “a framework of hope” and providing “some sort of 
affirmation of their value and worth and potential for change.” 
 In turn, practitioners were very open about how the diagnosis and treatment of childhood obesity 
is shaped by negotiation and compromise with patients and families to preserve the relationship and 
maintain “buy in” (Nancy). Patients are not always where practitioners “need them to be” in terms of 
“even thinking about changing” (Erin), and practitioners know that they are not going to make any 
progress until patients reach a baseline level of “finally wanting to set goals for themselves” (Joseph). 
This meant that a lot of the clinical protocols were accommodating of uncertainty in patients’ and 
families’ understandings of and beliefs about weight, obesity, and health. Many respondents described 
forgoing a clinical and diagnostic language to facilitate a working – rather than prescriptive – relationship. 
Family medicine clinician Robert, explained how emphasis on this long-term relationship shapes her 
diagnostic approach: 
I'm much, much more dedicated to this conversation because I'm now their primary care 
doc. I'm going to take care of them for a much longer period of time. And so I personally 
am more invested in making sure to have a thorough conversation and really explore: 
What does this mean? What does this weight mean to you? What does it mean for your 
body?... How can we start having a conversation that's valuable to you about changing 
some of the numbers that are valuable to me? And how can we do that together?... And 
then use that response as a way to move forward. 
 
Nancy also questioned how the things she said were interpreted, asking “What’s gonna mean the most?” 
in finding strategies that motivated patients since “I can tell people all day what I think they should do, 
but it may not be what they should do” based on where they are. This search for the interpretative 
meaning of diagnoses was difficult for practitioners because it runs against their training to “fix things 
and make them better” (Olivia); however, “changing the approach of the visit to be more collaborative 
and patient-centered” rather than just diagnosing children is important for “using what [patients] want” to 
structure care. Elliott also recognized how much of his training involved a “one size fits all approach” but 




conversation, like, we're going to do this, this, and this to granularly modify a particular number to our 
liking.” Rather, the trick was finding a “backdoor” into weight issues that works for individual patients. 
 Indeed, the interviews revealed uncertainty and apprehension in how explicit practitioners were 
when discussing weight and obesity; just because the clinical evidence suggested that weight merits 
attention does not mean that having a diagnostically oriented conversation was the best course of action. 
Later in the interview, Elliott explained that there is an “ideal situation [where] a young person is wanting 
in that moment” to have the conversation about weight, but that this is almost never the case. Elliott 
acknowledged that it is not a pleasant conversation to have or a diagnosis to hear, and the issue is not that 
he thinks he is saying “something that’s overtly wrong, or negative, but it’s just the timing” of the 
conversation being inappropriate. He maintained that “forcing the conversation in a particular direction 
because, clinically, I have to, or I’m supposed to in that moment” was unlikely to have a good payoff. 
Though it may run counter to clinical protocol, Nancy knew that it was important to “figure out where 
that family is in what they want to hear” because they might just “tune out if you bring up weight.” She 
instead changed the subject, knowing that “if I bring it up totally as something else, as a healthy, 
whatever, for whatever it is, they're more likely to hear” than bringing up weight. 
 In balancing this need to address weight as a health concern, while not imposing it on patients and 
families, respondents were comfortable extending the diagnosis of obesity over an extended period. 
Namely, in meeting patients where they are, practitioners set aside or delay the conversation about 
obesity, with the hope that both practitioner and patient interests are better aligned in the future. For 
instance, William explained that for some families the primary objective was simply “planting a seed” 
and then maybe “a year later, six months later, I am going to bring it up again, and they're gonna say, 
Well, you know, what, maybe we can talk about this a little bit more.” Joseph had a similar mentality 
about working with families to figure “what’s gonna work best for them” and to “know how far I can 
push them on things”: even if some families are incredibly responsive, for others “it’s almost like a one- 




in the larger narrative of patients’ lives and health, wherein a diagnosis of obesity might cause more harm 
than good: 
I think we all sort of acknowledge at some level weight is… an expression of a variety of 
things. And so I think it's helpful to try to sort of put it on the radar at some level [and] 
raise it as part of the conversation. But then to like, park it in a particular spot, and come 
back to it when it seems appropriate, right?... I see it as a long-term thing. And the only 
hope that I can help a young person with a long-term thing is if we engage in a long-term 
fashion…. And if I rush to judgment, and I sort of push my agenda upon them to do it 
like today, when they're not ready for that conversation, you know, I sort of see that as a 
loss, big picture, right? 
 
More broadly, nearly all respondents recognized that individuals – and especially children – were not 
ideal, rational actors who perfectly respond to health messaging and recommendations, and that there 
were many other factors at play influencing how a diagnosis related to weight and health is likely to be 
received and responded to. 
Defining Success Without a Diagnosis 
 Given these uncertainties in patients’ diagnostic trajectories, coupled with uncertainty in their 
cognitive and emotional preparedness to receive or act on concerns about weight and health, practitioners 
provided a broad definition of ‘success’ when it comes to characterizing patients’ and families’ progress. 
While weight loss may be the most obvious measure of success for a condition defined by weight, 
William noted the disconnect between the binary nature of a diagnosis and the nuanced reality of how and 
why a patient acquired this condition: 
It's unfortunate that we've gotten to this point of needing a number for… defining that 
cohort with no other way of defining kids that don't have other manifestations. And trying 
to hold that with the fact that there are 1000 different ways and 1000 different influences 
on that number. Yeah, it's just a weird thing. We have a disease that's defined by excess 
adiposity, which can be measured with two numbers. 
 
The emphasis on these numbers does not reflect the fact, as pediatrician Samantha explained, “in real life 
none of us have the same endpoint when we’re talking about our values for our own wellness, [which] are 
all over the map.” In that sense, practitioners like Elliott contended that patients can have legitimate 
definitions of success, and sometimes the doctor’s job is to assess the feasibility of their goals and 




observe the influence of thinking about patients on a trajectory in guiding these definitions of success, 
with pediatricians like Joseph explaining that the key question he asks himself when defining success for 
individual families is “where are you on your curve?,” knowing that the answer influences their 
probability of success. 
 In broadening their definitions of success to include patients’ and family’s input, many 
respondents were responsive to the notion that the field of medicine may, indeed, not have a “safe or 
reliable” way of keeping off weight (Greenhalgh 2015). Their challenge was instead to justify outcomes 
that adhered as closely as possible to safety and reliability – and thus sustainability – for the individual 
patients and families they work with. Tina recalled how in medical school she was taught “to be very 
prescriptive in care, meaning, we find a problem, we define that to the patient, and then we tell them what 
they do about it” but that this approach does not work with obesity; rather, she shifted towards “allowing 
[patients] to team with you, but really form their own plan, because they know themselves better than we 
do and what they are capable of and what they may or may not do.” Medical student Adele explained how 
this mentality helps her be more proactive when not seeing weight loss, leading her to ask “what’s been 
going on?” and probe deeper to realize that telling a patient to exercise after work might not be feasible as 
compared to just “taking the stairs at work, or taking a 10-minute walk break during lunch” as well asking 
them to generate ideas and then help tailor them. Elliott commented that many patients have well-
intended goals, but that they are “actually just not reasonable” or maybe “just kind of unfounded” even if 
they would result in a patient no longer having obesity. 
 Indeed, despite obesity being defined by BMI, this was rarely the key metric of success described 
by respondents. Many practitioners are happy to see patients’ BMIs decrease, but their preferred 
definition of a successful outcome involved a more holistic assessment of the patient. Nancy explained 
how “all of a sudden, [a patient’s] self-esteem is better, they have a healthier relationship with food and 
how they think about it, they have confidence to do whatever it is at a school…, they have more energy 
[were] all wins” even though “the weight didn’t change.” Likewise, pediatrician Joshua, who primarily 




focusing on a particular BMI,” telling patients that she wanted to make sure “you feel content in your 
body.” Approaching success from this perspective reinforced practitioners’ concerns about the utility of 
BMI as a diagnostic tool, especially if it contradicted patients’ experiences. Tina described how her 
definition of success has changed towards prioritizing “how the family feels like they’re doing” and “do 
they feel good about changes” even in those instances where “their weight is the same… or it's going up a 
little bit.” She was uncertain about how to proceed, explaining that: 
I don't want to show them the growth curves… I focus more on the history and follow up 
than I do in the actual numbers because it just feels like patients make a big change and 
sometimes those numbers don't confirm it. And that's just wrong. Like, why do I even 
bother? 
 
 The actions patients and families take to improve their health, and what the scale says or where 
their BMI falls on a growth chart, often follow different trajectories and time scales, especially in early 
life. Cognizant of this discordance, practitioners described goal setting and measures of success that may 
not comport with clinical standards of how we define healthiness and the types of behavioral changes that 
engender weight loss. In addition to the holistic emphasis described above, many practitioners focused on 
“really small things like… rather than drinking three bottles of juice a day, they’re going to drink one 
bottle” even if the practitioner did not want them drinking any juice (Kimberly). Similarly, G.P defined 
success as something as simple as “go[ing] for a walk around the block once a week”; she looks at their 
lab results and BMI but notes that “I really am mostly thrilled when they actually do the things that we 
discussed last time” or to even just “try” to do these things. Practitioners identified activities that are 
particularly important to children, like “joining a dance team” (Samantha) or “starting to play soccer” 
(Frederick), as worthwhile indicators when “things haven’t improved on the graph” (Frederick). Kimberly 
noted that some of these measures of success can “feel weird” and recounted an example of an 
endocrinologist who works with adults “cringing” when hearing about how the goals of obesity treatment 
are so low. However, Kimberly and other practitioners emphasized that if these are meaningful changes 




 Despite efforts to shift the nature of the clinical encounter and diagnosis away from obesity, many 
patients and families continued to define success based on weight, which provides a more direct and 
tangible measure than changes in behaviors and beliefs. Olivia talked about how she might try to focus on 
these small successes like “whether we were able to try a new vegetable every week,” but it is often the 
case that “parents are like, I don’t care” and the first thing they ask in in the visit is “What was their 
weight? Did they lose weight? Yeah, how much weight did they gain?” Patricia also noted this tension 
between trying to “celebrate the small behavioral changes” and encountering resistance among patients 
who “want to see weight loss” or having a mentality that “all their progress and changes are medical.” 
Samantha attributed this tension to confusion about BMI and the fact that “we’re a very weight-focused 
culture.” Even when she explains the concept of a BMI curve, how it varies across children and over time, 
and stresses the importance of long-term lifestyle changes, the response is a blunt: “Okay, I get it, and 
how much weight should she lose?... How much should he lose? What's an optimal weight for my child, 
like, the weight, pounds? Like that's sort of their focus.”   
Practitioners try to de-emphasize the importance of weight as a measure of success, but both 
patient’s and medicine’s desire for unambiguous and objective indicators of progress continues to be an 
obstacle. Respondents were sympathetic to patients’ and families’ confusion about what it means to be 
healthy based on weight, and how that intersects with social norms and expectations. Adele commented 
on how she’s seen “a provider be like, let’s try and climb the stairs more at work and a patient’s like, well, 
that’s not gonna get me to my 20-pound [weight loss] that I want to do.” She explained that this mentality 
meant that a lot of patients already felt like they failed when walking into the doctor’s office as the first 
thing they do is step on a scale and see the number is not where they want. Elliott was aware of this 
“super binary, black and white… success versus failure mindset” in patients that is “driven by the 
number”; thus, he tried to “diversify their view of what success could look like.” However, he knew that 
there was mixed messaging on BMI in the doctor’s office: “We spend so much time trying to like 
acknowledge the number and use it for what it's worth and recognize that it's a legit data point, but then 




emphasizing the importance of having a long-term view of weight and health, he tried to explain that 
patients should “not take too much stock in the number” because they “don’t truly have control over what 
the scale would say to you on a particular day” as opposed to looking at a trend over “a month or six 
months or a year” and how that is related to what you are doing. Samantha, who splits her time between 
research and practice, provided additional insight when comment on how much of the emphasis on BMI 
as an unequivocal measure of success comes from being “shoehorned into picking an outcome number, 
and that often is BMI, or relative BMI, or percent change or whatever”. These metrics are pervasive in the 
clinical and social context, but they do not always make sense for patients and families. Erika summarized 
this disconnect in the kinds of measures of success dictated by clinical standards and diagnoses as 
compared to the kinds of goals that work for individuals: 
I mean, this is, you know, qualitative versus quantitative, right? Where the only the only 
outcome that matters is did the BMI come down?... When actually, what if that kid feels 
stronger? What if that kid feels healthier? What if the goal of doing exercise wasn't to 
punish your body for eating?... Or toward losing weight? And if you don't lose weight, 
then you failed? What if it was like, my back doesn't hurt as much?... Or, you know, I can 
run and play with my friends, and I don't get tired?... What if those were our outcomes? 
And so I feel like those are the ones that actually matter. 
 
In turn, patience can be practitioners’ most valuable skill, in acknowledging and responding to the 
uncertainty in what works and why – and how long it might take – when it comes to seeing the weight 
loss that patients and families desire. Periods of plateauing or increases in weight may not be a signal of 
something being wrong, even if this is something that patients and families tend to fixate on. Frederick is 
very open with patients and families about the difficulty of seeing quick and clear improvements in 
weight, and gave an example of how he redirects questions like “what is my weight today?” towards his 
personal interest in “and emphasizes tangible accomplishments like looking for long-term changes in 
lifestyle [that] we hope will lead to healthier outcomes in the future” walking more. Olivia noted that 
having this patience, and maintaining positivity, is difficult to maintain when it’s hard to point to clear 
signs of improvement. Nevertheless, she described the importance of “focus[ing] on the loop” in terms of 




You know, we often have this conversation at that point where it's like, I'm doing all the 
right things, and I'm making all these changes – how come my weights not improving? 
It's a tough one. It’s hard to square. But I do try to be transparent with them that the 
changes are good, and that there are some parts of their health that they can't see that are 
improving. Usually though there is always something you can point to is better. It's not 
the number on the scale, like, they can run more laps or that, you know, they're thrilled 
that now they're eating vegetables. 
 
Samantha described how this patience and long-term mentality on the diagnosis and treatment of 
childhood obesity has a payoff. She recounted experiences where something has changed for the better, 
even if she was not certain about what exactly happened. She, and other practitioners, hoped it was a 
function of accumulated messages and behaviors over time, but also recognized that it could be due to 
factors shaping patients’ lives, weight, and health outside of the medicine entirely: 
I've had some families that have stuck with us for a really long time, like eight years, 10 
years. Like a really long time. To the point where their kids left home. It really took 
working on this for a long time and then something just like changed, you know, 
something just stuck… The behaviors they had to remind, remind, and remind and model 
and make the environment safe for healthy eating and blah, blah, blah, that they, they 
always had to push on it… All of a sudden, they turned 17 and the kids just decided to do 
it on their own. So there does seem to be an element of just sort of sticking with it, even 
through failure, you know, through hard times through not seeing body weight change, 
but just continuing to pay attention to it over time. 
 
Accounting for Social Sources of Uncertainty 
 Therein lies a final source of uncertainty for many practitioners working with patients and 
families: clinicians recognize that they play a minor part in the broader context of patients’ lives, and the 
many non-clinical reasons that help explain BMI trajectories. All respondents acknowledged the 
importance of non-clinical, social and structural factors as a key missing piece of information in their 
diagnostic assessments and resulting recommendations. As Erin explained, the physician’s role is to offer 
treatment and advice based on a diagnosis, but the major unknown in these encounters is whether 
“everything in [a patient’s] life being in a position for them to act on it.” Tina had the view that “this 
world just sets a lot of people up to be obese, just by living.” This made it hard for her to view obesity and 
her role in addressing it through a purely medical lens, explaining that “in medicine, we categorize 
everything based on a billing code, [which] are all clumped under something like the word disease when 




uncertainty in treating patients with obesity, reflecting on the challenges of understanding enough about 
patients to provide meaningful help: 
I think for me, the biggest thing is this is a clinical issue. And we sort of think about it 
medically… but it's kind of amplified and worsened and locked in by a lot of things that 
are just not medical. They're sort of out of out of the purview, and even out of line of 
sight of a clinician. And I think just the idea that I, as a clinician, can manage somebody’s 
weight… in brief visits every several months, without a full view of their social context, 
the, you know, inner workings of their emotional life, their financial wellbeing… There's 
a lot that goes into that. And so, I do feel like we're often flying blind, which is why, you 
know, we tend to cling so hard to like the number and specific things that we can like, 
just point to. But I tend to believe that for the vast majority of folks that we engage 
clinically, around this, that we just know the tip of their particular story, right? We don't 
know the full thing. And so when they come back, you know - IF they come back – and 
they've succeeded, or, you know, quote, unquote, or they haven't made progress, we're 
still blind, right? We really don't know the reality of what's going on.  
 
Elliott tied this uncertainty back to his original concerns that dealing with weight is often an issue of 
patients not having “confidence”; however, he now explained that it’s not necessarily an issue of 
confidence “in themselves, but in their circumstances.” These social aspects are hard to integrate into a 
medical, diagnostic lens, given that when he is defining the “problem statement” at the end of the visit, he 
realizes that “Oh, they're like, super poor… and there's no quick response to that.” 
 Many practitioners were quick to emphasize these social and structural factors when explaining 
the difficulty of responding to childhood obesity using traditional diagnostic protocols. Patricia explained 
that the standard protocol for diagnosis is to “talk to people about food intake and exercise… and then 
from there [it’s] like ‘Best of luck!’” in terms of knowing how the patients will act on this information. 
She knows there is much more that can be done for patients, in understanding issues of food insecurity 
and finding affordable and safe options for exercise, but “the problem is, this type of stuff to do the job… 
doesn’t occur in the 20-minute visit.” In an ideal world, practitioners could “prescribe food and activity” 
(Sandra), but this is not a right granted to health professionals. Adele commented on how “as with 
anything in medicine, I think like higher you raise your level of training, or rise in the ranks, you realize 
your own limitations, and I think it gets more and more frustrating that… there’s not that much in and 
individual moment you can do about it.” Indeed, many practitioners invoked income inequality, racism, 




to both their and patient’s success. However, Kathryn noted that even if clinicians are not able to directly 
intervene on these social determinants, “our roles as doctors have changed over the past several years” 
such that “we’re sticking our nose in, we’re investigating more aspects of our family’s life, rather than 
just looking at their blood pressure or some number on a piece of paper.” In turn, she found that “families 
are pretty receptive to it” and have “kind of accepted that this is the doctor’s role now” which involves 
“looking at the family more as a whole rather than just focusing in on the health problems.” 
 This broadening of clinicians’ responsibility and scope of practice to encompass non-clinical 
sources of uncertainty was reflected in respondents’ approaches to communicating with patients and 
families in a way that was sensitive to social influences. Practitioners realize they cannot use the same 
diagnostic protocol and apply the same standards of success to all individuals, cognizant of how their 
goals – and ability to attain them – is variable. Joseph explained how “no two families have the same 
situation,” with completely different barriers that he needs to be aware of. On the one hand, “for some 
families, they truly live in a place where they're not gonna be able to get healthy groceries… or to have a 
place where they can let their kids play outside without fear of, you know, gunshots and stuff.” On the 
other hand, even for a family that is “socioeconomically kind of in the dreamland,” the parents might both 
be “super busy career people” and not have time to be active with kids “because there is too much going 
on from work pressures and whatnot.” For Joseph, “the trick is to get on the same page” in figuring out 
what the specific barriers are. Kathryn echoed these concerns in explaining that “that you've definitely got 
to kind of assess the social situation a little bit more,” and then “kind of tailor your suggestions to that.” 
She also reflected on how diagnosis and treatment vary based on socioeconomic position, saying that “if 
I've got a more affluent family, who eat out all the time, because they can and it's not a resource problem, 
then we might make some suggestions from like, from the restaurants that they go, like let's look at the 
menus, let's look at the healthiest things they can pick; whereas I'm not going to do that for somebody 
who can’t afford it.”  
Practitioners explained that this tailored diagnosis and treatment is important in talking and 




of the person that needs to make the change” (Erin). Cassandra was explicit that “I don’t think 
[practitioners] should advise someone to do something unless they are really having some idea of the 
social context for this advice” and how it will be received. A lot of what people are doing is “a matter of 
habit and convenience and just like what they’re used to, or what they’re able to afford, or the food 
options available” (Sandra). Thus, the concern is creating a situation where following a diagnostic and 
treatment protocol centered exclusively on ‘fixing’ patients’ weight and health is counterproductive and 
results in a breakdown of the patient-provider relationship. To this end, Kathryn commiserated:  
I mean, how do I fix somebody's diet. Like, they can't afford to buy healthy food… I can't 
fix that. Specifically, I can give suggestions. I can give some low-cost healthy recipes and 
things like that. But I can totally see a family's struggle, and it must feel pretty bad for 
them – me telling them these are the things you need to do for your kids’ health. And 
they just can't do it for whatever reasons. I mean, that sucks. Everybody wants to have 
their kids be healthier… Knowing what you need to do, but just not being able to do it – 
it’s gonna feel pretty bad for the family. 
 
 Ultimately, the difficulty with childhood obesity is the fact that the diagnostic, prescriptive model 
of health often used in medicine does not lead to successful outcomes. Frederick reflected on his career-
long evolution in thought on childhood obesity in clinical settings, noting that he used to be far “more apt 
to be prescriptive of certain things the patient needed to do, because I’m the doctor and I’m supposed to 
tell you what you need to do.” Having seen this strategy fail on numerous occasions, he adheres to a more 
passive model of care, where the doctor’s authoritative, diagnostic role is less apparent. In maintaining 
positivity and preserving the patient-provider relationship, he is comfortable acknowledging uncertainty 
with patients, in seeing himself as “more of a partner, more of an advocate, who is here to try to be 
encouraging and to not promise more than I can about what’s possible.” 
Discussion and Conclusion 
Building on extant research on how uncertainty is managed in clinical settings (Berg 1997; 
Macintosh and Armstrong 2020) – and the utility of diagnoses as a source of certainty (Jutel 2014) – this 
study analyzed interview data from pediatricians and other health professionals working with young 
patients to understand the unique challenges of diagnosing and treating obesity in early life. As the results 




healthcare system that demands formal diagnoses and codes to help “put a name to” specific issues. Yet 
there is uncertainty about the clinical utility of these diagnoses and labels, as well as concern about their 
potential to undermine the provider-patient relationship. 
Thus, returning to the dilemma posed at the onset of this paper, how do practitioners make sense 
of imperfect and imprecise diagnostic tools, evidence, and criteria in addressing issues of weight, health, 
and overall wellbeing in early life? Though I do not claim to fully resolve this complex question, I use the 
findings to show how uncertainty is integrated into diagnosis and treatment and used to challenge medical 
standards and protocols. Clinicians acknowledge and capitalize on the uncertainty in the diagnosis of 
obesity to facilitate a better relationship with their patients and families. Moreover, uncertainty is an 
integral part of the diagnostic process, as it circumvents the needs for formal medical labels or language 
and offers pathways to treatment that reflect the needs and abilities of individual patients and families 
rather than adhering to “one-size-fits-all” solutions. By situating their young patients – and their BMIs – 
on a trajectory, clinicians counteract the biomedicalized framing of obesity as a sign that something is 
wrong and needs to be fixed in favor of a more socially-attuned view of weight and health as malleable 
processes that unfold over a lifetime.  
Specifically, the interviews demonstrate a consistent emphasis on framing childhood obesity in 
terms of prognosis rather than diagnosis. Emulating the prognostic framework (Croft et al. 2015; 
Timmermans and Stivers 2018), practitioners use children’s BMI trajectories as a diagnostic tool rather 
than focusing solely on their status at the time of the clinical encounter. Clinicians’ uncertainty about 
BMI as a measure of health is used to justify this approach. Patients’ BMIs are suggestive rather than 
declarative about their health at present and where it may be headed, which makes for an ineffective and 
unsatisfying “diagnosis,” to the extent that the label is used to provide clarity about a patient’s health 
(Jutel 2019). Thus, unlike the dominant conceptualization of diagnosis and disease in medical sociology, 
the clinicians in this sample actively choose to not “put a name to” obesity as a diagnosis to impose 




discern; clinicians still use a diagnosis of obesity for bureaucratic purposes, but this diagnosis is not 
verbalized because there may not be anything to formally diagnose beyond noting the child’s BMI.  
Extant theory on the sociology of diagnosis emphasizes its role as an explicit, disruptive label, 
demonstrating how the “diagnostic moment” serves as a point of cleavage in an individual’s social and 
health history and identity (Heritage and Macarthur 2019; Jutel 2014; Jutel 2019). However, this theory 
does not articulate a clear case for how we categorize diagnoses that are not shared with patients and thus 
do not provide this clear pre- and post-diagnosis moment of clarity intended to facilitate treatment and a 
path to wellness. The legitimization of obesity by way of diagnosis is the primary motivation for labeling 
it as a disease (Allison et al. 2008); yet the clinicians avoided the label, cognizant of how the meanings 
that obesity has outside of a clinical setting are not conducive to fruitful clinical interactions and care. 
Past medical sociological research on health and illness in early life emphasizes the concept of 
biographical disruption (Bury 1982), based on how children and young adults react and respond to being 
diagnosed with different conditions (Bray et al. 2014; Monaghan and Gabe 2015; Polidano et al. 2020). 
However, these theories are less applicable to a more fluid and less binary condition like childhood 
obesity, which is not treated as a formal diagnosis in clinical settings. 
Rather than treat this as an aberrant finding, I argue that the diagnostic process underlying 
childhood obesity provides novel insight on how a diagnosis can be continuously and smoothly integrated 
into an individual’s health narrative and trajectory. In avoiding the diagnostic moment, practitioners are 
no longer acting exclusively in response to the diagnostic label of obesity and the kinds of clinical 
guidelines and protocols designed to treat it. They feel free to talk around weight and obesity by focusing 
on the gradual, organic adoption of certain behaviors and lifestyles that promote better long-term health. 
The practitioners in this study consistently express a desire to engage in preventative, rather than 
prescriptive, care focused on future outcomes; in turn, they avoid direct emphasis on short-term weight 
loss as the only treatment befitting a diagnosis of obesity given that, medically-speaking, this is the only 




Beyond the implications for medical sociological theories of diagnosis, integrating uncertainty 
into the diagnostic process proves consequential for the kinds of relationships and interactions providers 
have with patients and families. Trajectories are not only a diagnostic tool in the context of childhood 
obesity; they also represent a diagnostic mentality that influences the nature of treatment and how 
practitioners and patients define success. Social diagnostic theory emphasizes the importance of diagnosis 
as a negotiation among the different stakeholders shaping the diagnostic process (Brown et al. 2011) – a 
sentiment which is echoed in the conceptual framework underlying prognosis as a more comprehensive 
model of care (Croft et al. 2015). This negotiation – or “meeting patients where they are,” as mentioned 
by many respondents – proves central to childhood obesity medicine, where clinicians are dependent on 
patients’ and families’ “buy in” to see some behavioral or lifestyle change. Treating childhood obesity is 
not a linear process, and clinicians acknowledge normal patterns of ebb and flow in their interactions with 
patients regarding their weight and weight-related behaviors. There is no guarantee, or certainty, that 
weight will be the focal topic of a given visit; patients may present with other health issues needing more 
immediate response or patients and families are not in an emotional or cognitive state to discuss weight. 
Indeed, these findings suggest that the role of emotion in the diagnostic process merits greater 
attention. Provider’s and patient’s “affect” – with respect to their emotional response during clinical 
encounters – is often framed as a source of unwanted bias (Kozlowski et al. 2017; NASEM 2015). 
Moreover, the underlying premise of a biomedical definition of diagnosis emphasizes rationality and 
certainty, seeking to minimize subjective sources of influence on clinical decision making (Marcum 
2013). Yet, patient’s emotional states readily influence childhood obesity diagnosis and discourse. 
Clinicians are not only evaluating patient’s weight and health, but also their emotional and cognitive 
capacity to instigate behavioral change, as an independent and valuable source of diagnostic information. 
As noted in the interviews, getting patients and families to a state where they can begin further discussion 





Relatedly, the acknowledgement of uncertainty in a patient’s trajectory of weight and health 
encourages providers and patients to arrive at mutual definitions of success that are not solely dictated by 
diagnostic criteria, such as dropping below a specific BMI. Many of the practitioners were comfortable 
with measuring success in more qualitative terms, based on how patients and families are feeling or what 
they are doing, even if the changes appear insignificant. While practitioners note the difficulty of 
exclusively relying on qualitative metrics in a field that values objective and numerical evidence, 
maintaining a long-term view of patient’s weight and health makes this uncertainty more tolerable. 
Namely, the lack of obvious signs of progress does not mean progress is not occurring. Unlike many 
health conditions diagnosed and treated in clinical settings, the timeframe for childhood obesity is fraught 
with uncertainty – if not stochasticity – in terms of when and why a child or adolescent may internalize 
certain weight-related beliefs and behaviors and attain a healthier BMI. This more passive approach to 
diagnosis and treatment speaks positively to a sociology of “doing nothing” (Scott 2018), which 
represents a plausible clinical approach amid ongoing concerns about overdiagnosis and overtreatment in 
the medical field (Armstrong 2021; Croft et al. 2015). This should not be interpreted as practitioners 
choosing to do nothing for their patients and families; rather, there is recognition that patience and 
vigilance is an appropriate course of action based on the limited knowledge on hand. 
Finally, these results provide empirical support for the theory that greater acceptance of 
diagnostic and clinical uncertainty leads practitioners to better engage with the wide range of social and 
non-medical factors shaping clinical encounters and patients’ health (Brown et al. 2011; Croft et al. 
2015). Though medicine, as a field, has elevated concern for social determinants of health over the past 
few decades, integrating these social factors into the practice of care remains a challenge (Metzl and 
Hansen 2014). The interviews demonstrate high levels of structural competency on the part of 
practitioners in recognizing that patients’ and families’ trajectories are shaped by their social 
environment. Indeed, there is considerable frustration – if not futility – among practitioners in reflecting 
on their individual ability to provide meaningful care that counteracts these structural forces. Recognition 




families as unique cases, rather than situating them within established clinical and diagnostic standards 
and guidelines. Practitioners acknowledge structural explanations for how and why certain patients and 
families do better than others. In turn, their communication with and expectations for these patients and 
families is contingent upon how ready and able the patients and families are to deal with weight and 
health at a given point in time. 
Limitations  
Prior to concluding with a discussion of how integrating uncertainty in diagnosis and treatment 
can inform future research on childhood obesity, I note the limitations of this analysis. First and foremost, 
the interview data come from a purposeful sample of childhood obesity practitioners whose views on 
weight and health may not be representative of the full spectrum of approaches among health 
professionals working with young populations. The relationship between weight and health is a pervasive 
issue in medicine, which many practitioners encounter on a regular basis: the challenge in this study was 
identifying respondents for whom childhood obesity is a key area of interest, but not the only health issue 
they encounter among patients. Consequently, most respondents were general pediatricians and medical 
students and residents interested in pediatrics. A larger sample could facilitate more in-depth comparisons 
of how childhood obesity is approached across different clinical subfields and specialty areas, such as 
endocrinology, gastroenterology, and rheumatology, where the role of obesity may vary based on both 
practitioners’ and patients’ concerns. Though I did not observe much variation based on providers’ 
background in this sample, it is worth noting that family medicine clinicians – who also deal with adult 
patients – tended to be more comfortable with “blunt” assessments of individuals’ weight and health, and 
more focused on weight loss. Likewise, medical students on surgical rotations noticed less apprehension 
about using BMI as a diagnostic tool among surgeons. Further exploring these sub-disciplinary 
differences could help uncover variation in diagnostic reasoning. 
Ideally, the practitioners’ perspectives in this study would be complemented by patients’ and 
family’s views to better illustrate the interpretation of diagnoses by all parties involved. An in-depth 




stakeholders shaping diagnosis as a process (Brown et al. 2011). I discuss how practitioners believe they 
arrive at mutual understandings of weight and health with their patients and families; yet, this may differ 
from patients’ and families’ interpretations of these same encounters and conversations, as noted in past 
literature (Lutz 2019). Cognizant of these limitations, this study limits itself to examining other aspects of 
social diagnosis, such as the emphasis on potentiality and patients’ future health and the structural sources 
of uncertainty that influence this diagnostic trajectory. The focus on practitioners – and openness to 
unexpected findings encouraged by abductive analysis (Timmermans and Tavory 2012) – allowed for a 
careful examination of growth curves/charts as both a diagnostic tool and diagnostic philosophy. I use 
these findings to suggest that uncertainty is openly acknowledged in clinical settings, as evidenced by a 
lack of clear diagnoses. However, directly observing clinical encounters could reveal important 
discrepancies in how practitioners recall their diagnostic strategy as compared to what they actually say 
and do in describing patients’ weight and health. 
Finally, the focus of the interviews on issues of diagnosis and uncertainty did not allow for a 
more comprehensive examination of how these topics intersect with patients’ and families’ identities and 
backgrounds with respect to gender, race and ethnicity, and socioeconomic status, among others. While 
respondents were well-aware of structural factors influencing patients’ trajectories and how that 
influenced the success of one patient as compared to another, this is an important topic that would require 
more focused questions geared towards understanding issues of social class and power dynamics in the 
context of clinical encounters. Likewise, many respondents understood the gendered nature of body 
weight and body image, and the need to tread more carefully when discussing these sensitive topics with 
girls versus boys, as well as how terms like “overweight” or “unhealthy” weight have very different 
cultural connotations. Unfortunately, the fairly limited time for interviews led to some inconsistency in 
how often these topics came up across respondents, and thus I did not feel it was appropriate to 
extrapolate from these conversations. It is interesting to note that a number of clinicians did not appear to 
be comfortable discussing about some of these topics – at least to the extent that they were explicit about 




However, this limitation uncovers an important – and heretofore unaddressed – question in 
medical sociology about the influence of structural factors and social identities on clinicians’’ 
management of uncertainty during diagnosis. Namely, how do clinicians’ perceptions of uncertainty about 
what body weight means for a child’s overall health and wellbeing – as well as their beliefs about how 
stigmatizing a conversation about body weight and health might be – change as a function of a patient’s 
background or identity? One can imagine that this question is further complicated by clinicians’ own 
background and identity. Critically, it is important to investigate whether and how these perceptions and 
beliefs affect patient outcomes and potentially shape population-level trends and disparities. 
Conclusion 
Uncertainty in the diagnosis and treatment of childhood obesity stems from the fact that health is 
a complex and multidimensional construct, and that medicine is rarely able to address a single dimension 
like body size without implicating many other aspects of individuals’ health and wellbeing. In keeping 
with Timmermans and Haas’s (2008) call for a sociology of disease – wherein distinct diseases, or 
conditions, serve as the units of sociological inquiry and analysis – this study examines the diagnosis of 
childhood obesity to better understand how practitioners evaluate body size as both a medical and social 
construct in the lives of their patients and families. The results document numerous challenges and 
sources of uncertainty in providing care. Clinicians are often tracking multiple metrics and aspects of 
physical, mental, and social health, which are not equally applicable to all individuals and operate on 
different time scales and trajectories; moreover, these trajectories are rarely linear or predictable. Patients’ 
BMIs are a central measure of progress – and the defining attribute of obesity as a diagnosis – but they 
can be a poor indicator of how patients and families are feeling and what they are doing to try and 
succeed. 
Despite the concern that the researchers and practitioners studying and diagnosing childhood 
obesity are perpetuating simplistic and harmful narratives about children and adolescents as ‘unhealthy’ 
and ‘diseased’ (Greenhalgh 2015; Moffat 2010; Saguy 2012; Shugart 2016), this study suggests that many 




comports with a more holistic understanding of health as more than the absence of disease or infirmity 
(VanderWeele 2017; VanderWeele et al. 2019). Practitioners working with youth encounter a variety of 
health issues and ailments; in many cases, they see entirely healthy patients with no concerns – as one 
would hope for children and adolescents. In this context, having too narrow a view or focus on weight is a 
liability, potentially leading them to overlook important information or cause harm by fixating on an 
attribute that is closely interlinked with many other domains of health and wellbeing. 
Maintaining this holistic view presents a challenge at the population level, where the focus is on 
broad interventions and solutions that have an impact at the aggregate level but may have no direct 
bearing on discrete individuals (Rose 1985). This tension is at the crux of the debate over obesity as a 
diagnosis and disease, wherein population-level narratives about weight and health often take precedence 
over the individual experiences and needs of people categorized by this medical label (Shugart 2016). 
Clinicians are actively “doing diagnosis” in this space between population and individual level health, 
making decisions about how much certainty to accord to aggregate-level medical knowledge when faced 
with conflicting and uncertain information about a given patient (Timmermans and Angell 2001). 
More importantly, population-level decisions about how we define and measure health – and 
what constitutes or counts as progress towards becoming healthier – are not always compatible with 
individual-level diagnoses and treatment. This is evident in the uncertainty and difficulty of reaching 
conclusive assessments about young patients based on a single data point. BMI provides a snapshot of a 
broader trajectory of health; measuring this trajectory is more informative, but it only reflects a single 
trajectory describing patients’ health, and only one way of tracking progress. Clinicians thus try to bring 
in additional information to form a more complete picture, which may complicate the otherwise ‘simple’ 
narrative provided by BMI alone. This study reveals myriad emotional, cognitive, and behavioral aspects 
of the diagnostic and treatment process that function independently of patients’ weight, but which are 
often more consequential for patients’ health. The discordance between these other outcomes and BMI 




mental, and social health is incomplete; thus, the diagnosis of obesity does not provide the clinical 
certainty desired by practitioners or patients.  
This disconnect underscores the importance of recognizing the reciprocal relationship between 
population- and individual-level health research and theory. The dominance of the evidence-based 
movement in medicine, and the influence of epidemiologic notions of screening and risk on clinical 
practice, demonstrate how population-based findings influence how practitioners view their patients, and 
the kinds of decisions and actions they take as a result (Armstrong 1995; Armstrong 2012; Armstrong and 
Eborall 2012). However, this downstream flow of scientific evidence and knowledge that creates and 
categorizes health can be reversed (Hacking 2007): the individual-level insights gained during clinical 
encounters – like the many non-diagnostic metrics used to assess patients and gauge progress in the 
treatment of childhood obesity – are an equally valuable source of evidence and knowledge that can 
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CHAPTER 3: POPULATION HEALTH AT EVERY SIZE?:BODY SIZE, CARDIOMETABOLIC 
RISK, AND EDUCATIONAL DISPARITIES IN MORTALITY AMONG U.S. ADULTS, 1988-
2015 
Introduction 
The growing proportion of adults classified as “obese” (in reference to a body mass index [BMI] 
exceeding BMI, per clinical definitions, rather than a qualitative descriptor) is a legitimate concern for 
researchers and policymakers seeking to improve population health in the United States. Reviews of 
large-scale epidemiologic studies consistently find that obesity is associated with elevated risk for many 
heart conditions, diabetes, cancer, and kidney disease (National Heart, Lung, and Blood Institute 
[NHLBI] 2013), as well as various other cardiometabolic conditions that account for the leading causes of 
mortality (Ahmad and Anderson 2021). In turn, the fact that over four-in-ten U.S. adults are now 
considered obese (Hales et al. 2020) – up from 30% only 20 years ago, and 14% in the early 1960s (Fryar 
et al. 2012) – has led to increasingly dire predictions about worsening health and declining life 
expectancy in the decades to come (National Academies of Sciences, Engineering, and Medicine 
[NASEM] 2021; Preston et al. 2018; Stokes and Preston 2016).  
At the same time, some scholars contend that this pessimism is misplaced, if not harmful, in 
perpetuating the belief that individuals’ body size is an accurate reflection of individuals’ underlying 
health and wellbeing (Saguy 2012; Shugart 2016). Decisions about how we conceptualize, define, 
measure, and then label health are consequential; many scholars note that obesity represents a crude 
categorization of individuals’ health status (Jutel 2009; Jutel 2011), whose issues are magnified by BMI 
being an imprecise measure of obesity as a state of excess adiposity (Burkhauser and Cawley 2008; 
Müller et al. 2016). Recent evidence suggests that many adults classified as obese are ‘misclassified’ as 
unhealthy, as they do not have a cardiometabolic health profile consistent with elevated chronic disease 
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risk; in fact, they are cardiometabolically healthier than many of their lower weight counterparts 
(Tomiyama et al. 2016; Wildman et al. 2008). Thus, with some estimates suggesting that over half of U.S. 
adults will be considered obese by the end of this decade (Finkelstein et al. 2012), more careful scrutiny 
of heterogeneity in a health condition that may soon categorize the majority of the U.S. population seems 
appropriate.   
More broadly, debates about the relationship between body size and health reflect the challenges 
of operationalizing health at the population Individuals’ health is rarely defined by a singular ailment, 
researchers have called for a more systems-wide approach to conceptualization and measurement that 
better accounts for the complexity and nuances of health, and the presence of multiple morbidities (Ahn et 
al. 2006; Barnett et al. 2012; Boyd and Kent 2014; Guthrie et al. 2012; Seeman et al. 2004). Indeed, 
current discourse on obesity assumes a relatively uniform distribution of risk at the population level, 
ignoring differing levels of severity (Sharma and Kushner 2009), and obscuring the fact that excess 
weight tends to be assumed as harmful even when co-occurring with more severe morbidities (Sharma 
and Campbell-Scherer 2017).  
National Heart, Lung, and Blood Institute guidelines for clinical practice already recommend that 
other risk factors are taken into consideration when evaluating obesity (Jensen et al. 2014). Fortunately, 
large-scale biomarker collection in nationally-representative surveys has facilitated the study of 
individuals as health systems rather than a collection of individual symptoms or risk factors. These data 
have been used to substantiate the presence of biological “phenotypes” of metabolically-healthy obesity 
(MHO) – as well as metabolically-unhealthy individuals without obesity – which have been theorized 
since the onset of the obesity epidemic in the United States (Ruderman et al. 1981). This research finds 
that individuals’ BMIs and the label of obesity are not definitive measures of their underlying health, as 
approximately one-third of adults with obesity do not exhibit cardiometabolic impairment (Smith et al. 
2019).  
Yet, in focusing on MHO as a biological phenotype and construct, researchers often neglect to 
consider how heterogeneity in body size and health is a function of social mechanisms, with MHO or 
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similar constructs representing social phenotypes as well. For example, socioeconomic disparities in 
obesity and cardiometabolic health are well-documented (Braveman et al. 2010; Krueger and Reither 
2015; Pampel et al. 2010), and often singled out as a key contributor to educational gradients in mortality 
and life expectancy in the United States (Cutler et al. 2011; Elo 2009; Vierboom 2017). To the extent that 
various combinations of these measures – such as metabolic syndrome and allostatic load – are socially-
patterned on the basis of education (Dowd et al. 2009; Loucks et al. 2007; Montez et al. 2016; Richardson 
et al. 2021; Seeman et al. 2010), we would anticipate that different profiles of body size and 
cardiometabolic health are not exclusively biologically-determined, and thus not randomly distributed 
throughout the population.  
The goal of this chapter is to assess the clustering, or co-occurrence, of obesity with other 
measures of adiposity and relevant cardiometabolic health risks and provide a better understanding of 
variation in body size and health at the population level. Rather than describe obesity and its threat to 
future health in monolithic terms, this study helps illustrate the importance of allowing for heterogeneity 
in how we think about and assess obesity and its risks for population health. Critically, extant research on 
education as a fundamental determinant of health – and key correlate of both obesity and cardiometabolic 
risk – provides a useful entrée for illustrating how a systems-wide, multimorbidity approach can provide 
insights on health disparities and educational gradients in mortality. Thus, rather than solely identifying 
groupings of body size and cardiometabolic risk, we can also examine their social patterning and estimate 
their contribution to educational disparities in premature mortality.  
The chapter begins by providing needed context on cardiometabolic health in the U.S. and the 
role of obesity, as well as reviewing extant research on heterogeneity in obesity and cardiometabolic risk 
and what past work suggests about educational attainment as a determinant of this heterogeneity. Using 
data from the National Health and Nutrition Examination Survey-Linked Mortality Files from 1988 
through 2015, I ask three key questions emergent from this literature. First, which body size and 
cardiometabolic health profiles best characterize U.S. adult population over the past decades? Past 
approaches tend to follow an a priori conceptualization of individuals as having or not having obesity and 
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having or not having elevated cardiometabolic risk – or just focus on MHO – without considering 
alternate possibilities, especially in using a more expansive set of comorbidities. Second, what is the 
association between these profiles and premature adult mortality risk in the United States? Though one 
may infer whether a given profile represents good or bad health based on the distribution of various 
comorbidities, validating these profiles based on their association with mortality risk allows for a more 
definitive assessment of their association with future health. Finally, how does the social patterning of 
these profiles explain educational gradients in mortality risk? These profiles of body size are likely to be 
unevenly distributed based on individuals’ educational attainment; knowledge of this broader spectrum of 
risk can identify which profiles are most consequential in accounting for higher mortality risk among 
adults with less education.  
Background 
Cardiometabolic Health in the United States and the Role of Obesity 
Despite recent downturns in U.S. life expectancy associated with opioid-related deaths and the 
COVID-19 pandemic, cardiometabolic dysfunction and disease has been the driving force behind 
improving trends in morbidity and mortality over the past 60 years (Ma et al. 2015). The broad spectrum 
of conditions associated with impaired cardiovascular and metabolic health account for the overwhelming 
majority of chronic diseases and leading causes of death in the U.S (National Center for Health Statistics 
[NCHS] 2021). While past decades have seen progress in declining rates of diabetes and cardiovascular 
disease-related mortality (Gregg et al. 2018; Koton et al. 2014; Ma et al. 2015; Mensah et al. 2017), as 
well as declining – or at least, non-increasing – prevalence of cardiovascular conditions like heart disease 
and stroke (Ford et al. 2014), the burden of poor cardiometabolic health remains considerable and may 
increase in the coming years (Masters et al. 2018; NASEM 2021). 
Over 30% of U.S. adults age 20 and above have hypertension (Fryar et al. 2017), approximately 
27% have some form of hypercholesterolemia (NCHS 2018), and over 26% of men and approximately 
9% of women have low levels of “good” high-density lipoprotein (Carroll and Fryar 2020), with 
increasing prevalence by age. Diabetes prevalence has seen a sharp increase in past decades as well; 
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whereas diabetes prevalence was under 1% in 1958 (Centers for Disease Control [CDC] 2017a), the 
current rate is over 9%, accounting for 30 million U.S. adults (CDC 2017b). Combined with an additional 
84 million considered “prediabetic”, over one-third of adults exhibit signs of impaired glucose regulation 
(CDC 2017b). Moreover, the prevalence of metabolic syndrome – a medical term for the clustering of 
cardiometabolic risk factors – is at an all-time high; anywhere from one-in-four to one-in-three U.S. 
adults present with multiple cardiometabolic morbidities, potentially indicative of an overall state of 
physiological dysregulation (Aguilar et al. 2015; Beltrán-Sánchez et al. 2013; Moore et al. 2017).   
Poor cardiometabolic health is seen as the consequence of the many unhealthy behaviors and 
lifestyles shaping contemporary society, which have replaced infectious disease, violence, and accidents 
as the major threats to population health (Olshansky and Ault 1986). In keeping with this perspective, 
obesity – or an “unhealthy” body size, more broadly – is typically the key factor implicated in the high 
prevalence of poor cardiometabolic health in the United States (Olshansky et al. 2005; Preston et al. 2014; 
Preston et al. 2018). This conclusion is not entirely surprising given the strong associations between BMI 
and many cardiometabolic diseases and associated causes of death (Mokdad et al. 2003; Sowers et al. 
2003; Steele et al. 2017; Van Gaal et al. 2006). Moreover, obesity and multiple cardiometabolic risk 
factors have seen parallel growth over past decades; while not indicative of causal associations, the 
correlation is concerning in its implications for the future of population health in the United States. 
Yet the overwhelming emphasis on body size as the singular determinant of poor cardiometabolic 
health has been challenged by recent efforts to promote a more holistic evaluation of health, recognizing 
multiple sources of risk and treating individuals as “systems” of comorbidities (Barnett et al. 2014; 
Bierman and Tinetti 2016; Salisbury 2012). For instance, a number of medical researchers and 
practitioners actively advocate against the conflation of individuals’ body size and their cardiometabolic 
health (Guo et al. 2014), recognizing that many adults who have obesity from a clinical perspective are 
not sick or diseased. This argument is rooted in the fact that “cardiometabolic risk factors confer much 
higher risk of diabetes, cardiovascular disease, stroke, and mortality than obesity per se” and a large 
proportion of obese adults are “devoid of metabolic syndrome risk factors” and thus “at markedly reduced 
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risk of cardiometabolic disease” (Guo and Garvey 2016: 524). Even the American Association of Clinical 
Endocrinologists and the American College of Endocrinology – which recognize obesity as a disease – 
emphasize that the binary classification of BMI as obese versus not obese is incommensurate with 
medical knowledge about the considerable heterogeneity in how it is observed throughout the population 
(Garvey et al. 2014). Specifically, they propose a more “medically-meaningful” diagnostic strategy that 
better recognizes variation and severity in “pathogenesis of obesity as a chronic disease”, allowing for 
greater “effectiveness of public health initiatives” (Garvey et al. 2014: 980). 
Health at Every Size 
Critically, most researchers and scholars expressing skepticism about obesity do not deny that 
there is a point at which body weight poses an issue; rather, the lack of a clear universal and biological 
threshold underscores the uncertainty in categorizing obesity as a state of poor health. For instance, 
almost a quarter of U.S. adults ages 30-74 in 2017-2018 fall within two BMI points of the clinical cutoff 
for obesity (based on author’s calculations), which is an approximately 13-pound range for an average 
adult. This not an insignificant amount of weight to gain or lose; but it is also not an immediately clear 
criteria by which to assess a meaningful change in health. Such narrow constraints on how we define 
health have significant implications, as millions of Americans are perpetually on the border between 
“good” and “bad” weight. In turn, relatively minor tweaks to BMI guidelines have substantial 
repercussions for how physicians, insurers, and the public at large perceive their health (Flegal 2010; Jutel 
2011; Kuczmarski 2007; Kuczmarski and Flegal 2000; Nicholls 2013).  
Recognizing these limitations, and better acknowledging diversity in weight and health, the 
central goals of the Health At Every Size movement (HAES), and similar initiatives, strive to promote 
good health rather than healthy weight (Bombak 2014; Bombak et al. 2019; Miller 2005; Penney and Kirk 
2015; Robison 2005; Tylka et al. 2014). There is a growing body of evidence to suggest that weight-
targeted interventions are often ineffective and unsustainable, emphasizing dietary and exercise regimes 
for which the only metric of success is a purely quantitative reduction in weight (Bacon and Aphramor 
2011; Kraschnewski et al. 2010; Mann et al. 2007). Many adults successfully and sustainably improve 
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many other cardiometabolic indicators that allow for better overall health and longevity (Bacon and 
Aphramor 2011; Mann et al. 2007; Tylka et al. 2014), suggesting that public health efforts may benefit 
from transitioning away from a “one size fits all” approach that treats weight loss as a panacea (Phillips 
2013). The discordance between individuals’ having an “unhealthy” body weight despite otherwise 
“healthy” measures of cardiometabolic functioning introduces doubt and dissatisfaction as to the overall 
utility of a clinical encounter or medical evaluation (Greenhalgh 2015; Saguy 2012). In turn, researchers’ 
and clinicians’ focus on weight can bias them towards ignoring other important signs and symptoms of 
both good and bad health (Puhl and Heuer 2009; Puhl and Heuer 2010), leading to skewed assessments of 
individuals’ health which only become magnified at the population level. 
Recent research sheds empirical light on these calls for a more holistic evaluation of weight and 
health, questioning the value of an exclusively body size-based measure of obesity as a measure of health. 
More detailed assessments of cardiometabolic health consistently find that a significant number of adults 
classified as obese are just as healthy, if not healthier, than their normal weight counterparts. Studies and 
meta-analyses of “metabolically-healthy obesity” (MHO) and “cardiometabolic risk clustering” among 
obese and non-obese adults finds that up to 40% of U.S. adults can be described as in good 
cardiometabolic health despite their having a BMI greater than 30 (Blüher 2020; Primeau et al. 2011; 
Stefan et al. 2008; Wildman et al. 2008). Likewise, many “normal” or “healthy” weight adults exceed one 
or more of the criteria for such risk factors as hypertension, hyperglycemia, and dyslipidemia, as well as 
more severe conditions like cardiovascular disease (CVD) and diabetes (Ahima and Lazar 2013; Aung et 
al. 2014). Granted, more long-term validation of the risk associated with MHO is mixed; some studies 
find that the relative risk of developing CVD, diabetes, and/or mortality (both all-cause and CVD-related) 
for metabolically-healthy obese adults is on-par or lower than their normal-weight counterparts (Appleton 
et al. 2013; Guo et al. 2014; Hamer and Stamakis 2012; Roberson et al. 2014), while others continue to 
find a small increased risk among otherwise healthy obese adults (Aung et al. 2014; Bell et al. 2014; 
Kramer et al. 2013; Kuk and Ardern 2009; Roberson et al. 2014). Critically, there appears to be no added 
risk associated with obesity when individuals already show signs of poor health (Kramer et al. 2013; 
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Roberson et al. 2014), reflecting how a narrow focus on obesity often ignores the large proportion of U.S. 
adults whose cardiometabolic profile portends higher risk of worse health and early death, even if their 
weight is considered “healthy” or “ideal.”  
Consensus on these studies is difficult to achieve because definitions of “metabolic healthiness” 
vary (Hinnouho et al. 2013; Primeau et al. 2011; Magkos 2019; Roberson et al. 2014). Despite their 
demonstrating broad variation in cardiometabolic health co-occurring with obesity, most studies continue 
to rely on fairly strict – albeit relatively arbitrary – definitions of poor cardiometabolic health, such as 
exceeding a risk threshold for at least one or two risk factors, or all risk factors, or based on a summed 
risk factor score/index (Blüher 2020; Magkos 2019; Phillips 2013). Critically, these approaches implicitly 
assume that these diverse indicators of cardiometabolic impairment are equivalent in their impact on 
individuals’ health. Yet, research has found that decisions about which combinations of measures to 
include in the definition of both obesity and cardiometabolic health are consequential for subsequent 
estimates of risk for worse health or mortality (Durward et al. 2012; Hinnouho et al. 2013; Pataky et al. 
2011), suggesting that subjectivity in how MHO is defined remains a key source of uncertainty in 
understanding the salience of this concept. 
Educational Attainment and Cardiometabolic Risk 
Research on MHO and similar concepts has been critical for broadening understanding of how 
body weight and cardiometabolic health co-occur in the population; however, the extent to which obesity 
is considered metabolically healthy or not is often framed as a biologically-preordained phenomenon that 
is randomly distributed throughout the population (Huang et al. 2017; Navarro et al. 2015; Telle-Hansen 
et al. 2013). Perhaps as a function of this research often being confined to medical and clinical settings, 
individuals’ “predisposition” for different phenotypes of obesity is described in terms of physiological, 
microbiotic, and genetic mechanisms underlying different body types, with additional considerations for 
the role of exercise and physical activity (Iacobini et al. 2019; Phillips 2013; Primeau et a. 2011). Yet, the 
role of larger social determinants underlying these processes cannot be ignored. While researchers are 
often careful to control for sociodemographic factors or note key correlates of MHO (Al-kaidi et al. 2019; 
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Wildman et al. 2008), to date there has been less attention to the social explanations for how these body 
size and health phenotypes are distributed throughout the population.  
Decades of sociological and social demographic research consistently find that population 
heterogeneity in health is not random, as fundamental causes of health like individuals’ socioeconomic 
status (SES) give rise to myriad beneficial resources and mechanisms that predispose highly-educated 
adults to have more favorable risk profiles (Link and Phelan 1995; Phelan et al. 2010). Though all 
educational groups have experienced increasing rates of obesity over past decades (Ljungvalla and 
Zimmerman 2012), highly-educated adults consistently have the lowest rates of obesity in the U.S. 
population, with less than three-in-ten adults with a college degree classified as obese as compared to 
over four-in-ten adults with lower educational attainment (Ogden et al. 2017). The many advantages that 
highly-educated adults tend to have – such as more disposable income, greater leisure time, better 
availability of healthy foods, and a higher probability of living in neighborhoods and communities that 
more easily facilitate physical activity – are all key mechanisms linking educational attainment to the 
types of health behaviors and lifestyles that we associate with individuals’ ability to maintain a ‘normal’ 
weight (Braveman et al. 2010; Krueger and Reither 2015; Pampel et al. 2010). Many of these same 
mechanisms underlie educational gradients in individual cardiometabolic risks and conditions like 
hypertension, hyperglycemia, and dyslipidemia (Kanjilal et al. 2006; Mensah et al. 2005; O’Rand and 
Lynch 2018). Recent evidence suggests that educational disparities across a broad array of 
cardiometabolic indicators emerge early in the life course, often many years before they present as clearly 
diagnosable conditions (Lawrence et al. 2018; Noppert et al. 2021).  
Given the associations between educational attainment and body size and cardiometabolic health 
– and the aforementioned links between obesity and a broad range of cardiometabolic conditions – it is 
unsurprising that a number of studies find educational disparities in metabolic syndrome and allostatic 
load. Though these constructs reflect different conceptual models of how and why individuals’ experience 
physiological decline, they are similar in using multiple measures of body size and cardiometabolic risks 
to present a more comprehensive profile of individuals’ health. Both Loucks et al. (2007) and Montez et 
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al. (2016) find anywhere from 25-75% higher probability of metabolic syndrome among adults with a 
high school degree or less as compared to those with greater educational attainment. Likewise, Dowd et 
al. (2009) and Seeman et al. (2010) both note a consistent, graded relationship between lower education 
and higher allostatic load in their reviews of past literature – though Dowd et al. contend that the 
cardiometabolic components of the allostatic load measure appear to be the key source of disparities. 
Once again, emerging evidence on emerging cohorts of young adults suggests that educational disparities 
in both metabolic syndrome and allostatic load present in early adulthood (Kane et al. 2018; Richardson 
et al. 2021), despite these constructs traditionally being measures associated with ‘aging’ and chronic 
‘wear-and-tear’ on the body. 
Despite the persistence of educational disparities in obesity and cardiometabolic risk across 
multiple indicators and dimensions of health – and focus on these disparities as an explanation of 
socioeconomic disparities in life expectancy (Elo 2009) – relatively few researchers have explicitly 
examined their role as mediators for educational gradients in mortality in the United States (Cutler et al. 
2011; Seeman et al. 2004; Vierboom 2017). Vierboom’s (2017) finding that approximately 10% of 
educational disparities in mortality risk are explained by differences in weight status is consistent with the 
minimal-to-modest contributions of individual cardiometabolic risk factors observed in non-U.S. data 
(Dégano et al. 2017; Dowd and Goldman 2006; Glei et al. 2013; Kershaw et al. 2013). Critically, there 
has been less research on multifactorial constructs like allostatic load, despite recognition that a failure to 
account for “multi-systems” approach to studying health has been a limitation of past research (Seeman et 
al. 2004; Seeman et al. 2008), and acknowledgement that health risks typically cluster together (Kershaw 
et al. 2013). Seeman et al. (2004) find that over a third of educational disparities in mortality (based on 
more or less than a high school education) were explained by an allostatic load index; however, their 
sample consisted exclusively adults in the 70-79 age range. Moreover, results from non-U.S. samples 
yield mixed results. For instance, Kim et al. (2018) find that allostatic load mediated less than 7% of the 
relationship between socioeconomic status and mortality in a sample of Korean adults, while Glei et al. 
(2013) observe ~20% mediation between education and general health in a sample of older Russian 
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adults. To my knowledge, there is no research examining the how the clustering of multiple 
cardiometabolic risks accounts for educational disparities in mortality for a more broadly representative 
sample of U.S. adults. 
In summary, though the formal, clinical definition of obesity is entirely based on individuals’ 
having a BMI of 30 or higher, recent evidence points to multiple “phenotypes” of obesity given 
heterogeneity in how body size co-occurs with other cardiometabolic risk factors of concern. Recognition 
of these phenotypes is critical in challenging the paradigmatic conceptualization of obesity as a binary 
state of health (Blundell et al. 2014), further emphasizing the importance of looking at a more expansive 
set of risk factors and biomarkers in helping to make assessments of how body size and cardiometabolic 
health are distributed throughout the population (Al-kaidi et al. 2019). However, past research and theory 
has largely focused on population heterogeneity in obesity as a function of biological and genetic 
mechanisms, failing to consider how a key social attribute like educational attainment structures 
individuals’ abilities to have a ‘healthy’ body size or a ‘healthy’ cardiometabolic risk profile, or both, or 
neither.  
Specifically, I examine broad sets of anthropometric and cardiometabolic measures used in this 
line of research to document probabilistic – rather than deterministic – groupings of body size and health 
in the US adult population. Rather than strictly rely on cross-sectional assumptions about the risk 
associated with these groupings, I examine their relationship with premature mortality risk across 
different causes of death to help validate this probabilistic approach and provide a substantive 
interpretation of what these groupings mean for long-term health. Finally, I examine how individuals’ 
educational attainment intersects with these groupings in demonstrating the “social” – rather than 
biological – patterning of these phenotypes and how they help to explain educational disparities in adult 
mortality risk. 
Data 
The data for these analyses come from the National Health and Nutrition Examination Survey 
(NHANES), a nationally-representative survey of U.S. adults combining extensive sociodemographic and 
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health questionnaires with clinically-assessed physiological and anthropometric measurements across a 
broad range of health outcomes (NCHS 2017). NHANES uses a stratified, multistage probability sample 
that is representative of the civilian noninstitutionalized U.S. population. Each survey participant is 
subject to a household interview with questions on their sociodemographic characteristics and multiple 
domains of health and health-related behaviors. Participants also undergo a comprehensive physical 
examination by trained health technicians in a mobile examination center, who collect data on multiple 
anthropometric and physiological metrics using standardized measuring procedures and equipment. Due 
to these rigorous data collection procedures, NHANES data are often considered the “gold standard” for 
assessing population health in the United States (Dillon et al. 2020). 
Critical to this study, NHANES data have been merged with mortality data, pooling from a 
variety of databases such as the National Death Index and the Social Security Administration, with a high 
probability of successful matches (NCHS 2019). In order to maximize the number of cases for identifying 
variation in body size and cardiometabolic health, as well as to ensure a sufficient sample size for 
subsequent analyses of mortality risk, this projects pools data from NHANES III (1988-1994) and 
continuous NHANES, collected biennially from 1999 through 2014. Due to concerns about respondents’ 
privacy in publicly-available data, information on cause of death is limited to ten broad categories through 
December 31st, 2015. This study focuses on all-cause mortality risk, but also presents results for causes 
of death where (1) hypertension or (2) diabetes is noted as a contributing cause, as well as (3) only heart 
disease-related deaths, and (4) a final fourth category of causes of death including heart disease, diabetes, 
and cancer. 
The primary variables of interest – i.e., the measures of body size and cardiometabolic health that 
I use to identify the different “phenotypes” – consist of self-reported and physical measurements, 
reflecting both diagnosed and undiagnosed conditions. There are numerous biomarkers of health in the 
NHANES data; I focus on measures that are comparable to those used in past research on metabolic 
syndrome and allostatic load, or that are plausibly associated with body size, rather than including any 
and all measures of individuals’ health risk (e.g., heavy metal blood tests). Additionally, these measures 
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were chosen to ensure as much harmonization across the survey cycles as possible given that NHANES 
varies testing protocols and measures across years. Specifically, the measures fall into four broad 
categories:  
(1) Body size and history, including: the “standard” measure of obesity based on a BMI of 30.0 
and higher; whether individuals ever were considered obese based on BMI calculated from 
their highest ever reported weight; whether individuals were classified as obese 10 years ago 
or at age 25, also calculated from retrospective reports of weight; whether their waist 
circumference to hip circumference exceeds gender-specific ratios associated with an 
unhealthy distribution of body fat (0.9 for males; 0.85 for females [World Health 
Organization 2011]); and whether the ratio of their waist circumference to height ratio 
exceeds 0.5, which has been proposed as a more generalizable measure than waist 
circumference on its own in suggesting increased risk for central adiposity (Ashwell and 
Gibson 2012; Baioumi 2019; Schneider et al. 2010). The inclusion of retrospective weight 
measures is a key addition to research on multimorbidity, as individuals’ BMI at time of 
survey provides a limited snapshot of their body size and does not allow researchers to 
understand individuals’ weight history. The latter point has been a key area of concern in 
recent years, with a number of studies suggesting that retrospective measures provide more 
accurate assessments of the population burden of obesity by correcting for biases due to 
illness-related weight loss among individuals who previously were obese (Stokes and Preston 
2016). 
(2) Cardiovascular health, including: a resting pulse rate exceeding 100 beats per minute, as 
indicative of tachycardia (Mayo Clinic 2020); measured pre-hypertension, based on an 
elevated mean blood pressure reading at examination (≥120 mm Hg for systolic or 80 for 
diastolic [Muntner et al. 2018]); and diagnosed hypertension based on individuals’ having 




(3) Dyslipidemia, including: measured high cholesterol, based on elevated total cholesterol at 
examination (≥200 mg/dL [Davidson 2020]); diagnosed high cholesterol based on 
individuals’ having been given a diagnosis of high cholesterol by a physician or currently 
using cholesterol-lowering medications; measured high triglycerides at examination (≥150 
mg/dL [Davidson 2020]); and measured high apolipoprotein B at examination (≥100 mg/dL 
[Paredes et al. 2019]). 
(4) Hyperglycemia, including: measured hemoglobin A1c percentage (providing a ~three-month 
average of blood sugar based on what percentage of hemoglobin proteins in the blood are 
glycated, or coated with sugar) greater than or equal to 5.7%, indicative of a pre-diabetic state 
(Dansinger 2020); measured high blood glucose in serum or plasma (≥100 mg/dL [fasting] or 
≥200 mg/dL [non-fasting] [Khatri 2019]); measured high fasting insulin level (≥25 mIU/L 
[Melmed et al. 2015]); and diagnosed diabetes based on individuals’ having been given a 
diagnosis of diabetes by a physician or currently using antidiabetic medication. 
(5) Other relevant measures, including: measured high C-reactive protein at examination (≥3.0 
mg/L), indicative of a high-risk, elevated inflammatory state (Pearson et al. 2003); and 
evidence of albuminuria or kidney damage, defined as albumin-to-creatinine ratio in urine 
greater than or equal to 30 at examination (Mayo Clinic 2021).  
NHANES provides continuous versions of the biomarker and anthropometric measures used in 
the analysis; however, I choose to dichotomize the indicators for two key reasons. The first is to maintain 
comparability between these analyses and extant work focusing on the co-occurrence of distinct 
“comorbidities” as measures of underlying health (i.e., the aforementioned literature on metabolic 
syndrome and allostatic load). Though scholars have noted that clinical cutoffs are often a function of 
arbitrary – and/or bureaucratic – decisions about how to operationalize health (Jutel 2011; Timmermans 
and Epstein 2010), they allow for easier interpretability of the various measures and what they imply 
about individuals’ risk. Secondly, dichotomized categories are well-suited to this study’s overarching goal 
of explicitly challenging core assumptions about obesity as a binary state, in demonstrating that the same 
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category of “unhealthy” body size corresponds with different levels of underlying risk. Using a binary 
conceptualization of health across these measures can also help to reveal the limitations of said categories 
for understanding heterogeneity in population health. Nevertheless, I consider alternate specifications and 
combinations of measures as part of the sensitivity analyses. 
Educational attainment is the key non-health measure used in the analyses, as a general indicator 
of individuals’ SES. While there are many ways to operationalize SES, education is the most common 
measure in research on health because it typically precedes attained occupation or income (Elo 2009), and 
is less prone to reverse causation bias (Seeman et al. 2008). This is not to suggest that educational 
attainment is the most important social factor associated with obesity and cardiometabolic health; past 
studies consistently document important gender and racial/ethnic disparities in body size and various 
indicators of cardiometabolic dysregulation, as well as at the intersection of the two (Borrell et al. 2010; 
Geronimus et al. 2006; Geronimus et al. 2010; Hargrove 2018; Levine and Crimmins 2014). Rather, this 
study focuses on educational attainment in response to the mixed findings identified in past research on 
the role of obesity and cardiometabolic health as a mediator between SES and subsequent morbidity and 
mortality. I acknowledge that the meaning of educational attainment for health exhibits considerable 
variation on the basis of gender and race/ethnicity (Goldman et al. 2006; Kimbro et al. 2008; Ross et al. 
2012; Ross and Mirowsky 2010), but these additional analyses are challenging with the more limited 
sample sizes in the NHANES Linked Mortality Files, as described later. 
Educational attainment is categorized as less than a high school education, a high school degree 
or GED equivalent, some college education or an associate’s degree or equivalent, or a college education 
or greater. I also control for survey year, individuals’ age, gender, and race/ethnicity based on NHANES-
defined categories (“White” [non-Hispanic], “Black” [non-Hispanic], “Mexican-American,” “Other”), 
nativity, income-to-needs ratio based on federal poverty thresholds adjusted for inflation and family size 
(0-0.99; 1.00-1.99; 2.00-3.99; 4.00+), smoking status (“Never,” “Former” [ever smoked 100 cigarettes, 
but currently does not], “Current”), and health insurance coverage. These controls were chosen because 
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they are measured relatively consistently across the NHANES years I used and they help address issues of 
confounding often neglected in research on adiposity and mortality (Stokes and Preston 2016).  
The final analytic sample is limited to adults ages 30-74 at time of survey/examination, with the 
exclusion criteria being pregnant women, adults who did not participate in the clinical examination, and 
those who are not eligible for mortality follow-up because of very poor identifying information. Mortality 
is assessed through age 85 or the end of the calendar year of 2015. The sample includes 40,095 adults, 
with 7,106 deaths during the follow-up period. In sum, this represents 417,076 person-years, with an 
average follow-up duration of about 10.4 years.  
Methods 
Using the above-mentioned measures of body size and cardiometabolic risk, I first use Latent 
Class Analysis (LCA) to identify different profiles of health based on the probabilistic co-occurrence of 
these measures across the adult population. LCA is a commonly used form of finite mixture modeling, 
allowing researchers to identify “unobserved” groupings or relationships among variables given a broad 
array of possible combinations and no clear a priori theoretical or empirical guidance on how these 
variables may be clustered (Masyn 2013). It is an increasingly popular technique in health research, 
allowing researchers to identify meaningful groupings of health behaviors and outcomes amid the 
numerous measures available in contemporary health surveys (Collins and Lanza 2010; Lanza and 
Rhoades 2013; Kongsted and Neilsen 2017), such as in identifying patterns of multimorbidity among 
adults (Larsen et al. 2017; Olaya et al. 2017; Schüz et al. 2009; Whitson et al. 2016). Indeed, Larsen et al. 
(2017: 2) note that “multimorbidity is a highly complex phenomenon, and the vast variety of disease 
combinations makes it a difficult phenomenon to analyze”, hence “[i]t is hardly practical to describe the 
prevalence and health outcomes of every conceivable disease combination, and much information is lost 
if multimorbidity is explored solely by counting disorders or applying one of several disease severity 
indices.” 
 Consequently, LCA is a less reductive approach as it divides the population into groups 
representing distinct and meaningful patterns based on individuals in the same group “shar[ing] a 
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common joint probability distribution among the observed variables” (Larsen et al. 2017: 3). Unlike its 
close analogue of confirmatory factor analysis, LCA draws on a covariance matrix of individuals to 
uncover latent groups of individuals, rather than to uncover latent constructs drawn from a matrix of 
items or measures (Bauer and Curran 2004). In other words, the focus is on identifying logical 
relationships and patterns among respondents which might otherwise be missed with interindividual, 
variable-centered analyses (Ferguson et al. 2020). 
LCA is particularly useful for this study because extant research makes it difficult to anticipate 
how many classes one might expect to observe based on this set of indicators, or exactly what they would 
look like in terms of their composition. Based on the consistency in the health profiles observed in past 
research on MHO, I would not be surprised to observe the emergence of four groupings of body size and 
cardiometabolic health that are consistent with four-way categorization implied by dichotomizing both 
body size and cardiometabolic health as either healthy or unhealthy. However, I do not rule out the 
possibility that the groupings proposed in past literature are limited by researchers’ focus on identifying 
these exact combinations of body size and health in their data (i.e., pre-defining and then identifying 
“phenotypes”). While concern about the data, rather than hypothesis, driven nature of LCA is warranted 
(Schmiege et al. 2018), this approach can be instructive when there is a lack of clear theory, as in this 
case. Thus, LCA can help confirm extant theory on how body size and cardiometabolic health co-occur, 
refute these theories outright, or – as is likely the case with something as complex as health – augment 
extant theories with novel and interesting categorizations that may not be anticipated.  
An additional useful aspect of LCA is its ability to efficiently handle missing data given the many 
indicators being used in these analyses. LCA uses a maximum likelihood estimation, assuming data are 
missing at random (Muthén and Muthén 2017). Indeed, actual missingness due to nonresponse is very 
low in NHANES; in these analyses, the majority of missing cases are attributable to their systematically 
not being asked in a given year or among a given portion of respondents (e.g., only those respondents 
being examined in the morning session to ensure fasting). For missingness among covariates in 
subsequent analyses, multiple imputation with chained equation is used, creating 10 imputed data sets 
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corresponding with the 10% missingness on the full set of covariates (White et al. 2011). Throughout all 
stages of the analyses, NCHS-provided survey weights are used per the method suggested by NHANES 
when pooling across multiple NHANES cycles of data (NCHS 2021). 
In identifying the optimal number of classes that describe these NHANES data – and U.S. adults 
more generally – I examine changes in model fit statistics (AIC, BIC) with an increasing number of 
classes, where lower values are preferred, as well as conduct likelihood ratio tests which compare the 
nested k and k+1 class solutions, with a significant p-value suggesting the k+1 solution is not necessarily 
a better fit (Nylund et al. 2007). I also consider how well-differentiated these classes are, indicative of 
how accurately the indicators identify distinct groupings of individuals (Masyn 2013). A measure of 
entropy is often used as an “omnibus index” where values greater than 0.8 suggest individuals are 
accurately sorted into individual classes (Clark and Muthén 2009; Nylund-Gibson and Choi 2018). The 
average posterior probabilities (AvePP) provide additional information about how well a hypothesized 
model categorizes individuals into a given class as compared to one of the other options; values greater 
than 0.7 for the most-likely class indicate good separation (Nylund-Gibson and Choi 2018). Ensuring that 
the classes are well-differentiated is critical for these analyses, as evidence of a poorly-separated model 
would suggest considerable measurement error in the assignment of classes, and thus biased estimates in 
any subsequent analyses predicting membership into classes and estimating the association between 
classes and a distal outcome (Asparouhov and Muthén 2014; Bray et al. 2015). 
Finally, the substantive interpretation of a given class – based on conditional probabilities – is 
important in identifying meaningful and plausible groupings, as is the relative size of the class within the 
population (Nylund-Gibson and Choi 2018). Focusing on the indicators of body size and cardiometabolic 
risk used in the analyses, LCA assigns an individual membership to a certain class based on a maximum 
likelihood estimate of their inclusion probability. These classes are in turn defined by conditional 
probabilities representing the likelihood that an individual within that class is likely to be characterized by 
a specific measure of body size or cardiometabolic risk. For instance, individuals in a class similar to the 
“metabolically-healthy obesity” phenotype noted in past research may have a >80% conditional 
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probability of having obesity but relatively low conditional probabilities (<40%) of having hypertension 
or dyslipidemia. Conversely, a “metabolically-unhealthy” normal-weight individual may have a <20% 
conditional probability of having obesity but higher conditional probabilities (>60%) of other measures of 
poor cardiometabolic health. 
Having identified the best-fitting and substantively-meaningful number of latent classes 
describing body size and cardiometabolic health risk, I estimate the association between these classes and 
premature mortality risk. Survival time is measured using detailed information on individuals’ month of 
birth and death: discrete time-to-event Poisson regression models are used to obtain estimates of relative 
mortality risk (i.e., odds ratios) for different latent classes, relative to the referent group (or whichever 
would appear to be the lowest-risk, in this study). Specifically, I construct person-year file, wherein each 
individual has a record for each full or fraction of a year contributed at a specific age between 30 and 85 
(Keyes et al. 2018).  
Pursuant of the objective of understanding how these groupings of body size and cardiometabolic 
health are related to individuals’ educational attainment, I predict membership into the latent classes using 
multinomial logistic regression models, with latent classes as the outcome and educational attainment as 
the focal independent variable. To facilitate easier interpretation, I present these results as marginal 
probabilities and average marginal effects (Williams 2012), showing how the distribution of the different 
latent classes varies based on individuals’ educational attainment in both unadjusted and adjusted models. 
In the final analyses, I combine information on educational attainment and mortality into a single 
model to estimate how much of the educational gradient in mortality is explained when accounting for the 
different distribution of latent groupings of body size and cardiometabolic risk across individuals. As 
death is defined as a binary outcome – and the resultant model assumes a logistic regression – simply 
comparing the change in coefficients after adding covariates, as in an OLS model, is likely to lead to 
biased results. Karlson, Holm, and Breen (2011) refer to this as an issue of “rescaling,” in the sense that 
the underlying latent variable corresponding with the probability of death is unobserved and thus differs 
between models as a function of the other covariates that included/excluded. Thus, standard comparisons 
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across models are misleading in failing to account for the confounding introduced by the outcome 
variable having a different underlying scale in each model (Breen et al. 2018). Their proposed solution – 
which can be applied using the “khb” command in Stata (Kohler et al. 2011) – distinguishes changes in 
the coefficients due to this “rescaling” from the changes that occur due to adding variables to the model 
(i.e., the substantive changes of interest).  
Given that these are cross-sectional data linked to longitudinal death records, I cannot definitively 
claim that these models represent a true “mediation” analysis, in the causal sense. However, this approach 
is consistent with extant research assessing how educational disparities in mortality risk change when 
accounting for plausible intermediate health mechanisms like body size and various biomarkers for 
cardiometabolic health. The Karlson, Holm, and Breen (KHB) method outlined above provides a more 
formal framework for making these comparisons of coefficients across models as compared to manually 
calculating the difference, as in past studies (Seeman et al. 2004). Moreover, this method not only 
estimates how much these latent classes mediate educational disparities in mortality, but it also estimates 
how much the individual classes contribute to these differences (Breen et al. 2013), providing novel 
insight on which groupings appear to be most influential. 
Results 
 As seen in the weighted, descriptive statistics in Table 3.1, NHANES is a nationally-
representative sample of the U.S. adult population over the last three decades. Given that 50% of the 
sample is drawn from the NHANES III cycle – which is the largest single NHANES data collection on 
record – the overall sociodemographic profile skews slightly towards the earlier portion of this period. 
The average age is 49, 51% of respondents identify as female, and about 15% are foreign born. The 
sample is majority non-Hispanic White (74%); non-Hispanic Black adults represent 11% of respondents, 
Mexican-American adults (who are over-sampled in NHANES), represent approximately 6% of 
respondents, and the remaining 9% are a broad category of respondents with a racial/ethnic background 
that is not represented by the above categories. Educational attainment is fairly evenly distributed among 
the four categories, with 26% adults having a four-year college degree or more, 24% having some college 
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education or an associate’s degree (or equivalent), 29% having a high school degree or equivalent, and 
approximately 21% having less than a high school degree. The modal income-to-needs category is a ratio 
of 4.00 or higher (35.1%), followed by 2.00-3.99 (34.5%), 1.00-1.99 (18.7%), and 0-0.99 (11.7%). About 
86% of respondents had health insurance coverage, and just under half had never smoked (47%), while 
approximately a quarter of respondents were former or current smokers (28% and 26%, respectively). 
Finally, 18.7% of respondents were determined to be deceased based on NCHS data linkages during the 
follow-up period. 
Table 3.1 Descriptive Statistics, National Health and Nutrition Examination Survey-Linked Mortality 
Files, 1988-2014, Ages 30-75 
            
      
    95% C.I. 
Age (μ)  48.8 48.5 49.2 
Survey Cycle     
 1988-1994 50.0% 47.7% 52.2% 
 1999-2000 5.44% 4.99% 5.88% 
 2001-2002 6.23% 5.62% 6.84% 
 2003-2004 6.03% 5.29% 6.77% 
 2005-2006 6.17% 5.33% 7.01% 
 2007-2008 6.31% 5.54% 7.08% 
 2009-2010 6.44% 5.67% 7.20% 
 2011-2012 6.62% 5.64% 7.61% 
 2013-2014 6.79% 5.93% 7.65% 
Female  51.4% 50.7% 52.0% 
Race/ethnicity     
 NH White 73.8% 71.9% 75.7% 
 NH Black 10.9% 9.94% 11.8% 
 MX-American 5.84% 5.15% 6.54% 
 Other  9.45% 8.33% 10.56% 
Foreign-born  15.2% 13.7% 16.6% 
Education     
 Less than HS 20.8% 19.5% 22.1% 
 HS or equal 28.9% 27.8% 30.0% 
 Some college 24.3% 23.4% 25.1% 
 BA or higher 26.0% 24.7% 27.4% 
Income-to-needs ratio    
 0-0.99  11.7% 10.8% 12.7% 
 1.00-1.99  18.7% 17.8% 19.6% 
 2.00-3.99  34.5% 33.2% 35.8% 
 4.00+  35.1% 33.3% 36.8% 
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Health insurance 86.3% 85.2% 87.3% 
Smoking status    
 Never  46.7% 45.5% 47.9% 
 Former  27.8% 27.1% 28.6% 
 Current  25.5% 24.5% 26.5% 
      
Proportion  
"determined deceased" 
18.7% 17.6% 19.7% 
         
Sample size   40,095     
      
Notes:      
Estimates and associated confidence intervals account for 
NCHS-provided survey weights. 
Estimates and associated confidence intervals based on  
multiple imputation to account for missing data. 
 
 Table 3.2 presents the weighted distributions of the body size and cardiometabolic health 
measures used to construct latent classes, as well as notes on the number of respondents with available 
data, which years the data come from, and how the measures are constructed (corresponding with the 
earlier explanation in the “Data” section). Once again, these indicators are representative of the entire 
time period covered by the NHANES data, and are thus slightly skewed towards population health 
patterns from the earlier years of the data range. For instance, approximately 31% of respondents have 
obesity at time of survey, which is lower than the current estimate of 40% referenced earlier (Hales et al. 
2020). However, 42% of adults were ever considered obese based on retrospective measures. 
Approximately one-in-five adults (19%) report having obesity 10 years ago, and only 7.5% report having 
obesity at age 25. In terms of other anthropometric measures, the majority of adults are at risk for central 
obesity based on the waist-to-height ratio (78.4%), as well as having an unhealthy distribution of body fat 
based on their waist-to-hip ratio (71.9%), though the latter measure is only available in the NHANES III 
data from 1988 to 1994. 
 With respect to cardiovascular health, just over 1% of respondents had a dangerously elevated 
pulse rate at time of examination; however, 57% of adults had a blood pressure reading consistent with 
elevated risk of poor cardiovascular health, and approximately three-in-ten adults reported having 
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received a diagnosis of hypertension or were using antihypertensive medication. Similarly, 54% of 
respondents had elevated levels of total cholesterol, and three-in-ten were told they had high cholesterol 
by a doctor or were currently on cholesterol-lowering medications. Approximately 37% of adults had 
high triglyceride readings, and 39% had elevated levels of Apolipoprotein B, though the latter measure 
was only collected among morning session participants from 2005 through 2014. Under a quarter (23%) 






Table 3.2 Distribution of Latent Class Indicators, National Health and Nutrition Examination Survey- 
Linked Mortality Files, 1988-2014, Ages 30-75 
            
    95% C.I. 
 N used in LCA  Availability  Notes on measures 
Body Size and History          
 
Obesity  30.8% 29.9% 31.8%  39567  1988-2014  
Obesity defined as BMI ≥ 30.0; Body 
Mass Index (BMI [kg/m2]) based on 
measured height and weight at 
examination. 
 
Ever obese 41.7% 40.6% 42.7%  38847  1988-2014  
Ever obese defined as maximum BMI ≥ 
30.0; Maximum BMI based on 
measured height at examination and 
highest ever recalled weight. 
 
Obesity 10 years ago 18.8% 18.0% 19.7%  32586  1988-2014  
Obesity 10 years ago defined as BMI 
10 years ago ≥ 30.0; BMI 10 years ago 
based on measured height at 
examination and recalled weight from 
10 years ago. 
 
Obesity at age 25 7.54% 7.07% 8.03%  37691  1988-2014  
Obesity at age 25 defined as BMI at age 
25 ≥ 30.0; BMI at age 25 based on 
measured height at examination and 
recalled weight from age 25. 
 
Waist-to-hip 71.9% 69.7% 74.0%  10714  1988-1994  
High waist-to-hip ratio defined as 0.9 
for males and 0.85 for females; Waist-
to-hip ratio based on measured waist 
circumference and hip circumference at 
examination. 
 
Waist-to-height 78.4% 77.4% 79.3%  38189  1988-2014  
High waist-to-height ratio defined as ≥ 
0.5; Waist-to-height ratio based on 
measured waist circumference and 
measured height at examination. 
Cardiovascular          
 
Pulse  1.28% 1.14% 1.44%  38663  1988-2014  
High pulse rate, or tachycardia, defined 








Hypertension (M) 57.4% 56.4% 58.3%  38724  1988-2014  
High blood pressure, in the pre-
hypertensive range, defined as mean 
systolic blood pressure ≥ 120 mm Hg 
or diastolic blood pressure ≥ 80 mm Hg 
at examination. 
 
Hypertension (Dx) 29.5% 28.6% 30.3%  39938  1988-2014  
Hypertension based on received 
diagnosis or use of antihypertensive 
medication. 
Dyslipidemia          
 
High Chol. (M) 53.5% 52.3% 54.7%  37933  1988-2014  
High cholesterol, in the "abnormal" 
range, defined as measured blood 
cholesterol ≥ 200 mg/dL at 
examination. 
 
High Chol. (Dx) 29.6% 28.8% 30.5%  39133  1988-2014  
High cholesterol based on received 
diagnosis or use of cholesterol-lowering 
medication (e.g., statins). 
 
High Trigly. 36.9% 35.6% 38.2%  37862  1988-2014  
High triglycerides, in the "abnormal" 
range, defined as measured blood 
triglycerides ≥ 150 mg/dL at 
examination. 
 





High ApoB (Apolipoprotein B), in the 
"abnormal" range, defined as ≥ 100 
mg/dL at examination. 
 
Low HDL 22.6% 21.6% 23.6%  37841  1988-2014  
Low HDL (high-density lipoprotein), in 
the "abnormal" range, defined as 
measured blood HDL < 40 mg/dL at 
examination. 
Hyperglycemia          
 
High HbA1c 20.6% 19.5% 21.6%  38338  1988-2014  
High HbA1c (hemoglobin A1c), in the 
"prediabetic" range, defined as ≥ 5.7% 
at examination. 
 
High Glucose 42.5% 41.3% 43.6%  38157  1988-2014  
High glucose, in the 
"prediabetic/insulin resistance" range, 
defined as glucose in serum or plasma 
≥ 100 mg/dL (fasting) or ≥ 200 mg/dL 












High insulin level, indicative of 
"insulin resistance," defined as fasting 
insulin ≥ 25 mIU/L; Morning 
examination to help ensure fasting 
levels among participants. 
 
Diabetes (Dx) 7.66% 7.27% 8.07%  40062  1988-2014  
Diabetes based on received diagnosis or 
use of antidiabetic medication. 
Other           
 
High CRP 31.0% 29.6 % 32.4%  30476  1988-2010  
High CRP (C-reactive protein), 
indicative of a high-risk "inflammatory 
state/response," defined as ≥ 3.0 mg/L 
at examination. 
 
High Alb.-to-Creat. 1.26% 1.13% 1.42%  39223  1988-2014  
High albumin-to-creatinine ratio in 
urine, indicative of microalbuminuria 
or kidney damage, defined as ≥ 30 at 
examination. 
                        
            
Notes:            




Turning to indicators of hyperglycemia, approximately one-in-five adults had a high hemoglobin 
A1c reading suggesting consistently elevated levels of blood sugar for the past three months. Likewise, 
over 40% of respondents had elevated levels of blood glucose, and 7% of respondents had high insulin 
levels, though insulin was only collected for fasting participants in the morning session across all survey 
years. Approximately 8% of respondents had received a diagnosis of diabetes or were currently taking 
antidiabetic medication. Finally, approximately three-in-ten adults had a level of C-reactive protein 
consistent with an elevated inflammatory state, though these data were not collected in the 2011-2012 and 
2013-2014 NHANES cycles. Just over 1% of respondents had an albumin-to-creatinine ratio in their 
blood consistent with evidence of microalbuminuria or kidney damage. 
 Based on this set of body size and cardiometabolic indicators, I address the first research aim by 
using LCA to examine how these measures co-occur within the U.S. adult population. Table 3.3 
summarizes changes in fit statistics as the estimated number of latent classes increases from two to six 
across models. In general, all of the models appear to be well-differentiated based on the entropy and 
AvePP for classification: the entropy is above or near 0.8, and the AvePP consistently exceeds 0.7. Both 
the entropy and AvePP decline across classes, but these measures have to be contextualized among other 
measures of fit in helping to determine the best model. Namely, the likelihood ratio tests (Vong-Lo-
Mendell-Rubin and Lo-Mendell-Rubin) comparing adjacent class solutions help to rule out the six-class 
solution based on the non-significant test result and the emergence of a fairly small class (5%). Likewise, 
the likelihood ratio tests help to rule out the two- and three-class solutions, as the significant test result for 
the k+1 classes (three and four, respectively) suggest that a four-class solution is preferred to both.   
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Table 3.3 Fit Assessment for Models with 2-6 Latent Class Solutions 
           
 Measures of Fit  
Likelihood 
Ratio Test of 
K/K-1 
Solution 
 Additional Diagnostics 















2 Classes 611376 611729 611599  0.000 0.000  0.880 0.964 39% 
3 Classes 593315 593848 593651  0.000 0.000  0.862 0.909 30% 
4 Classes 584432 585146 584882  0.000 0.000  0.847 0.869 12% 
5 Classes 581173 582067 581737  0.062 0.063  0.807 0.840 10% 
6 Classes 577952 579027 578630  0.184 0.186  0.794 0.817 5% 
                      
           
Notes:            
National Health and Nutrition Examination Survey, 1988-2014, Ages 30-75. 
Estimates account for NCHS-provided survey weights. 
Non-significant LRT indicates K-1 class solution preferred over K class solution. 
Entropy >0.8 indicative of good separation of individuals into classes. 
Average posterior probabilities >0.7 indicative of well-separated classes. 
 
 By contrast, there is some ambiguity in deciding between the four- and five-class solution. As 
seen in Figure 3.1, the AIC, BIC, and SSA-BIC values decrease across models, but there is no clear 
“elbow” in the trend at either the four- or five-class solution to suggest a large improvement after which 
there is leveling-off in fit (Nylund-Gibson and Choi 2018). The advantages of the four-class solution are a 
slightly higher entropy and AvePP, as well as a marginally non-significant likelihood ratio test compared 
to the five-class solution. However, Chen et al. (2017) warn that likelihood ratio tests have a tendency to 
“over-extract” the correct number of classes in large-N samples, such as these data. Consequently, I 
examine estimates from the conditional item probabilities to see if the five-class solution offers 




Figure 3.1 AIC, BIC, and Sample Size Adjusted BIC Across Latent Class Solutions 
 
As seen in Table 3.4, the conditional probabilities from the five-class solution suggest five fairly 
distinct groupings of body size and cardiometabolic health. Approximately three-in-ten U.S. adults (28%) 
are described by an “Ideal” latent class, in reference to their very low conditional probabilities of having 
any of the body size or cardiometabolic risks considered in these analyses. Indeed, the highest conditional 
probabilities are for waist-to-hip, waist-to-height, measured hypertension, and measured high cholesterol, 
but none of them exceed 34%. On the opposing end of the risk spectrum, one-in-ten adults (10%) are 
represented by a High Risk group, based on their high conditional probabilities of key risk factors across a 
majority of measures. These individuals have a greater than 80% conditional probability of current 
obesity, ever having obesity, and being at risk for central obesity, as well as the highest probability of 
having obesity 10 years ago (65%). They also have higher probabilities of measured or diagnosed 
hypertension (~75%) and high hbA1c or glucose (>80%); while the conditional probabilities for high 
insulin and diagnosed diabetes are lower (40% and 53%, respectively), they are higher than any other 








2 Classes 3 Classes 4 Classes 5 Classes 6 Classes
AIC, BIC, and Sample Size Adjusted BIC
Across Latent Class Solutions
AIC BIC SSA BIC
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Table 3.4 Conditional Item Probabilities for 5-Class Solution 
           
  "Ideal"  
(28%) 


















Body Size and History  
        
 Obesity 0.50% 
 68.10%  4.10%  85.2%  83.5% 
 Ever obese 2.20% 
 100%  11.7%  100%  100% 
 Obesity 10 years ago 0.00% 
 42.6%  0.00%  41.8%  65.4% 
 Obesity at age 25 0.00% 
 22.9%  0.00%  15.0%  24.4% 
 Waist-to-hip 30.0% 
 73.6%  93.3%  96.9%  97.1% 
 Waist-to-height 33.9% 










 Pulse 0.70% 
 1.10%  1.30%  1.20%  3.40% 
 Hypertension (M) 30.3% 
 51.5%  68.1%  75.6%  79.0% 
 Hypertension (Dx) 7.40% 










 High Chol. (M) 33.6% 
 29.7%  69.2%  80.7%  48.6% 
 High Chol. (Dx) 11.2% 
 15.4%  38.7%  43.1%  49.8% 
 High Trigly. 5.80% 
 12.9%  49.7%  72.3%  61.7% 
 High Apob 10.1% 
 5.10%  60.1%  93.5%  32.5% 
 Low HDL 6.20% 










 High HbA1c 4.10% 
 8.30%  20.8%  18.0%  84.7% 
 High Glucose 19.7% 
 28.2%  50.9%  48.5%  87.1% 
 High Insulin 0.40% 
 3.70%  3.80%  10.9%  40.0% 
 Diabetes (Dx) 0.60% 










 High CRP 12.4% 
 45.6%  28.8%  42.8%  65.5% 
 High Alb.-to-Creat. 0.20% 
 0.40%  1.10%  0.60%  6.80% 
                      
           
Notes:           
National Health and Nutrition Examination Survey, 1988-2014, Ages 30-74. 
Estimates account for NCHS-provided survey weights. 
 
Interestingly, between the “Ideal” and High Risk group, I find that a majority of adults (62%), fall 
into what might be described as intermediate risk classes. Closer to the “Ideal” class, 13% of adults can 
be described as “Fat but Fit” – to use the language of past research on MHO – in the sense that they are 
virtually indistinguishable in their cardiometabolic health from adults without obesity. As seen in the 
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conditional probabilities, this group is more likely to have obesity (68%) or to have ever had obesity 
(100%), as well as to have risks of central adiposity (>70%). Yet, with the exception of measured 
hypertension (52%), only high C-reactive protein exceeds 30%. The Mixed Health without Obesity class 
is the modal group (35%), representing the inverse of the “Fat but Fit” class. Their probability of ever 
having had obesity is very low, yet they have elevated probabilities of a number of cardiometabolic risks, 
like measured hypertension (68%), measured high cholesterol (69%), high glucose (50.9%), and a high 
level of apolipoprotein B (60%). Granted, their conditional probabilities for high waist-to-height and 
waist-to-hip ratios are elevated as well, exceeding 90%. Finally, there is a Mixed Health with Obesity 
group, resembling the former group in terms of their cardiometabolic risk, but not quite having the 
consistently elevated risk profile associated with the High Risk group. The conditional probabilities of 
obesity, ever having obesity, or being at risk for central obesity exceed 85%, while the conditional 
probabilities for measured hypertension, measured high cholesterol, and high triglycerides exceed 70%. 
This group also stands out for having the highest conditional probabilities of high levels of apolipoprotein 
B (93%) and low levels of HDL (40%). 
Compared to the four-class solution (Table A.1 in Appendix), there are key similarities with 
regards to the “Ideal,” High Risk, and Mixed Health groups. However, the five-class solution offers an 
important substantive addition of the aforementioned “Fat but Fit” class, as well as greater differentiation 
in how cardiometabolic risk is distributed among the other intermediate groups. Per the recommendation 
by Nylund et al. (2007), Figure 3.2 presents a linear plot comparing the conditional probabilities across 
the four- and five-class solutions to help differentiate between the two. Both models echo some of the 
basic findings about metabolically-healthy/unhealthy obesity/non-obesity in past research; however, the 
added nuance provided by the five-class solution without an appreciable decrease in fit leads me to 




















Conditional Item Probabilites for 4-Class Solution
"Ideal" (29%) "Mixed" Health
w/ Obesity (25%)












Conditional Item Probabilities for 5-Class Solution
"Ideal" (28%) "Fat but Fit" (13%)




Having identified the five-class solution, I address the second research aim of “validating” these 
classes in estimating their associated mortality risk and, thus, their implications for long-term health. In 
these models, I use the “Ideal” class as the baseline, anticipating that this group of individuals should 
have the lowest mortality risk due to the substantially lower conditional probabilities of both high body 
size and worse cardiometabolic health. As seen in Table 3.5, this assumption is accurate; all of the four 
other classes have significantly higher mortality risk relative to the “Ideal” group. In these unadjusted 
models, the “Fat but Fit” group still has higher relative risk (OR 1.57 [1.34-1.84]), but this risk is lower 
than both of the other Mixed Health classes, whose relative risk is similar to one another (OR ~2.65). 
Unsurprisingly, the High Risk group has the highest relative risk of early death, more than sixfold higher 
than the “Ideal” comparison (OR 6.11 [5.30-7.05]). This pattern is repeated across all causes of death, 
though the smaller counts of death in the underlying diabetes, underlying hypertension, and heart disease 
categories result in very large confidence intervals and less reliable risk estimates for the smaller High 
Risk class. Even after adjusting for the additional covariates described earlier, all classes are associated 
with increased risk relative to the “Ideal” group (Table A.2 in Appendix). However, the magnitude of the 
risk is substantially reduced, such that the High Risk group is associated with a twofold increase in risk 
(OR 2.04 [1.77-2.35]) and the three other groups are very similar to each other, indicating a ~30% 
increase in mortality risk relative to the “Ideal” group. Interestingly, the “Fat but Fit” group is not 







Table 3.5 Cause-specific Mortality Risk Across Latent Classes 


































                        
5-Class Solution  
(ref. "Ideal") 
                   
 "Fat but Fit"   1.57 1.34 1.84  1.52 0.62 3.74  1.88 1.04 3.40  1.35 0.84 2.15  1.35 1.10 1.65 
 Mixed Health w/ 
Obesity 
 2.72 2.36 3.14  5.52 2.74 11.1  4.28 2.53 7.24  4.11 2.95 5.72  2.76 2.31 3.29 
 Mixed Health w/o 
Obesity 
2.57 2.22 2.98  7.55 3.77 15.1  5.61 3.08 10.2  4.18 2.99 5.85  2.61 2.16 3.16 
 High Risk   6.11 5.30 7.05  51.6 26.4 101  18.0 10.4 31.1  11.88 7.82 18.1  6.24 5.02 7.77 
                        




  7,106   1,017  1,014  1,395  3,502 
                        
Notes:                       
National Health and Nutrition Examination Survey, 1988-2014, Ages 30-75. 
Deaths restricted to ages 30-85. 
Estimates account for NCHS-provided survey weights. 
Estimates based on multiple imputation to account for missing data. 
 
89 
In the final section of the analyses, I address the goals of the third research aim by examining the 
association between individuals’ educational attainment and how these different latent classes of body 
size and cardiometabolic health are distributed throughout the population. As seen in the predicted 
probabilities from a multinomial logistic regression in Figure 3.3, the distribution of these “phenotypes” 
is far from random, and clearly socially-patterned on the basis of individuals’ educational attainment. The 
overall distribution of classes is more favorable among higher-educated adults as compared to those with 
less education – especially those with less than a high school degree, who are nearly half as likely to be in 
the “Ideal” class (19% vs. 39%), and three times more likely to be in the High Risk group (15% vs. 5%). 
Those with a high school degree or some college education are fairly similar to one another, with a 
distribution in between the two ends of the education spectrum (~27% in “Ideal” and ~10% in High Risk). 
Interestingly, however, the three intermediate risk groups are fairly evenly distributed across all four 
levels of educational attainment. College-educated adults are least likely to be “Fat but Fit” (11%), 
whereas those with some college education are most likely to be represented by this group (17%). Mixed 
Health with Obesity is least prevalent among the highly educated (10%), but fairly similar across other 
groups (~15%). Finally, the fairly high risk set of individuals with elevated cardiometabolic health but not 
considered obese constitute about a third of all four educational groups, albeit being more highly 




Figure 3.3 Multinomial Predicted Probabilities for 5-Clas Solution 
 
Table 3.6 provides a more formal comparison of these predicted probabilities based on average 
marginal effects (AME) from both unadjusted models (the same as the results in Figure 3.3) and adjusted 
models, where all covariates are held at their means across individuals. While the AMEs decline in the 
adjusted models, the general pattern noted above remains the same, as seen in the much larger differences 
in the lowest and highest risk groups contrasted with small and non-significant differences across the 
other latent classes. For example, there is a graded relationship between educational attainment and 
membership in “Ideal” group, ranging from an 11.1% lower predicted probability among those with some 
college education relative to a college degree, to a 15.5% lower probability among those with less than a 
high school education compared to those with a college degree. The inverse pattern is observed for the 
High Risk group. Differences in the intermediate groups are less apparent, with no significant difference 




























Less than HS HS or equal Some college BA or higher
Multinomial Predicted Probabilities for 5-Class Solution
"Ideal" "Fat but Fit" Mixed Health w/ Obesity Mixed Health w/o Obesity High Risk
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Table 3.6 Average Marginal Effects for Educational Attainment Across Latent Classes 
   "Ideal" 
   Unadjusted 
 Adjusted 
   
 95% C.I.   95% C.I. 
Education (ref. BA or higher)       
 Less than HS -19.9% -22.5% -17.4%  -15.5% -18.1% -12.9% 
 HS or equal -12.5% -14.6% -10.4%  -12.3% -14.3% -10.2% 
 Some college -11.7% -14.7% -8.74%  -11.1% -13.8% -8.29% 
          
   "Fat but Fit" 
   Unadjusted 
 Adjusted 
   
 95% C.I.   95% C.I. 
Education (ref. BA or higher)       
 Less than HS 1.46% -0.16% 3.08%  2.69% 0.85% 4.52% 
 HS or equal 1.96% 0.61% 3.31%  2.19% 0.81% 3.57% 
 Some college 5.63% 4.15% 7.11%  4.14% 2.68% 5.60% 
          
   Mixed Health w/ Obesity 
   Unadjusted 
 Adjusted 
   
 95% C.I.   95% C.I. 
Education (ref. BA or higher)       
 Less than HS 3.80% 2.16% 5.44%  4.29% 2.11% 6.48% 
 HS or equal 4.45% 2.80% 6.09%  4.57% 2.79% 6.35% 
 Some college 4.45% 2.65% 6.3%  4.16% 2.32% 5.99% 
          
   Mixed Health w/o Obesity 
   Unadjusted 
 Adjusted 
   
 95% C.I.   95% C.I. 
Education (ref. BA or higher)       
 Less than HS 4.95% 2.33% 7.56%  1.77% -0.99% 4.54% 
 HS or equal 1.13% -1.31% 3.56%  0.87% -1.63% 3.37% 
 Some college -2.17% -4.65% 0.32%  -0.29% -2.66% 2.09% 
          
   High Risk 
   Unadjusted 
 Adjusted 
   
 95% C.I.   95% C.I. 
Education (ref. BA or higher)       
 Less than HS 9.71% 8.53% 10.9%  6.71% 5.27% 8.15% 
 HS or equal 4.97% 3.77% 6.17%  4.64% 3.34% 5.93% 
 Some college 3.80% 2.91% 4.68%  3.04% 2.11% 3.96% 
                    
          
Notes:          
National Health and Nutrition Examination Survey, 1988-2014, Ages 30-75. 
Estimates account for NCHS-provided survey weights. 
Estimates based on multiple imputation to account for missing data. 
Adjusted for educational attainment, age, survey year, gender, race/ethnicity, nativity, income-
to-needs ratio, health insurance, and smoking status. 
 
The full set of AMEs for all covariates used in the adjusted models is included in the Appendix 
(Table A.4). Briefly, the AMEs generally follow expected patterns based on past research on 
 
92 
sociodemographic measures and health. Age is inversely related with the probability of being in a higher-
risk class; female respondents are more likely to be represented in the lower-risk “Ideal” and “Fat but Fit” 
groups; non-Hispanic Black and Mexican-American adults are less likely to be in the “Ideal” group and 
more likely to be in the High Risk group relative to non-Hispanic White adults. Interestingly, being a 
current smoker relative to never smoking is associated with a higher probability of being in the “Ideal” 
group and a lower probability of being in the High Risk group; however, it is important to note that 
smoking is associated with weight loss and a lower BMI (Stokes and Preston 2016), and not necessarily 
positively associated with all of the specific cardiometabolic risk indicators under consideration (e.g., 
measures of hyperglycemia). 
For the final set of analyses, I consider how differences in the educational distribution of these 
latent classes of body size and cardiometabolic health can help to explain educational disparities in 
mortality risk. Namely, while the distribution of the high- and low-risk classes is clearly stratified by 
education, the fact that intermediate classes of risk are more evenly represented across all levels of 
education makes it hard to anticipate how these different groupings contribute to overall educational 
disparities in mortality risk. Based on the KHB results in Table 3.7, I find that accounting for these 
groupings of body size and cardiometabolic risk alone mediates 17% of the differences in mortality risk 
for those with a college degree or higher relative to their less than high school-educated counterparts, 
16% of the differences compared those with only a high school degree, and 18.5% compared to those 
with some college education or the equivalent. In the models controlling for additional covariates, the 
average percent of the gradient mediated decreases to 14%. The estimated mediation is largely unchanged 
in the adjusted models for the high school only and less than high school groups, though only 11.7% of 





Table 3.7 Percent Contribution of Latent Classes to Educational Disparities in  
All-Cause Mortality 
        
     Percent Mediated 
     Unadjusted  Adjusted 
Education (ref. BA or higher)            
 Less than HS (ref. “Ideal”)   17.3 
 16.2 
  "Fat but Fit"  1.06 
 1.79 
  Mixed Health w/ Obesity 2.35  2.97 
  Mixed Health w/o Obesity 3.99  1.67 
  High Risk   9.92 
 9.72 
        
 HS or equal (ref. “Ideal”)   15.8 
 14.8 
  "Fat but Fit"  1.70 
 2.43 
  Mixed Health w/ Obesity 4.10  3.72 
  Mixed Health w/o Obesity 1.48  1.37 
  High Risk   8.55 
 7.27 
        
 Some college (ref. “Ideal”)   18.5 
 11.7 
  "Fat but Fit"  5.33 
 4.25 
  Mixed Health w/ Obesity 5.80 
 2.99 
  Mixed Health w/o Obesity -1.54 
 0.79 
  High Risk   8.91 
 3.72 
                
Notes:        
National Health and Nutrition Examination Survey, 1988-2014, Ages 30-75. 
Deaths restricted to ages 30-85. 
Estimates account for NCHS-provided survey weights. 
Adjusted for age, age-squared, survey year, gender, race/ethnicity, nativity, income-to-needs 
ratio, health insurance, and smoking status. 
 
Critically, the KHB method allows for additional insights on the individual contributions of the 
latent classes themselves, estimating the percent mediation of each class as compared to the “Ideal” 
group. This additional “disentangling” feature of the KHB method is only possible in non-imputed data, 
so I checked that the overall estimated proportion of mediation is the same in both the imputed and non-
imputed samples before proceeding with analyses; fortunately, the results were nearly identical. Similar to 
the clear educational disparities in the High Risk group observed earlier, these results show that this class 
accounts for the majority of the overall mediation, whereas the intermediate risk classes individually 
account for a much smaller proportion of the overall differences. This pattern is less clear among those 
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with some college education, where the Mixed Health without Obesity group accounts for the smallest 
proportion in the adjusted model, while the other three groups are relatively similar in the magnitude of 
their contribution (~3.5%).  
I also ran these adjusted KHB mediation models for the other cause of death categories, as seen in 
Table 3.8. Overall, there is a very similar pattern of mediation, albeit with considerably higher estimates 
for underlying diabetes, underlying hypertension, and heart disease – as might be expected for causes of 
death more closely linked with these latent class indicators of body size and cardiometabolic health. 
Indeed, the latent classes explain approximately one-third of the educational gradient in mortality risk 
among deaths were diabetes or hypertension were contributing causes. They also account for 
approximately one-quarter of the educational gradient in heart disease mortality risk when comparing 
college educated adults to those with a high school education or less. However, the percent mediation is 
closer to the all-cause mortality estimates when examining deaths from heart disease, diabetes, or cancer. 
Once again, the High Risk group accounts for a very large proportion of the difference, close to or greater 
than half of the total mediation across the different causes of death. There is a fairly minimal contribution 
from the “Fat but Fit”, and greater influence for the two Mixed Health groups, especially with obesity.  
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Table 3.8 Percent Contribution of Latent Classes to Educational Disparities in Cause-specific Mortality 
            
     Percent Mediated 













Education (ref. BA or higher)                    
 Less than HS (ref. “Ideal”)   35.6 
 28.5  24.4  16.5 
  "Fat but Fit"  1.00 
 2.00  0.48  1.15 
  Mixed Health w/ Obesity 8.44  7.00  6.07  3.14 
  Mixed Health w/o Obesity 5.15  3.39  3.60  1.83 
  High Risk   23.0 
 16.1  14.2  10.4 
   
         
 HS or equal (ref. “Ideal”)   31.7 
 21.8  25.2  13.9 
  "Fat but Fit"  1.30 
 2.25  0.75  1.47 
  Mixed Health w/ Obesity 10.06  7.27  8.76  3.72 
  Mixed Health w/o Obesity 4.01  2.30  3.40  1.42 
  High Risk   16.32 
 10.0  12.3  7.31 
   
         
 Some college (ref. “Ideal”)   37.2 
 41.9  13.7  9.84 
  "Fat but Fit"  4.02 
 10.2  1.08  2.51 
  Mixed Health w/ Obesity 14.3 
 15.1  5.80  2.90 
  Mixed Health w/o Obesity 4.08 
 3.43  1.61  0.79 
  High Risk   14.8 
 13.2  5.17  3.64 
                        
Notes:  
National Health and Nutrition Examination Survey, 1988-2014, Ages 30-75. 
Deaths restricted to ages 30-85. 
Estimates account for NCHS-provided survey weights. 
Adjusted for age, age-squared, survey year, gender, race/ethnicity, nativity, income-to-needs ratio, 
health insurance, and smoking status. 
 
Sensitivity Analyses 
As noted in the description of the methods, this analytic approach is what researchers describe as 
the “one step” method for LCA, wherein individuals are assigned to a specific latent class that are then 
used in subsequent analyses with predictors and outcomes. Though the estimates of entropy and average 
posterior probabilities in these analyses suggest well-differentiated models, there is still a possibility that 
the decision to assign individuals to a specific class as opposed to an alternate option could change the 
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results. Recent years have seen the development of new methods that better account for uncertainty in the 
latent class assignment (Bakk et al. 2013); however, they are not well-suited for the discrete-time survival 
models with mortality as the distal outcome. Indeed, there was some ambiguity in the results concerning 
the choice of the four- or five-class model. Even though the literature on LCA suggests that researchers 
have some discretion in identifying the most appropriate model, I wanted to make sure that the choice of 
five rather than four classes did not alter key substantive takeaways. Thus, I conducted a robustness check 
to see if the key results of these analyses are upheld when using the four-class solution. As seen in the 
Appendix (Tables A.5-A.8), these sensitivity analyses provide results that are very similar to those in the 
primary analyses, both in terms of how they characterize the population with respect to body size and 
cardiometabolic health and how these groupings are related to mortality. These analyses also result in 
similar estimates of educational differences in the groupings, as well as comparable estimates of the 
educational gradient in mortality risk explained by the latent classes. 
I also ran Latent Profile Analyses (LPA) using continuous versions of the same set of indicators, 
finding similar patterns of results up through the four-class solution. However, these models consistently 
encountered greater convergence and replication issues, leading me to question the reliability of these 
estimates; indeed, convergence and replication issues are common given the sensitivity of LPA models to 
the different scales and distributions of indicators (Berlin et al. 2014), as in these analyses. More broadly, 
throughout the analysis I examined the sensitivity of the latent class solutions to alternate specifications of 
indicators with respect to the cut-point for ‘high’ vs. ‘low’ risk, finding that the results were very 
consistent in terms of both distribution and substantive interpretation of the latent classes. I also 
considered different groupings of variables – such as limiting the analyses to only those variables with 
data on all respondents across all years, or avoiding multiple measures of a given domain of health, or 
including only measures with conditional probabilities <30% or >70%, among others – again finding that 
the emergent latent class solutions were largely unchanged. Importantly, the set of variables used in the 




Finally, I also ran gender-stratified models, finding the four- and five-class LCA solutions for 
both females and males were fairly similar, albeit with slightly different conditional probabilities among 
indicators. Moreover, subsequent analyses of both educational distribution and mediation were also 
comparable, largely mirroring the findings noted above; generally, the proportion of educational 
disparities in mortality mediated by the latent classes was higher for women than men. However, the issue 
of unstable estimates associated with some of the latent groupings was magnified when running stratified 
models; the intersection of gender, education, latent classes, and specific causes of death resulted in cells 
with relatively few cases. Given the lack of major differences in findings, and to avoid any ambiguity in 
the interpretation of the results, I limit my discussion to the sample as a whole. 
Discussion and Conclusion 
There is compelling evidence that obesity is a key driving force underlying patterns and trends of 
morbidity and mortality in the United States (NASEM 2021; NHLBI 2013), yet research based on 
biomarker data from large national surveys suggests that body size is not a monolith when it comes to 
individual and population health (Tomiyama et al. 2016; Wildman et al. 2008). Examining heterogeneity 
in body size and health is an important consideration in the United States, where over four in ten adults 
are considered obese (Hales et al. 2020). While excess body size can be harmful, it is not a definitive 
marker of health (Gutin 2018); thus, a large proportion of adults with obesity, and the population as a 
whole, may be able to enjoy “good” health. More importantly, knowledge of this heterogeneity is critical 
for reevaluating population health priorities centered on weight loss and maintaining a “normal” weight 
given the abundance of research highlighting the failures of weight-focused interventions (Bacon and 
Aphrarmor 2011; Kraschnewski et al. 2010; Mann et al. 2007). However extant research on this subject 
has focused on predefined categories of body size and cardiometabolic health – often with a fairly limited 
set of indicators – rather than identifying patterns emerging from the rich population health data at our 
disposal (Blüher 2020; Magkos 2019; Phillips 2013). This research tends to focus on identifying 
“phenotypes” of metabolically-healthy obesity, but does not fully consider the population health 
relevance of other body size and health groupings. Moreover, this research has adopted a largely 
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biological and genetic perspective on these phenotypes (Huang et al. 2017; Navarro et al. 2015; Telle-
Hansen et al. 2013), giving less attention to key social factors – like individuals’ educational attainment – 
as a determinant of these health profiles. 
Drawing on clinical and epidemiological research on body size and health, as well as sociological 
and social demographic work examining the role of educational attainment disparities in health, this study 
identifies probabilistic groupings of body size and cardiometabolic health in the U.S. adult population and 
examines their contribution to educational gradients in mortality. Based on the results of latent class 
analysis and survival analysis with National Health and Nutrition Examination Survey data from 1988-
2015, approximately one-third of adults have a clinically “Ideal” health profile, in terms of having a 
medically healthy body size and not exhibiting any major cardiometabolic dysregulation. However, the 
remaining two-thirds of adults show some degree of ‘unhealthiness’ on the basis of either body size, 
cardiometabolic health, or both, having body size and cardiometabolic health profiles associated with 
increased all-cause mortality risk relative to their “Ideal” health counterparts. The five latent groupings of 
body size and cardiometabolic health identified in the data are consistent with past research on MHO, 
wherein adults are categorized as either metabolically-healthy or unhealthy and either having obesity or 
not. However, the results document greater heterogeneity in obesity as a risk group, to the extent that 
adults with obesity exhibit relatively low, medium, and high levels of risk relative to the “Ideal” group. 
As expected, the High Risk group – consisting of adults with a higher probability of both obesity and 
impaired cardiometabolic health – have the highest relative mortality risk, and represent one-in-ten adults. 
By contrast, a “Fat but Fit” group – conceptually similar to MHO – represents 13% of adults, with a 
slightly elevated mortality risk relative to the “Ideal” group. The remaining two groups consist of adults 
that are very similar in terms of their cardiometabolic health profiles, yet one has obesity (14%) and the 
other does not (35%). Indeed, the latter is the modal group, accounting for over a third of the sample, 
whose mortality risk is significantly higher than both the “Ideal” and “Fat but Fit” groups across all 
causes of death, and on par with their nearly identical cardiometabolic counterparts who have obesity. 
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Moreover, these are not exclusively biological phenotypes, as college-educated adults generally 
have a more advantageous distribution of these latent groupings relative to their less-educated 
counterparts. The most apparent differences are in the low-risk, “Ideal” group, where college-educated 
adults are more than twice as likely to be represented relative to their less than high school educated 
counterparts, and about one-and-a-half times more likely to be represented than those with a high school 
but not college degree. The High Risk group shows an inverse pattern, as less than high school educated 
adults are three times more likely to be represented than college educated adults, and one-and-a-half times 
more likely to be represented than those with a high school but not college degree. However, these 
educational differences are far less pronounced among the intermediate risk groups, which is where the 
majority of adults are classified across all educational groups. When combining information on education, 
latent groupings, and mortality, these educational differences in groupings of body size and 
cardiometabolic health account for approximately 17% of educational disparities in mortality when using 
only latent classes as a mediator, and 14% of differences when adjusting for a comprehensive set of 
covariates. This mediation is larger for causes of death more closely associated with obesity and 
cardiometabolic health (20-40%). Notably, the High Risk group accounts for the majority of this 
mediation relative to the “Ideal” counterfactual; nevertheless, differences across all latent groupings tend 
to favor highly-educated adults. 
First and foremost, this study reaffirms past research suggesting that body size and 
cardiometabolic health exhibit considerable variation in the United States, with various combinations of 
body size-related and other clinically significant cardiometabolic risks. As noted in past work, treating 
obesity as a singular category of poor health represents a false binary from a population health 
perspective, as evidenced by the more nuanced configurations seen in these results. Nearly one-in-eight 
adults are represented by the “Fat but Fit” group similar to MHO, which is associated with increased 
mortality risk in the bivariate models but is not significantly associated with increased risk relative to the 
“Ideal” group in cause-specific models adjusted for covariates. While not addressing the psychosocial 
implications of HAES, these findings confirm the perspective that individuals can maintain relatively 
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good health without a narrow focus on weight and weight loss (Bombak 2014; Penney and Kirk 2015). 
Critically, high body weight or excess adiposity is not the only factor associated with elevated mortality 
risk, as nearly one-third of adults do not have obesity yet exhibit signs of cardiometabolic dysfunction 
that places them at higher risk of early death, relative to both the “Ideal” and “Fat-but-Fit” groups. 
Moreover, their cardiometabolic profile and risk level is nearly identical to the latent grouping of 
individuals who share the same cardiometabolic profile but have obesity.  
These findings echo extant concerns that a narrow-minded focus on obesity and its associated 
cardiometabolic implications leads us to falsely equate thinness with good health (Saguy 2012; Shugart 
2016; Tomiyama et al. 2016). As seen in these data, and found in past research, the proportion of U.S. 
adults who do not have obesity but are not necessarily ‘healthy,’ is nearly equivalent to the proportion of 
adults who have obesity. While parsimony is valuable in population health, and there are many instances 
where researchers have a legitimate interest in examining a singular risk factor, this study emphasizes 
how the broader agenda of improving population health is incomplete without considering the multiplicity 
of risk factors affecting individuals and how they may present themselves in distinct, but substantively 
important, configurations. Even though existing theories and related measurement schemes on health and 
aging provide some guidance on how to conceptualize different combinations of comorbidities – like 
MHO, metabolic syndrome, and allostatic load – methods like LCA can be used to scrutinize these 
theories/methods or to find ways that they can be refined, such as looking at probabilistic groupings rather 
than using sum scores or indices in identifying latent classes with unique substantive interpretations. 
On the subject of multiplicity in risk and morbidity, this study has key implications for our 
understanding of educational disparities in mortality and the different mechanisms, or combinations of 
mechanisms, that have the greatest impact. Indeed, a central contribution of fundamental cause theory 
(FCT) is that population health researchers observe the “net” effect of SES on health via “massively 
multiple mechanisms” (Freese and Lutfey 2011: 69). Critically, all that is required to sustain the 
relationship is that net effect is consistently positive over time and place, and across many changing 
mechanisms and outcomes; i.e., not that all of the mechanisms linking education to health and mortality 
 
101 
have to follow the same causal direction or have the same causal impact (Lutfey and Freese 2005; Freese 
and Lutfey 2011). This point is best illustrated in Lutfey and Freese’s (2005) ethnographic investigation 
of how FCT is observed in the context of diabetes – a key source of cardiometabolic morbidity and 
mortality in the United States. One of their key findings is that better adherence and outcomes among 
high-SES diabetic patients is a function of multiple systemic advantages, given there were many instances 
of both low-SES and high-SES patients failing to follow through with management or care protocols. 
Along these lines, a recent report from the NCHS finds that the percentage of U.S. adults regularly 
consuming fast food increased based on their income level (Fryar et al. 2018), even though rates of 
obesity and poor cardiometabolic health are generally lower among more affluent adults (O’Rand and 
Lynch 2018). Perhaps most broadly, Cockerham’s (2005) framework for the formation of “health 
lifestyles” across different socioeconomic groups theorizes that not all of the behaviors and beliefs 
embodied by higher-status individuals are universally salubrious on account of both class- and individual-
based preferences.  
In the case of this study, the examination of heterogeneity and identification of distinct groupings 
of body size and cardiometabolic health helps identify particular clusters of concern contributing to 
educational disparities in mortality. Just as there is heterogeneity in the groupings of body size and 
cardiometabolic health, there is heterogeneity in how these risk profiles are represented across educational 
groups. College-educated individuals have a more favorable proportion of the “Ideal” type and a lower 
proportion of higher-risk classes, reaffirming the fact that the health-advantages enjoyed by higher-SES 
adults are not limited to a single source of risk, or even multiple measures (Link and Phelan 1995; Phelan 
et al. 2010). However, cardiometabolic health is fairly evenly distributed among intermediate risk 
profiles; while this does not quite rise to the level “countervailing mechanisms” suggested by Lutfey and 
Freese (2005), the more equal representation likely mitigates the percentage of educational disparities in 
mortality attributable to this set of body size-related and cardiometabolic risks. Namely, higher-educated 
adults are not immune from poor health across a broad set of cardiometabolic health profiles, having 
prevalence on par with their lower-educated counterparts. More broadly, this reinforces the notion that 
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individuals’ SES does not make them a homogenous group in all aspects of their health and wellbeing 
(Cockerham 2005).  
Empirically speaking, the differential impact of the latent classes in these analyses can help 
explain some of the inconsistencies in past research on the role of obesity and other cardiometabolic risks 
as mediators of socioeconomic disparities in health and mortality. More critically, knowledge of the 
contribution of these intermediate risk profiles to observed disparities can be instructive in identifying 
which risk profiles should be prioritized for intervention. FCT’s core argument is that we can achieve the 
broadest possible impact on improving population health by intervening on distal determinants of health 
like education; yet, the practical reality is that meso-level processes and mechanisms continue to be the 
focus of many population health initiatives (Goldberg 2014). In turn, better knowledge of which 
mechanisms merit the most concern can be informative, even if these approaches do not represent the 
desired macro-level intervention. Indeed, Phelan et al. (2010) recognize that that the focus on addressing 
fundamental causes of mortality need not come at the expense of understanding and intervening on 
intermediate mechanisms; rather, they stress that these intermediate mechanisms need to be targeted in a 
way that does not further exacerbate social disparities in health and mortality.  
Consequently, this study addresses the issue of what it means to focus solely on obesity in the 
hopes of mitigating educational disparities in mortality, given that obesity and poor cardiometabolic 
health do not co-occur identically across different levels of educational attainment. In turn, these different 
groupings of body size and health do not equally contribute to the educational gradient in mortality; this 
may be less apparent in the case of all-cause mortality, but it is clearer when examining disparities in 
heart disease-related deaths, and those where hypertension or diabetes are contributing causes. Among the 
different latent classes of body size and cardiometabolic health where obesity is a defining attribute, the 
group represented by both obesity and high cardiometabolic risk accounts for a majority of the disparities 
in mortality. Conversely, the fact that the “Fat but Fit” class accounts for a smaller share of mortality 
disparities suggests that obesity in and of itself is a more limited concern when it comes to disparities. 
The more “medium” level of risk associated with obesity in the Mixed Health group accounts for a larger 
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proportion of disparities, but is still less than the “High Risk” group for those with a high school 
education or less. Though its contribution varies across different levels of educational attainment, the 
Mixed Health without Obesity group accounts for a greater proportion than of disparities than the “Fat but 
Fit” group (and the Mixed Health without Obesity group in some cases), but might be neglected given a 
singular focus on obesity as the driving mechanism. These results underscore that contextualizing 
population health risks is important: a relatively small group of high-risk adults – accounting for only 
10% of adults as a whole, and 5-15% across educational groups – accounts for the majority of educational 
disparities in mortality in this study. Yet the contribution of intermediate risk groups, representing 
different combinations of risk factors, is more variable. This confirms, and potentially helps explain, 
mixed findings from extant research suggesting that not all cardiometabolic risks have the same 
explanatory power when it comes to educational gradients in health (Dégano et al. 2017; Dowd and 
Goldman 2006; Kershaw et al. 2013; Kim et al. 2018). 
Returning to the question of fundamental causes, it is clear that the reducing educational 
disparities at a societal level would be the most effective intervention in reducing social disparities in 
mortality. Though looking at individual mechanisms is informative, the results of this study ultimately 
reaffirm the motivating principles of FCT, as even this broad set of body size and cardiometabolic 
measures only explains ~15% of educational disparities in mortality risk. This serves as an important 
reminder of how even a more holistic or multi-systems view of health does not account for numerous 
other risks shaping social disparities in health. Even with causes of death more tightly-linked to 
cardiometabolic health, one can imagine numerous unmeasured, subclinical, and accumulated stressors 
that account for increased mortality (Gutin 2020), as posited by the large sociological body of literature 
on individuals’ SES and the overall burden of stress in their lives (Elo 2009; Lantz et al. 2005; Mirowsky 
and Ross 2003).  
Moreover, it is clear that no single combination of body size and cardiometabolic mechanisms 
accounts for the entirety of the mediation, as adults with a college education tend to have lower mortality 
on account of a more favorable profile across all latent classes. Examining these intervening mechanisms 
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demonstrates how certain pathways – such as the High Risk minority – might take precedent over a 
broad-based approach focused on obesity as the single source of social disparities in mortality. Population 
health researchers interested in disparities might draw on recent research identifying “super-utilizers” in 
health care, wherein a very small proportion of patients accounts for a disproportionate amount of 
healthcare spending (Aldrige and Kelley 2015; Johnson et al. 2015; Mitchell 2020). Efforts to identify 
and directly target this group via social programs and services has been successful in both lowering costs 
and improving overall population health (Kangovi and Grande 2020); this may have implications for 
targeting especially high-risk populations with the goal of reducing disparities. More generally, however, 
the key takeaway is recognizing that obesity is not the only mechanism by which we observe poor 
cardiometabolic health among U.S. adults, regardless of their level of education. Thus, when evaluating 
the target or outcome of a given intervention population researchers and policymakers should invest in a 
more holistic understanding of how individuals’ health has changed, given that a focus on body size can 
be misleading and/or incomplete. 
Limitations 
Prior to concluding, it is important to note the limitations of these analyses and how they may be 
addressed in future research. First and foremost, there are valid concerns related to potential sources of 
measurement error in two respects. One important source of measurement error pertains to the various 
indicators of body size and cardiometabolic health used in the analysis. Earlier, I discussed the similarities 
between LCA and confirmatory factor analysis (CFA), wherein a key distinction is an emphasis on 
individuals rather than the measures themselves (Bauer and Curran 2004). In this study the choice of LCA 
is strategic in identifying meaningful groupings among respondents, as befitting the research aims. 
However, a key limitation of LCA relative to CFA is that the focus on individuals does not allow 
researchers to correct for measurement error in the individual measures themselves by modeling them as 
indicators of a shared latent construct. Even though most of the NHANES measures used in the analyses 
are based on examination data collected by trained professionals using validated methods and techniques, 
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there is still likely to be measurement error from random sources – such as user error or poorly calibrated 
instruments – that is not accounted for (Bollen 1989: 151-178).  
A secondary source of measurement error is in the assignment of individuals to specific latent 
classes. Making the latent class an ‘observed’ variable in the analysis requires a strong assumption of high 
reliability in classification (i.e., minimal classification bias [Clark and Muthén 2009]). Researchers have 
developed methods to estimate measurement error in assignment, and then incorporate this uncertainty 
into the subsequent regressions using the latent classes as variables (Asparouhov and Muthén 2014); 
unfortunately, these methods are not validated for survival analysis and lead to convergence issues in a 
sample as large as the NHANES. The high entropy and AvePP for the five-class solution in this study 
mitigates these concerns – as does the robustness check based on the four-class solution and alternate 
specifications of measures – but they cannot be entirely discounted. Based on past research, the estimates 
and standard errors presented in these analyses may be conservative due to misclassification bias (Bolck 
et al. 2004). 
Relatedly, one may expect some variation in the results based on the choice of measures used in 
the LCA, with respect to both the types of measures included and how they are categorized in terms of 
risk. In the present study, different combinations of variables and cutoffs did not alter the substantive 
latent classifications; thus, I used a set of variables and cutoffs exhibiting the best classification criteria 
and separation among respondents. A dataset as rich as the NHANES provides numerous other 
biomarkers and self-reports that have been used in past research on socioeconomic disparities in health 
(Dowd and Zajacova 2009); future research may consider how including an even broader set of measures 
affects the conclusions. However, researchers should be careful in providing some theoretical and/or 
empirical basis for how and why they might expect the various measures to co-occur, especially in 
making arguments about the interpretability and validity of the resulting latent classes. 
Further work with more recent restricted-use mortality data would allow researchers to examine 
additional cause-specific analyses and better address issues of temporality, given the many period- and 
cohort-based influences on obesity, cardiometabolic risk, and their associations with mortality (An and 
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Xiang 2016; Bell and Jones 2014; Keyes et al. 2010; Masters et al. 2013; Reither et al. 2009; St-Onge et 
al. 2010). With public-use data I was limited to the ten broad categories of leading causes of death in the 
United States, along with deaths where hypertension or diabetes are contributing causes. As demonstrated 
in the results, the cause of death under consideration greatly influences the mortality risk associated with 
classes as well as their estimated mediation of educational disparities in mortality. Critically, a longer 
mortality follow-up period would help address some of the small cell sizes that produce such unstable 
estimates. This would then facilitate additional group-specific analyses and/or looking at trends over time, 
as would be of interest across this broad range of years. As noted, the intersection of gender and/or 
race/ethnicity with education is a key area of future work. Past work consistently documents lower 
educational returns to health for both women and non-White adults, with a particularly notable 
disadvantage among non-Hispanic Black females (Borrell et al. 2010; Geronimus et al. 2006; Geronomus 
et al. 2010; Hargrove 2018; Levine and Crimmins 2014). The most appropriate course of action would be 
to conduct a more systematic examination of group differences, estimating separate latent class models 
across these different categories of gender and race/ethnicity. In addition to better understanding the 
groupings of body size and cardiometabolic health that describe these demographic groups, we would 
also gain valuable insight on group differences in which latent groups appear to have the greatest 
explanatory power when it comes to SES gradients in mortality. 
Finally, on a more abstract level, this study represents one of many approaches researchers could 
use in trying to add nuance to our understanding of the relationship between body size and health. 
Namely, proponents of HAES might argue that even this multimorbidity, multi-systems view of body size 
and health provides limited insight on individuals’ experiences and understanding of their health as a 
function of their body size. Even if LCA captures important nuances in how body size and 
cardiometabolic health co-occur, individuals are still being categorized on the basis of health, thus 
obscuring additional levels of heterogeneity. There are also many aspects of individuals’ health and 
wellbeing that are not addressed in these data, such as key dimensions of psychosocial and emotional 
health that also factor into a HAES-based understanding of how our bodies affect our health (Bombak 
 
107 
2014; Penney and Kirk 2015). Thus, in arguing that I provide importance evidence of variation in how 
body size and health co-occur, I concede that this variation may not rise to the level of nuance advocated 
for by the HAES framework, or by other scholars seeking to diminish the categorical power afforded to 
BMI and obesity as measures of health. 
Conclusion 
The growth of biosocial data in the past 20 years provides researchers with a novel opportunity to 
use a systems-level approach in the study of population health (Seeman et al. 2004), integrating multiple 
dimensions and measures of health to attain a better and more comprehensive understanding of 
underlying risk (Harris 2010). Indeed, the lack of a more integrative approach has a been a key issue in 
the study of obesity, wherein the fairly imprecise measure of BMI – and the corresponding categorization 
of obesity – provides limited insight on individuals’ overall health. This is not to suggest that BMI and 
obesity are uninformative in understanding population health and identifying important social disparities; 
rather, orthodoxy in their use as unequivocal measures of overall health often biases researchers, policy 
makers, and the public at large from adopting a more comprehensive view of the full spectrum of 
individuals’ cardiometabolic health (Jutel 2011; Saguy 2012; Shugart 2016). Fortunately, the 
aforementioned availability of innovative data and methods has allowed researchers to document the 
complexity and multidimensionality of population health, as seen in recent work on metabolically-healthy 
obesity, HAES, and in the broader call for understanding heterogeneity in the relationship between body 
size and health. 
Thus, rather than continuing to substantiate a biomedical view of obesity as a homogeneous risk, 
population researchers have unprecedented access to the kinds of rich biosocial data and novel 
methodological tools that allow them to challenge and improve the conceptualization, definition, and 
measurement of health and healthiness at the population level. As this analysis shows, by situating obesity 
among many other indicators of cardiometabolic health, researchers can employ a more comprehensive 
and holistic systems-level view that allows for a better understanding of the nuances in how body size and 
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cardiometabolic risk are distributed across the population, and where we might best direct efforts to 
improving health and reducing disparities. 
Indeed, this chapter underscores the utility of these multi-systems, multimorbidity approaches 
when examining the social patterning of health. Applying a sociological and social demographic lens to 
the same questions explored in clinical and epidemiologic research on body size and cardiometabolic 
health shows that the different combinations and ‘phenotypes’ observed throughout the population are not 
random – as befitting biological or genetic perspectives – but instead highly stratified based on social 
factors, like education. In turn, we obtain a better understanding of which health risks help explain 
educational disparities in mortality, and identify combinations of risk factors that merit greater attention. 
Moreover, this multi-systems perspective and analytic approach provides empirical support for extant 
sociological concepts like fundamental cause theory, demonstrating how the multiple mechanisms 
connecting social determinants to disparities in mortality work in concert with one another to shape 
individuals’ health. Critically, while fundamental cause theory emphasizes the upstream determinants of 
health, the arguments it makes about meso-level processes have important implications as well by 
highlighting how not all of the mechanisms linking education to mortality have the same impact. In turn, 
this knowledge can and should be leveraged to better understand where the limited time and resources 
available for intervening on population health should be directed.  
More broadly, this study contributes to the growing body of research advocating for a more 
comprehensive approach to studying population health in a world where multiple risks and conditions 
simultaneously influence premature aging and mortality (Belsky et al. 2015; Moffitt et al. 2017). Defining 
health on the basis of individual measures, and along strict binaries of healthiness and unhealthiness, 
continues to provide important population health knowledge; however, there is more to be learned in   
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broadening these definitions. Leveraging all available tools and methods facilitates a better understanding 
of not only the full spectrum of health, but also how individuals’ social attributes and environments 
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CHAPTER 4: DOUBLE JEOPARDY: PATHWAYS OF OBJECTIVE AND SUBJECTIVE 
WEIGHT STATUS THROUGHOUT THE LIFE COURSE AND HEALTH IN ADULTHOOD 
Introduction 
Since the early 1960s, the mean weight of U.S. adults has increased by more than 24 pounds and 
obesity rates have more than tripled for men and doubled for women, with much of the growth occurring 
in just the last three decades (Fryar et al. 2012). At present, over one-in-four of the U.S. adult population 
is considered to have obesity (Hales et al. 2020), with some projections suggesting half of the population 
will have obesity by 2030 (Finkelstein et al. 2012). Most worryingly, the rise in obesity among 
adolescents and young adults has been especially pronounced, with obesity rates quadrupling among 
those ages 12-19 since the 1980s (from ~5% to 20%) – a growth rate higher than any other age group 
(Ogden et al. 2014; Ogden et al. 2016). High and raising rates among more recent cohorts of U.S. adults 
raise well-founded concerns about reductions in life expectancy and quality of life for future generations 
of Americans (Jia and Lubetkin 2010; Olshansky et al. 2005; Reither et al. 2011), many of whom may 
experience the cumulative effects of having spent the majority of their lives living with obesity (Ferraro 
and Kelley-Moore 2003; National Academies of Sciences, Engineering, and Medicine [NASEM] 2021). 
While no single factor is responsible for the sharp increase in adolescent and adult obesity, its 
rapid onset underscores the urgency of understanding potential precursors to obesity and related diseases. 
One line of recent inquiry has emphasized the critical role of individuals’ “self-perception” of their 
weight as a potential explanatory and/or mediating factor underlying obesity and health outcomes. 
Researchers posit individuals’ satisfaction with their weight (i.e. an individual’s belief that their current 
weight is appropriate, or just right, or does not require change) influences the degree to which they 
perceive excess body weight as “unhealthy”, thus mitigating the extent to which they then view their 
overall health and wellbeing as a function of their weight status. The misperception of weight (i.e., 
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“discordance between an individual's actual weight status and the perception of his/her weight status” 
[Duncan et al. 2011: 2]) can lead individuals to downplay or be unaware of the consequences of excess 
body weight, giving rise to an ongoing cycle of weight gain. 
Indeed, a growing body of evidence demonstrates that individuals’ perceptions of themselves as 
“overweight” do not necessarily align with their “clinical” weight status on the basis of body mass index 
(Burke et al. 2010; Chang and Christakis 2003; Maximova et al. 2008; Robinson and Kirkham 2014). 
These findings are consistent with previous research on subjective evaluations of overall health, as reports 
of “poor” or “excellent” self-rated health are not necessarily concordant with more objective indicators of 
individuals’ health on the basis of diagnosed conditions, limitations, and measured physiological 
impairment (DeSalvo et al. 2006; Dowd and Zajacova 2010; Franks et al. 2003; Garbarski 2016; Layes et 
al. 2012). Yet, the same benefit of doubt granted to self-rated health as an independent and valid measure 
of health has not been extended to self-perceived weight. Researchers frame the ambiguity and 
uncertainty in the measurement of self-rated health as one of its key strengths; namely, self-rated health 
has strong predictive validity for health outcomes net of “objective” measures of health, as it potentially 
captures unmeasured (or unmeasurable) aspects of health and other experiences that are implicitly 
factored into individuals’ subjective evaluations (Huisman and Deeg 2010; Jylhä 2009; Jylhä 2010). The 
aforementioned objective-subjective discordance is not framed as an issue of incorrect reporting, but 
instead an acknowledgement that subjective and objective measures can represent different dimensions of 
health, complementing one another in trying to account for the complexity of health as a multi-
dimensional and holistic construct.  
Critically, subjective measures speak to the value of understanding the experiences associated 
with health and the body, which are distinct from the direct physiological processes underlying health and 
disease (Lupton 2012). Much like with self-rated health, perceiving oneself as overweight can provide 
valuable insight on the psychosocial insults associated with the stress due to having a negative self-image 
or being stigmatized on the basis of one’s physical appearance (Puhl and Huerer 2009; Puhl and Huerer 
2010), especially in a highly weight-conscious and body-normative society like the United States 
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(Greenhalgh 2015; Oliver 2006; Saguy 2012). This is a particularly important issue with respect to 
sociological theory on the body and what it represents in a given social context (Bourdieu 1984); bodies 
are defined both biologically and socially (Fox 2012), often as a function of what they do or what 
individuals assume they can do. Considerable social meaning is projected onto body weight and size and 
what it communicates about a person’s health status (Jutel and Buetow 2007; Shugart 2016), beyond their 
physiological implications for health.  
Indeed, there is increased recognition of body size as a key axis of inequality in a weight 
conscious society like the United States (Gutin 2021); “overweight” – as an identity – is one of the 
earliest examples cited in foundational research on stigma (Cahnman 1968; Maddox et al. 1968), and 
continues to be a socially acceptable form of bias (Puhh and Heuer 2010). In turn, stigma is a fundamental 
cause of health (Hatzenbuehler et al. 2013), wherein the aspect of body weight as an embodied social 
identity, and social source of stress, can be uniquely consequential. Thus, subjective weight might be 
highly predictive or better associated with certain health outcomes than objective weight in capturing 
individuals’ lived experience of weight – such as poor psychosocial health stemming from institutional 
and interpersonal discrimination (Hatzenbuehler et al. 2009; Papadopoulos and Brennan 2015; Puhl and 
Heuer 2010; Puhl and Suh 2015; Schafer and Ferraro 2011). This may be especially pertinent at younger 
ages, where the more “objective”, (pre)disease-related symptoms and evidence of poor weight-related 
health have yet to manifest (Altman et al. 2016), or are largely subclinical.  
Thus, rather than focusing on discordance in the objective and subjective reality of weight, it is 
important to recognize how these measures reflect body weight as both a physical and social identity, 
with differing implications for individuals’ health. Such is the focus of this study, which seeks to better 
understand the relationship between these two dimensions. Both are likely subject to unique trajectories, 
potentially categorized by different processes of stability and change, requiring systematic examination. 
Rather than simply noting the binary occurrence of “misperceptions,” this work shows how subjective 
and objective weight influence one another in complex and dynamic ways. Consequently, this study uses 
longitudinal data from adolescence to adulthood and structural equation modeling with latent variables to 
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assess the measurement and predictive properties of subjective weight, as well as its associations with 
objective weight and health. Specifically, the research questions addressed in this project are twofold: 
(1) How do subjective and objective weight affect one another over time? Although prior 
research finds considerable discordance between perceived and measured weight, this 
neglects the possibility that subjective and objective weight influence one another in complex 
ways over time. There may be cross-lagged effects between these measures, as well as cross-
sectional associations and correlations, potentially across all points in the life course or only 
at specific points in time. Identifying an appropriate longitudinal trajectory will also allow for 
better models in subsequent analyses.   
(2) What is the influence of both subjective weight and objective on later life health outcomes? 
Having identified the parallel, and potentially intersecting, trajectories of subjective and 
objective weight, I assess the extent to which they are both predictive of later life health 
outcomes – demonstrating how both the subjective experience of feeling overweight and the 
physiological condition of being overweight represent distinct lifelong “exposures” that are 
associated with physical and mental health in adulthood.  
Given the highly gendered-nature of weight identity and body image in the United States (Fikkan and 
Rothblum 2012; Puhl et al. 2008 Saguy 2012), I also compare the overall results to gender-stratified 
models to see if the trajectories, and their associations with health outcomes in adulthood, differ between 
female and male respondents. 
The study begins with an overview of research on weight perception in the context of the U.S. 
obesity epidemic, the role of subjective measures in health research, and emerging work on individuals’ 
perceived weight as a distinct construct separate from objective body weight and size. I then proceed with 
a detailed description of the data and methods used in the analyses, explaining the step-wise approach to 
model building and comparisons used throughout the analysis. Following the results, I discuss the 
implications of the findings for knowledge of subjective and objective weight over the life course and 
how they relate to adult health. I close by emphasizing the importance of distinguishing between 
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subjective and objective dimensions of health in population research, especially when studying body 
weight size as both a physical characteristic and social identity. 
Background 
Weight Perception and the Obesity Epidemic  
Many studies point to steady changes in individuals’ standards for a “normal” body weight as a 
potential explanation for the dramatic increase in obesity from the 1980s onward, suggesting that 
individuals’ accuracy in self-perception of their weight has been negatively influenced by increases in 
average body size across the communities and social networks in which they are embedded (i.e. social 
comparison framework: Burke and Heiland 2007; Christakis and Fowler 2007; Wedow et al. 2018). 
Empirical work testing the theory that increases in average body size have led to more individuals 
viewing their weight as “just right” rather than “overweight” finds evidence in favor of a “generational 
shift in social norms related to body weight… such that people may be less likely to desire weight loss 
than previously” which has potentially “limit[ed] the effectiveness of public health campaigns aimed at 
weight reduction” (Burke et al. 2010: 1226).  
Indeed, the “misperception” of overweight – i.e., believing oneself to be “normal” weight when, 
objectively, one’s BMI puts them in the overweight or obese categories – is negatively associated with 
weight management and key health-promoting behaviors like eating healthy foods and performing 
physical activity (Duncan et al. 2011). This discordance has been implicated as a significant barrier to 
many interventions aiming to raise awareness about obesity as a health issue and triggering more positive 
health-related decision-making (Johnson-Taylor et al. 2008; Kuchler and Variyam 2003), as the 
individuals targeted by these interventions may not perceive themselves as unhealthy to begin with. 
Moreover, the aforementioned “generational shift” in attitudes towards weight suggests that 
adolescence and early adulthood represent critical points in the life course for better understanding the 
effects of weight perception on future weight and health. These early life attitudes and feelings towards 
weight and health are often the foundation for weight-related behaviors and beliefs well into later life 
(Bauldry et al. 2012; Harris 2010; Harris et al. 2006), as is shown in past research examining the 
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persistence of obesity and other weight-related behaviors from adolescence into adulthood (Laska et al. 
2012; Nelson et al. 2008; Viner et al. 2012). Individuals’ early perceptions of their weight may be 
particularly influential in crystallizing certain assumptions about the relationship between weight and 
health that persist through their adult years.  
However, the lack of many “objective” measures of physiological dysregulation at younger ages 
suggests that subjective assessments or perceptions of health are particularly valuable indicators of poor 
health and wellbeing (Bauldry et al. 2012; Boardman 2006; Sokol et al. 2017). This is an especially key 
issue among younger adults, given that the most serious and obvious health consequences of excess body 
weight and obesity (e.g., chronic disease and disability) often do not manifest until later life (Altman et al. 
2016; Zajacova and Burgard 2010). Thus, rather than exclusively focusing on individuals’ subjective 
weight status as an obstacle in health promotion efforts, medical, epidemiologic, and public health 
research could stand to benefit from a better understanding of subjective weight as a meaningful measure 
in and of itself. 
Subjective Measures in Health Research 
Researchers valorize subjective reports of health for their parsimony and predictive power, 
summarizing complicated and potentially unobservable health processes that cannot be comprehensively 
documented in survey research due to “practical limitations of empirical studies, or… the inadequacy of 
our present knowledge to appropriately measure these aspects” (Jylhä 2009: 312). Subjective or perceived 
measures of health have shown considerable predictive value in social and health research over past 
decades, as most clearly evidenced by the large body of work using self-rated health or similar 
assessments of general health. Namely, individuals’ self-perceptions of their health status are strongly 
associated with a greater frequency and probability of numerous health outcomes, including medical care, 
disability and functional ability, physiological dysregulation, chronic diseases (such as coronary heart 
disease, diabetes, stroke, lung disease, arthritis, and cancer), and premature mortality across multiple 
causes of death (Benjamins et al. 2004; DeSalvo et al. 2006; Dowd and Zajacova 2010; Goldman et al. 
2004; Idler and Benyamini 1997; Halford et al. 2012; Idler and Kasl 1995; Jylhä et al. 2006; Latham et al. 
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2012). In nearly all studies, the strong associations between negative assessments of one’s health and 
negative health outcomes persist even after accounting for more detailed questions about one’s health and 
various morbidities, physician evaluations, and, increasingly, direct biophysiological measures of health.  
More narrowly-focused subjective assessments of health – such as self-rated mental health 
(Fleishman and Zuvekas 2007; Lee 2000) and oral health (Benyamini et al. 2004) – have similar 
predictive properties, lending further empirical support to the utility of subjective and more ‘holistic’ 
assessments of health in survey research. Even perceived physical activity has been documented as a 
significant predictor of premature mortality (Zahrt and Crum 2017). This growing body of research has 
spurred researchers to think more critically about the relationship between subjective assessments of 
health and the objective health conditions that they are proposed to reflect. While primarily focused on 
better understanding the predictive power of self-rated health, emergent theories provide a much broader 
framework for recognizing the complex social, psychological, and biophysiological processes underlying 
subjective measures of health. 
Namely, extant theory and research underscores the importance of conceptualizing subjective 
reports as separate health constructs, rather than just reports of the “true” objective health they 
supposedly measure (Goldman et al. 2004; Huisman and Deeg 2010; Jylhä 2010; Layes et al. 2012; 
Quesnel–Vallée 2007). As Quesnel–Vallée (2007) notes, much of the research on self-rated health 
operates “under the broad assumption that ‘true’ health is defined as the absence of diseases and 
especially those that are life-threatening,” which often implies that “‘true’ health is equated with objective 
measures of health” (p.1161). However, the complexity and multidimensionality of individuals’ health 
suggests that this idea of ‘true’ health is “a non-existent, impossible, ultimate, total entity” and thus not 
very useful in seeking to unpack subjective assessments of health (Jylhä 2010: 657). Consequently, 
researchers are better-served by shifting the focus away from trying to “validate” subjective measures 
against their objective counterparts (Huisman and Deeg 2010), and toward recognizing perceptions of 
health as “a valid measure of those aspects of health that are related to the likelihood of survival and 
mortality” (Jylhä 2010: 657, emphasis mine), or positive health and well-being more broadly. As Bombak 
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(2013) notes, “individuals are capable of recognizing their own state of wellbeing, regardless of whether 
this reflects the views held by practitioners and researchers” (p.2); thus, an overwhelming focus on 
discrepancies or inaccuracies in subjective and objective health is inappropriate, as it implicitly expects 
that “individuals… rate their health according to others’ standards, identify deficiencies, and correct their 
behaviors to achieve “better” health” (p.2), rather than consider the individual merits of these subjective 
measures. 
Perceived Weight as a Distinct Construct 
Even though subjective weight status has been less thoroughly examined in extant theoretical and 
empirical research on subjective health, the arguments presented above extend to individuals’ self-
assessments of their weight. To date, relatively few studies have assessed the predictive power of 
subjective weight on future health outcomes. Recent work by Daly et al. (2017) and Unger et al. (2017) 
challenges the assertion that “misperception” of one’s weight is necessarily harmful to one’s health, 
shifting the focus to negative self-assessments of one’s weight as having a negative impact on health 
independent of objective weight. Specifically, both studies find that perceiving oneself as overweight – 
irrespective of the accuracy of this assessment – is associated with a significant increase in worse 
subjective health, depressive symptomology, and a broad set of indicators representing physiological 
dysregulation, including blood pressure, C-reactive protein, waist circumference, the ratio of total blood 
cholesterol to levels of high-density lipoprotein cholesterol, total triglycerides, glucose, and glycated 
hemoglobin (Daly et al. 2017: 877; Daly et al. 2019; Frisco et al. 2010; Haynes et al. 2019; Unger et al. 
2017).  
These studies, as well as reviews of the physiological and psychological health consequences 
associated with negative perceptions of weight, increasingly point to the deeply stigmatizing aspects of 
being “overweight” in contemporary society as a driving force underlying the association between high 
body weight and poor health (Daly et al. 2019; Haynes et al. 2018; Robinson et al. 2017; Tomiyama et al. 
2018). Having “knowledge that you possess a characteristic devalued and derogated by society is likely to 
be psychologically damaging”, leading to deterioration in one’s mental and physical health (Robinson et 
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al. 2017: 1160). Thus, “the stigma attached to identifying as being a person with overweight or obesity 
may ironically exacerbate these conditions” (Robinson et al. 2017: 1160), as it engenders stress and 
continued weight gain, calling into question the efficacy of clinical and public health messaging intended 
to raise awareness about one’s weight status.  
Past studies have suggested that this stigma is especially consequential for girls and women, 
given the highly-gendered environment for body size and beauty norms in the United States, and many 
other societies (Fikkan and Rothblum 2012; Puhl et al. 2008). Namely, the “thin ideal” type for bodies 
and health is most directly applicable to young women, while there is more flexibility in the range of 
body types and sizes that is considered “acceptable” for men (Bordo 2004; Grogan 2007). For instance, 
women are far more likely to express dissatisfaction with their weight throughout the entirety of the life 
course, such that concern about body image does not begin to attenuate until they are elderly (Tiggemann 
2004). Thus, the stigma attached to having the “wrong” body or weight – or feeling like you have the 
wrong body size – is likely to be exacerbated among women, who are regularly exposed to messages in 
mass media, advertising, and popular culture promoting a body image valuing thinness and low weight 
(Arciszewski et al. 2012; Bordo 2004; Homan et al. 2012). 
The psychological aspects of one’s weight-related health are likely to be particularly influential in 
early life and into adulthood. Body weight-related stigma is commonplace in contemporary society, 
manifest as chronic discrimination and bias against overweight individuals who experience social 
ostracism, verbal and physical abuse, bullying, harassment, and the internalization of this negative self-
imagery due to their bodies not conforming to social and medical standards for “healthiness” or 
“normality” (Bucchianeri et al. 2013; Durso and Latner 2008; Lewis et al. 2011; Puhl and Brownell 2001; 
Puhl and Brownell 2006; Puhl and Heuer 2009; Puhl et al. 2007). Many researchers in this area 
emphasize the impact of these chronic insults on youth, who experience some of the harshest encounters 
with size-based discrimination on a daily basis (Puhl and Latner 2007); moreover, poor mental health is 
likely to be the earliest “symptom” of poor health associated with one’s weight, prior to the onset of either 
physical or functional declines. Indeed, the cumulative toll of weight-based stigmatization and 
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discrimination throughout the life course may be particularly damaging (Puhl 2011), as implied by the 
strong association between weight-related stigma and premature mortality (Sutin et al. 2015). As noted 
above, rigid and gendered standards for body size throughout the life course help explain why these 
negative health outcomes – especially with respect to psychosocial and mental health – are consistently 
more pronounced among girls and women (Ciciurkaite and Perry 2018; Frisco et al. 2010; Hilbert et al. 
2014; Puhl et al. 2008; Yuan 2010). 
Thus, subjective weight constitutes an important predictor of future health outcomes, representing 
key psychosocial mechanisms independent of objective weight. The aforementioned studies by Daly et al. 
(2017) and Unger et al. (2017) support this claim, albeit limiting the scope of subjective weight’s 
predictive validity to its influence on psychosomatic mechanisms related to weight stigmatization and 
(paradoxical) weight gain. These mechanisms are important to emphasize in a society where body weight 
and size are heralded as measures of one’s health and moral character (Brownell et al. 2010; Mata and 
Hertwig 2018; Oliver and Lee 2005; Saguy and Gruys 2010; Saguy and Riley 2005). Indeed, there is 
compelling evidence that psychosocial mechanisms constitute some of the primary pathways through 
which individuals’ body size negatively impacts their health (Pearl and Puhl 2018; Puhl et al. 2020; 
Tomiyama et al. 2018); in turn, studying subjective and objective weight as separate constructs can help 
distinguish these important physiological and psychosocial mechanisms. 
Limitations of Past Longitudinal Research on Perceived Weight 
On a final note, while the research discussed above is important in acknowledging the experience 
and perception of one’s weight as an important aspect of health, this work has not explicitly 
acknowledged the issue of measurement error in subjective weight – especially as it relates to individuals’ 
trajectories of subjective weight over time. First and foremost, subjective weight status is undoubtedly 
susceptible to measurement error, as individuals’ feelings about their weight are shaped by numerous 
contextual factors in their social environments that influence their responses at a given point in time 
(Wedow et al. 2018). Secondly, an outstanding issue in the subjective health literature is the extent to 
which subjective measures, such as self-rated health, reflect a relatively “stable” baseline assessment of 
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health that varies across individuals as compared to a more dynamic assessment of health that changes 
with respect to “new” information about health (Bailis et al. 2003; Boardman 2006; Bollen et al. 2021; 
Dowd and Zajacova 2011; Huisman and Deeg 2010; Jylhä 2009). Often framed as an issue of 
“reliability,” a number of studies have examined the extent to which subjective assessments of health vary 
over time despite “objective” changes to individuals’ health, finding support for both static and dynamic 
processes indicative of individuals “self-enduring” conceptualization of their health, as well as more 
“spontaneous” assessments based on near-present circumstances (Bailis et al. 2003; Boardman 2006; 
Dowd and Zajacova 2011). Recent work suggests that more complex processes may be at work, wherein 
these subjective measures are governed by multiple longitudinal processes operating in tandem with one 
another (Bollen and Gutin [Forthcoming]). 
This simultaneously dynamic and stable conceptualization of health is most effectively 
documented in research on self-rated health, yet extant research suggests similar processes with respect to 
individuals’ perceptions of their weight. Scholars have written extensively on how individuals’ life and 
health experiences lead to the formation of certain “health identities”, and even “weight identities”, which 
are fairly static over time and have a strong influence on specific health beliefs and behaviors throughout 
the life course (Blaxter 2004; Fox and Ward 2008; Sobal and Maurer 2017; Whyte 2009). While few 
studies have empirically assessed these theories, Wedow et al.’s (2016) study on adolescent and young 
adult weight identity finds evidence of both stability and change. Namely, a large proportion of the 
variance in subjective weight status can be explained due to differences and changes in individuals’ 
objective weight; nevertheless, a significant proportion of the stability in subjective weight remains 
unaccounted for, strongly suggestive of stable genetic or “heritable” traits influencing this measure, 
especially among females. Thus, identifying the appropriate longitudinal model for perceived weight is 
critical for understanding its association with both objective weight and later life health. 
Data 
Data for this project come from the National Longitudinal Study of Adolescent to Adult Health 
(Add Health), a nationally-representative survey of adolescents (grades 7-12) who, along with their 
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parents, were initially interviewed in 1994-1995, with additional respondent interviews in 1996 (Wave II: 
grades 8-12), 2001-2002 (Wave III: ages 18-26), 2008 (Wave IV: ages 24-32), and 2016-2018 (Wave V: 
ages 32-42). A key strength of the initial study design is its use of a complex, stratified sampling strategy 
that accounts for the region, urbanicity, size, type, and racial composition of schools from which students 
were recruited, thus maintaining the national representativeness of the data at the initial wave and through 
the follow-up (Harris et al. 2019). Further, Add Health is ideally suited for examining both the 
measurement properties of subjective weight and its associations with other aspects of health; while 
questions about individuals’ perceptions of/feelings about their weight are relatively common in survey 
research (e.g., National Health and Nutrition Examination Survey, Jackson Heart Study), they are far less 
frequent in longitudinal data sets that span critical points in the life course (e.g., National Longitudinal 
Survey of Youth 1997 [NLSY97]), let alone in conjunction with many other measures of health in 
adulthood, as is crucial for this analysis. Additionally, Add Health provides longitudinal survey weights 
that ensure the sample is representative of U.S. adults in this cohort, while accounting for attrition over 
time. 
Individuals’ subjective weight status is the focal variable in this project, based on respondents’ 
answer to the question, “How do you think of yourself in terms of weight?”, with “very underweight”, 
“slightly underweight”, “about right”, “slightly overweight”, and “very overweight” as possible options. 
This measure is asked in the first four waves of Add Health, providing a comprehensive history of 
individuals’ perceptions of their weight over nearly 20 years and across multiple important stages in the 
life course. I treat subjective weight as a continuous measure, influenced by an underlying continuous 
latent variable of perceived weight. Past research suggests that this is a plausible assumption for a five-
category ordinal measure (Rhemtulla et al. 2012), especially as it facilitates easier estimation in what are 
already demanding models; however, I make sure to test alternate specifications in case the choice of 
measurement introduces bias. Given the focus on overweight and obesity in health research, more positive 
values indicate a greater propensity to view oneself as overweight (i.e., subjective weight). Thus, in the 
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first part of the analysis, I focus on establishing the measurement properties of subjective weight as 
indicative of stability or change in individuals’ latent beliefs about their current body weight. 
Though I return to this in the limitations, I would be remiss to ignore the large body of literature 
in psychology examining body image, body satisfaction, and weight bias or stigma, often using multi-
item scales to capture different dimensions of these complex latent constructs (Lillis et al. 2010; Sandoz 
et al. 2013). The perceived weight measure used in these analyses (or a close analogue) can be found in 
these scales (Durso and Latner 2008), suggesting that these perceptions are reflective of multiple latent 
constructs surrounding one’s body, weight, and how individuals feel about it. While perceived weight is 
an imperfect measure, it is the best available option in a longitudinal, nationally-representative data set 
like Add Health; thus, in referring to subjective weight, I focus on perception and subjective evaluation, 
but consider its implications for broader constructs like body image, body satisfaction, and weight bias or 
stigma. 
I also account for changes in individuals’ trajectories of “objective” weight, in estimating how 
much of the variation in subjective weight is based on actual changes in body size over time. In defining 
“objective” weight, I use the established measure of individuals’ body mass index (BMI: 
mass[kg]/height[cm]2). The focus is on BMI as a relative estimate of body size – wherein higher values 
suggest one’s weight is increasingly disproportionate to one’s height – rather than using clinical 
categories of “normality” or “healthiness” into which BMI is sorted, as is often the case in past research 
on individuals’ perceptions of weight. Given the large age range under consideration, a continuous 
measure of BMI helps reduce any additional measurement error introduced by categorization, especially 
with respondents still growing in the early waves of the data. BMI is collected in all five waves of Add 
Health, but only self-reported measures are available in Wave I when respondents are adolescents. There 
is evidence to suggest reporting bias based on self-reported, rather than measured, height and weight in 
this age group (Sherry et al. 2007); however, this bias is fairly low and this study takes steps to correct for 
measurement error in the analysis. 
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Pursuant of the second research goal, I examine the association between intersecting trajectories of 
subjective and objective weight and a diverse set of health outcomes. These outcomes represent a mix of 
both physical and mental health measures examined in past research on perceived weight and BMI; 
however, this study focuses on subjective and objective weight as indicative of individuals’ exposures to 
physiological and psychosocial “stress” – both of which may be captured by the same health outcomes – 
rather than examining a broader set of indicators associated with all domains of health (e.g., blood lipids 
and blood sugar [Daly et al. 2017]). Consequently, the measures noted below emphasize this notion of 
underlying stress across various domains: 
1. Wave V BMI: Extant research on misperception of weight implicitly assumes that individuals’ 
accurate perception of themselves as overweight is key to instigating the kinds of weight-related 
behaviors that engender weight loss. However, there is evidence of a “paradoxical” relationship 
between perceived weight and BMI, such that individuals who perceive themselves as overweight 
experience further weight gain, possibly on account of unhealthy dieting behaviors (e.g., yo-yo 
dieting, where short-term weight loss precedes further weight gain) and/or other coping 
mechanisms brought on by the stress of overweight as a social identity (Tomiyama et al. 2018). 
Wave V BMI is already used in modeling the trajectory of objective weight, but I can further 
examine how this relationship does or does not change in accounting for subjective weight.  
2. Blood pressure: Decades of research show higher blood pressure is associated with the 
physiological consequences of a higher body weight and the stresses this weight places on the 
body by requiring the heart and cardiovascular system to work harder in maintaining homeostasis 
(Kotchen 2010). However, higher blood pressure is also thought to be associated with the 
increased stress of having a negative body image or greater body dissatisfaction, stemming from 
the social factors noted prior. Drawing on past research, I leverage the fact that Add Health 
provides three reports of blood pressure to estimate a latent variable associated with both systolic 
and diastolic blood pressure (SBP and DBP: Bauldry et al. 2015). 
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3. Measured hypertension and/or taking medication: This is a constructed variable in Add Health, 
based on clinical cutoffs for hypertension from measured blood pressure (130/80 SBP/DBP), 
while also taking into account individuals’ use of antihypertensive medications that can affect 
these measurements (Whistsel et al. 2020).  
4. C-reactive protein (CRP): While this is not a measure available in all data sets, it is increasingly 
used as a marker of “chronic” (or sustained) stress on the body, to the extent that this stress is 
reflected in a sustained inflammatory response (Harris and Schorpp 2018). As with blood 
pressure, CRP doubles as both a physiological and psychosocial marker of stress associated with 
objective and subjective body size, respectively. 
5. Depression: Many studies have found robust longitudinal associations between depression and 
obesity or a higher BMI, but the proposed explanations typically favor psychosocial mechanisms 
(Frisco et al. 2010; Luppino et al. 2010). In using depression as an outcome, this study assumes 
that the subjective weight variable is likely to capture this psychosocial process identified in past 
research, as a function of the worse mental health typically associated with negative body image 
and stigma (Friedman et al. 2005; Harriger and Thompson 2012; Stevens et al. 2017). Rather than 
using a sum-score or index approach to measuring depression, I estimate a latent variable model 
based on indicators with the highest reliability (Perreira et al. 2005). Namely, this measure is 
constructed from reports of how many times respondents felt depressed in the last week, how 
many times they had the blues, and how many times they felt sad, with responses recoded as ever 
or rarely (0), sometimes (1), a lot of the time (2), or most or all of the time (3). 
6. Diagnosed depression: As with blood pressure, I include this measure to account for any formal 
diagnosis of depression that may not be reflected in the previous latent measure of depression, 
especially if it is influenced by a diagnosis. 
7. Diagnosed anxiety: Like depression, this is another common measure of mental health examined 
in conjunction with obesity and BMI, and yet largely explained as a function of psychosocial 
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mechanisms (Gariepy et al. 2010). Thus, it presents another opportunity to assess the role of 
perceived weight – or the social aspects of overweight – rather than body size itself.  
8. Sleep trouble: I include this final measure given emerging research on the importance of high-
quality sleep for many of the health outcomes listed above. Individuals’ quality of sleep is not 
necessarily a definitive “outcome” in this analysis, but it is likely correlated with the other 
measures and represents an important health issue in and of itself. Explanations for the 
association between poor sleep and obesity/BMI reflect psychosocial mechanisms as well – 
wherein the role of perception is once again highly salient – but there are many reasons to believe 
that a high body size is positively associated with trouble sleeping on account of physiological 
mechanisms, such as breathing difficulties. Indeed, evidence on the association between 
individuals’ quality of sleep and obesity varies based on the measures being used (Rahe et al. 
2015). In Add Health, respondents are asked how often they experience trouble sleeping, with 
responses recoded as never (0), less than once a week (1), one or two times a week (2), three or 
four times a week (3), or five or more times a week (4). 
Finally, I include key sociodemographic variables in the analysis. As noted, I consider gender-
stratified models, checking for configural invariance in the fit of the intersecting trajectories of subjective 
and objective weight between female and male respondents. I also include basic controls for respondents’ 
age and their race/ethnicity, coded as non-Hispanic (NH) White, NH Black, Hispanic, and NH Other. 
Educational attainment is allowed to vary over time. Since most respondents have not yet completed their 
education at Waves I and II, it is coded as 0 or 1 based on whether a parent had at least a college degree. 
At Wave III, educational attainment is coded as 0 or 1 based on whether respondents are in college or 
have completed a college degree, given the mixed age range in the sample. At Waves IV and V, 
educational attainment is coded as 0 or 1 based on whether respondents have completed a four-year 
college degree. Ideally, the analysis would include more detailed categories for educational attainment, 





This analysis uses structural equation models (SEM) with latent variables to assess the 
measurement properties of subjective weight status over time, as well as its relationship with other 
measures of health. Critically, by fitting a single hypothesized model that accounts for trajectories of 
perceived weight, BMI, health outcomes, and covariates – while accounting for measurement error in key 
variables – I can explicitly account for important relationships among variables that would be neglected 
using a more traditional OLS approach, or other methods where researchers cannot specify specific 
pathways of interest. A distinct advantage of SEM is the ability to assess and compare multiple fit 
statistics across nested models in identifying the hypothesized model structure (i.e., the interrelations 
among latent and observed variables specified in the latent and measurement models) most closely 
corresponding to the relationships and covariance among variables observed in the Add Health data, thus 
providing important context for assessing the veracity of the estimates. The current study uses a 
systematic approach to model-building, making sure that the individual components of the larger 
structural model demonstrate good fit before proceeding with testing additional components. 
The first step of the analysis involves identifying the appropriate trajectories of both perceived 
weight and BMI over time. This work builds on recent literature emphasizing the utility of SEM for 
testing nested longitudinal modeling frameworks (Bauldry and Bollen 2018; Bianconcini and Bollen 
2018; Bollen and Curran 2004; Bollen and Gutin [Forthcoming]), especially when clear guidance on a 
choice of model is lacking or unavailable, as is the case for both measures. Indeed, there is evidence of 
many different trajectories in research on BMI, though the lack of systematic testing of these trajectories 
does not provide researchers with clear guidance as to which models are most appropriate in a given 
context. Many studies invoke some kind of “growth” trajectory over the life course – including past 
studies of the Add Health data (Burdette and Needham 2012; Hargrove 2018; Sokol et al. 2019) – while 
other research suggests more straightforward autoregressive frameworks (Konttinen et al. 2014; Sokol et 
al. 2020), or more complex trajectories that incorporate both random intercepts and slopes and 
autoregressive relations (Aitkin and Alfò 2003). There are compelling reasons to suggest one longitudinal 
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approach is more or less appropriate than another, and a full review of these explanations is beyond the 
scope of the current study; however, these models can be tested and compared to one another in 
identifying the best choice for these analyses. 
Likewise, there is limited knowledge of what categorizes longitudinal trajectories of subjective 
weight, beyond what researchers might infer based on how well it does (or does not) track with 
individuals’ objective weight. On the one hand, if subjective weight is largely a reflection of individuals’ 
objective weight, then we might expect to see the same “growth,” or life course, patterns as those seen in 
past work on BMI. However, recent studies suggest that weight identities may be relatively “sticky,” such 
that individuals exhibit a fair degree of stability in assessments of their weight despite changes that occur 
in their BMI over time (Wedow et al. 2016; Wedow et al. 2018). These findings would suggest the 
presence of some kind of time-invariant or enduring influence on perceived weight (Bollen and Gutin 
[Forthcoming]), and/or the presence of a strong lagged effect. In general, many measures used in health 
and social research can be described as path dependent, to the extent that we might anticipate strong 
lagged effects, where the best predictor of a measure is its prior value, as in an autoregressive model 
(Adachi and Willoughby 2015; Biesanz 2012; Bollen and Gutin [Forthcoming]). Critically, none of these 
models are mutually exclusive, as it is possible to integrate multiple longitudinal properties reflecting 
different underlying assumptions about the longitudinal processes at work (Bauldry and Bollen 2018; 
Bianconcini and Bollen 2018; Bollen and Curran 2004; Bollen and Gutin [Forthcoming]). Finally, both 
subjective and objective weight can be categorized by some degree of “spontaneity” in their 
measurement, such that they are largely a function of momentary contextual influences – as hypothesized 
in research on self-rated health (Gunaseraka et al. 2012; Peruccio et al. 2010). In this case, there is no 
overarching longitudinal trajectory or pattern that is appropriate, as would be evidenced by the poor fit of 
all models under consideration (Bollen and Gutin [Forthcoming]). Once again, SEM provides the 
opportunity to consider multiple plausible options and identify the most appropriate model.  
Furthermore, these longitudinal models allow researchers to correct for measurement error in the 
observed measures by modeling them as single indicators of an underlying latent variable. Typically, such 
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a model would not be identified; however, researchers can make reasonable assumptions about the error 
variance of the observed measures as being the same over adjacent repeated measures (or fixed over the 
entire observation period), thereby providing an estimate of the reliability of the measure in the form of 
the R-squared value (Bollen and Gutin [Forthcoming]; Heise 1969; Werts et al. 1971; Wiley and Wiley 
1970). Specifically, by estimating how much of the error variance in the observed measure is explained 
by the latent variable (as the observed measure is regressed on the latent variable), the remaining 
unexplained variance provides an estimate of the random measurement error.  
One can think of this as a way of assessing how much variance might be expected in the observed 
response by virtue of asking respondents the same question while erasing their memory of past responses 
or, alternatively, if individuals were asked the same question in slightly different ways. For instance, there 
is likely to be considerable measurement error in perceived weight; inherent differences across 
individuals’ frame of mind or emotional state, as well as their interpretation of the question and the 
underlying ideas or beliefs that it triggers, may limit the reliability of perceived weight as an accurate 
measure of individuals’ subjective weight. This can lead to biased estimates in the relationship between 
subjective weight and other variables, such as later life physical health and well-being (Daly et al. 2017; 
Unger et al. 2017). Likewise, random measurement error in BMI may occur from issues in self-reporting, 
the instruments being used to measure height and weight, and user-error on the part of those using the 
instruments (Bollen 1989). Thus, correcting for measurement error allows for longitudinal analyses using 
the underlying error-free latent constructs rather than observed variables (Bianconcini and Bollen 2018), 
while also providing insight on the reliability of these observed variables over time. In this first step of the 
analysis, I use the full sample of the 12,300 Add Health respondents who participated in Wave V and at 
least one other wave, thus allowing maximum flexibility in identifying the appropriate trajectories without 
further limiting the sample due to the absence of survey weights. 
The second step of the analysis builds on the prior in testing plausible models of how the 
trajectories of subjective and objective weight are associated over time. Depending on the nature of the 
best-fitting models for both measures, one may expect direct associations between the measures 
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themselves – such as cross-lagged relationships across waves and direct relationships within waves – or 
relationships among the latent intercepts and slopes for these measures – as consistent with latent growth 
models – as well as different assumptions about correlated errors (Bollen and Curran 2004). Critically, the 
different models may also incorporate various combinations of these features, all of which are testable 
assumptions, as seen in past research (Kane et al. 2018). These models are initially estimated using the 
unweighted sample of 12,300 Add Health respondents, which are compared to weighted estimates from 
the 7,105 Add Health respondents with valid longitudinal survey weights. This weighted sample is used 
in subsequent analyses because I want to make sure the estimated associations with the Wave V health 
outcomes are nationally-representative and account for potential selection bias among adults without 
weights. 
The third and final step incorporates Wave V health outcomes into the best-fitting model 
identified in the prior step: thus, the estimated associations may be between Wave IV subjective and 
objective weight and Wave V health; between the intercepts and slopes explaining the longitudinal 
patterns of subjective and objective weight; or both the latent variables and latent intercepts and slopes, 
depending on the nature of the trajectories and their intersections.  
Throughout the analysis, I examine how well the model fits for female and male respondents, as 
one should verify that the structure is well-fitting for both groups prior to making comparisons in the 
nature of the trajectories or their associations with health outcomes. One cannot reliably make claims 
about gender differences if a given model does not appear to work equally well for both groups. 
Model fit is examined across multiple criteria commonly used in SEM. Specifically, I use chi-
square tests and other measures to assess how closely the hypothesized models fit the Add Health data. 
Given the large sample size in Add Health, it is likely that even minor specification errors could lead to 
statistically significant chi-square (χ2) tests; thus, I also use a BIC comparison statistic that compares the 
fit of the saturated and hypothesized models, which is obtained by subtracting the degrees of freedom 
times the natural log of the sample size from the chi-square value (Raftery 1995). Negative values – 
ideally, greater than 10 – provide evidence favoring the hypothesized over the saturated model (Raftery 
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1995). The same logic can be applied to nested models, where models with larger negative BIC values are 
favored. The CFI, TLI, and RMSEA (or 1-RMSEA, in this case) are other common fit statistics (Bentler 
1990; Steiger and Lind 1980; Tucker and Lewis 1973). Across all three, values closer to 1 represent better 
fit, while values less than 0.9 are considered inadequate.  
I use Casewise Maximum Likelihood (also called FIML) estimation to account for missing data 
among endogenous variables, which assumes data are Missing Completely at Random or the less 
restrictive Missing at Random. Critically, this approach allows individuals to contribute any available 
information on observed variables at any wave, which is especially useful in longitudinal data where 
researchers often limit their sample to only those adults meeting a minimum number of waves for 
inclusion. Overall model fit is then derived from fitting equations across all of the individual cases 
(Arbuckle 1996). In the models with endogenous categorical outcomes – such as those testing alternate 
specifications for perceived weight and models with binary health outcomes – I instead use the weighted 
least square mean and variance adjusted (WLSMV) estimator, with the theta parametrization. Both the R 
package “lavaan” (Roseel 2012) and Mplus are used to estimate models (Muthén and Muthén 2018); 
lavaan allows for more flexibility in estimating the different longitudinal models in the first step of the 
analysis, as convergence issues are less frequent, while Mplus is better suited for incorporating survey 
weights in the latter part of the analysis. 
Results 
Table 4.1 provides a descriptive summary of all variables used in the analysis, both for the overall 
sample and stratified by gender, accounting for complex survey weights. The average age for respondents 
at Wave I is 15.4, half are female, and approximately 70% identify as non-Hispanic White, 16% as non-
Hispanic Black, 9% as Hispanic, and 5% as a different non-Hispanic race or ethnic group. About one-
third of respondents had at least one college-educated parent, and just under half were in college or had 
completed college at Wave III (50% among females, compared to 45% among males). However, many   
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respondents did not complete college, as the percentage with at least a college degree is 32% in Wave IV 
and 36% by Wave V, with a higher proportion among females at both waves (34% vs. 29% at Wave IV; 







Table 4.1 Descriptive Statistics for Perceived Weight, Body Mass Index, and Sociodemographic Covariates and Health Outcomes 
               
    Overall  Female  Male 
               
    Mean/Prop.  
Std. 
Dev. 
 Mean/Prop.  
Std. 
Dev. 
 Mean/Prop.  
Std. 
Dev. 
               
Perceived Weight   
   
 
   
 
   
 Wave I  3.180  0.803  3.356  0.785  3.007  0.782 
 Wave II  3.195  0.789  3.375  0.771  3.018  0.766 
 Wave III  3.337  0.809  3.538  0.784  3.140  0.785 
 Wave IV  3.625  0.823  3.804  0.804  3.448  0.802                
Body Mass Index (BMI)             
 Wave I  22.565  4.590  22.440  4.585  22.686  4.591 
 Wave II  23.276  5.197  23.292  5.367  23.260  5.026 
 Wave III  26.791  6.426  26.973  7.016  26.612  5.782 
 Wave IV  29.223  7.631  29.416  8.242  29.033  6.969                
Sociodemographic             
 Age at Wave I  15.396  1.761  15.317  1.726  15.475  1.791 
 Female  0.497  0.500  -  -  -  - 
 Race/Ethnicity             
  NH-White  0.700  0.458  0.699  0.458  0.702  0.457 
  NH-Black  0.159  0.366  0.164  0.370  0.154  0.361 
  Hispanic   0.093  0.290  0.088  0.285  0.097  0.295 
  NH-Other  0.048  0.214  0.049  0.214  0.048  0.214 
 College-educated Parent  0.320  0.466  0.313  0.464  0.326  0.469 
 Wave III In-College +  0.476  0.499  0.499  0.500  0.453  0.498 
 Wave IV B.A. Degree +  0.316  0.465  0.337  0.473  0.294  0.456 
 Wave V B.A. Degree +  0.357  0.479  0.389  0.488  0.324  0.468 
               
Wave V Outcomes             
 BMI  30.969  7.958  31.349  8.613  30.517  7.073 
 Syst. BP (1)  124.969  15.978  120.631  15.191  129.891  15.413 







 Syst. BP (3)  123.090  15.042  119.263  14.230  127.444  14.755 
 Diast. BP (1)  80.628  11.270  78.194  10.785  83.389  11.171 
 Diast. BP (2)  80.243  11.162  77.862  10.775  82.947  10.977 
 Diast. BP (3)  79.755  10.924  77.415  10.464  82.417  10.826 
 
Measured 
Hypertension/Rx  0.334  0.471  0.261  0.439  0.416  0.493 
 C-reactive Protein  3.947  5.650  4.900  6.555  2.821  4.067 
 Felt Depressed Freq.  1.419  0.699  1.453  0.725  1.385  0.669 
 Felt Blues Freq.  1.372  0.691  1.388  0.694  1.357  0.687 
 Felt Sad Freq.  1.585  0.672  1.638  0.690  1.532  0.649 
 Depression Dx  0.256  0.436  0.328  0.469  0.185  0.389 
 Anxiety Dx  0.234  0.423  0.300  0.458  0.169  0.374 
 Sleep Trouble Freq.  1.774  1.345  1.957  1.355  1.592  1.309 
                              
               
N(Overall)=7,105; N(Female)=4,152; N(Male)=2,953. 
Results based on casewise maximum likelihood (also called FIML) estimation to account for missing data,  
with robust (Huber-White) standard errors. 
Weighted estimates account for person-level longitudinal survey weights (WI-V), school-level clustering,  
and regional strata. 
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The focal variable of interest, perceived weight, has an increasing trend over time, following the 
same trend in BMI across the first four waves. Namely, while respondents have a mean perceived weight 
of 3.19 in Waves I and II – slightly above a value corresponding with perceiving oneself as at about the 
right weight – this value increases to 3.63 by Wave IV, closer to the “slightly overweight” threshold. 
However, there are clear gender differences in this pattern between women and men. Women perceive 
themselves as more overweight across all four waves, with a consistent gap of 0.35 in the mean value 
over time; indeed, not until Wave IV does the mean value among men (3.45), exceed the mean value for 
women at Waves I and II (3.36). By contrast, BMI means are much closer for female and male 
respondents, and track more closely over time, shifting from a BMI (~23) that is considered “normal” 
based on BMI categories in Waves I and II (albeit these categories are not necessarily appropriate for the 
age range represented in Wave I), to overweight in Wave III (26.8), and being close to the cutoff for 
obesity by Wave IV (29.2). 
Finally, mean values and proportions for Wave V health outcomes show clear evidence of gender 
differences in both physical and mental health. BMI has increased further and is above the cutoff for 
obesity at mean value of 31, which is slightly higher for females (31.3) than males (30.5). Conversely, 
systolic blood pressure is higher for males (128.6) than females (119.8), with a pattern of decreasing 
values across repeated measures. Likewise, diastolic blood pressure is higher for males than females (82.9 
vs. 77.8), also with a pattern of decreasing values across measures. Unsurprisingly, over two-in-five 
males have a prevalence of high blood pressure or report using anti-hypertensive medication, as compared 
to just over one-quarter of female respondents. The overall mean for systolic over diastolic blood pressure 
is 123.9/80.2, and about one-third of adults have measured hypertension or are on medication. Looking at 
C-reactive protein, the mean value for the sample is 3.9 mg/L, which exceeds the “high” risk threshold of 
3.0 often used in medicine and research (Ridker 2003); however, female respondents have much higher 
average CRP (4.9) compared to males (2.8). Female respondents are also more likely to report poor 
mental health symptoms than their male counterparts, as seen in the measures used to estimate latent 
depression (Depressed frequency 1.45 vs. 1.38 [1.42 Overall]; Blues frequency 1.39 vs. 1.36 [1.37 
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Overall]; Sad frequency 1.64 vs. 1.53 [1.59 Overall]), as well as prevalence of diagnosed depression (33% 
vs. 18.5% [26% Overall]) and diagnosed anxiety (30% vs. 17% [23% Overall]). Finally, the overall mean 
score of 1.77 on sleep trouble frequency suggests the average respondent had trouble falling asleep closer 
to one or two times a week as compared to less than once a week, though this average is closer to the one 
or two times threshold for females (1.96) as compared to male respondents (1.59). 
Since I use non-weighted estimates in some of the analyses, the descriptive statistics for the 
unweighted sample of 12,300 Wave V adults are shown in Table A.9 in the Appendix. The most notable 
differences in this sample are the higher proportion of female respondents (57%) and lower percentage of 
non-Hispanic White adults (60%). However, most of the other estimates and patterns are largely the same. 
As discussed earlier, there is nothing in the literature on perceived weight to suggest a specific 
longitudinal model best-suited for the measure; thus, I test plausible options consistent with different 
assumptions about lagged effects, enduring influences, and growth trajectories, as well as possible 
combinations therein. With only four waves of data for perceived weight, one cannot test all possible 
longitudinal model types and trajectories. In some cases, constraints need to be imposed (Bollen and 
Curran 2004). However, I am still able to examine five distinct models consistent with the different 
plausible longitudinal processes at work, as seen in Figure 4.1. The five models are consistent with a 
“lagged effects” perspective on perceived weight (as represented by an autoregressive model), an 
“enduring influence” framework (equivalent to a traditional fixed effects model [Bollen and Brand 
2010]), two different growth trajectories assuming either linear slopes or freed loading slopes that vary 
over time (Bauldry and Bollen 2018), or a final “hybrid” model where the enduring influence is 








Lj = Latent subjective weight at Wave j; j = 1,2,3,4. 
PWj = Measures of Perceived Weight at Wave j; j = 1,2,3,4. 
α, β, ζ = Latent intercepts and slopes. 
Open arrows indicate error terms. 
 
Figure 4.1 Plausible Longitudinal Trajectories for Subjective Weight  
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Table 4.2 presents fit statistics for these different longitudinal models, as well as any additional 
notes on the estimation. The best fitting model is clearly the autoregressive trajectory, wherein the best 
predictor of individuals’ subjective weight is its prior value. This model has a non-significant chi-square 
value and a negative BIC, providing evidence that the hypothesized model fits the data well. Moreover, 
the CFI, TLI, and 1-RMSEA values are either at the perfect value of 1, or very close to it, with no 
estimation issues or additional constraints. With the exception of the fixed effects model, all of the other 
models show good fit on the basis of CFI, TLI, and 1-RMSEA; however, the positive BIC values suggest 
they are not appropriate for modeling subjective weight. These models also produce negative variances 







Table 4.2 Comparison of Longitudinal Models for Subjective Weight 
                 
Model     χ2   DF   BIC   CFI   TLI   1-RMSEA   Notes 
                 
Autoregressive  1.841  1  -7.576  1.000  1.000  0.991  None                  
Fixed Effects  437.891  3  409.639  0.933  0.865  0.838  Negative variances 
                 































Regressions constrained to be equal 
                                  
                 
N=12,300. 
Results based on casewise maximum likelihood (also called FIML) estimation to account for missing data,  
with robust (Huber-White) standard errors. 
Variance on first and last two observed measures of perceived weight constrained to be equal, respectively. 
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The models above use a continuous specification for perceived weight, based on a five-point 
scale from very underweight to very overweight. To ensure that the choice of specification does not result 
in different conclusions about the choice of the most appropriate model, I present a comparison of all the 
aforementioned models based on alternate specifications for perceived weight in Table A.10 in the 
Appendix. Namely, I compare models with only three categories where underweight and about right 
responses are combined into a single category; three categories where respondents are either underweight, 
about right, or overweight; a dichotomous indicator of overweight or not; and ordinal specifications of the 
five and three category specifications. These additional analyses provide clear evidence that the 
autoregressive (AR) model outperforms the other longitudinal models across most specifications. There is 
some ambiguity when treating subjective weight status as a five-category ordinal measure, wherein the 
ALT-fixed effects (ALT-FE) model (combining an enduring and lagged effects perspective) and freed 
loading growth models also have good fit. However, the general pattern across specifications favors the 
AR model, and thus I feel confident using a continuous version of the perceived weight measure. 
Following the same approach described above, I proceed with identifying the appropriate 
longitudinal model to describe the trajectory of BMI in the Add Health sample. Though I am primarily 
focused on Wave V BMI as an outcome, I include the measure in this trajectory to have more flexibility 
in estimating the models over five rather than four waves. As seen in Table 4.3, the autoregressive model 
once again has excellent fit, with a nonsignificant chi-square and a large, negative BIC, exceeding the 
recommendation for “strong” evidence of good fit (Raftery 1995). As before, there is evidence of 
relatively good fit for a number of the models based on CFI, TLI, and 1-RMSEA, but most have large and 
positive BIC values, as well as possible issues in the estimation or require many additional constraints to 
converge or be identified. There is good support for the ALT-FE model; a likelihood ratio test comparing 
the ALT-FE and AR model is nonsignificant, favoring the ALT-FE model. However, the BIC difference 
of 16 between these models favors the AR model (Raftery 1995). In assessing the resulting parameters, 
there appear to no major differences; AR coefficients are consistently larger than 1.000 in the ALT-FE 
model, albeit with larger standard errors. Given that the substantive interpretation of the models is similar, 
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I proceed with the AR model, which also allows for a more straightforward interpretation of how the 
trajectory of objective weight intersects with subjective weight over time. Finally, the AR models for both 
subjective and objective weight demonstrate configural invariance between female and male respondents, 







Table 4.3 Comparison of Longitudinal Models for Objective Weight 
                 
Model     χ2   DF   BIC   CFI   TLI   1-RMSEA   Notes 
                 
Autoregressive  2.561  3  -25.691  1.000  1.000  1.000  None                  
Fixed Effects  1627.872  6  1571.368  0.822  0.703  0.689  Negative variances 
                 
Linear Growth  1263.366  7  1197.445  0.907  0.868  0.792  Negative variances                  
Quadratic Growth  118.473  4  80.804  0.992  0.980  0.919  Negative variances                  
Freed Loading Growth 142.254  4  104.585  0.988  0.970  0.901  Negative variances                  
ALT-Fixed Effects  0.087  1  -9.330  1.000  1.000  1.000  None 
                 
ALT-Linear Growth  30.279  2  11.444  0.999  0.988  0.954  None                  












Regressions constrained to 
be equal; Observed BMI 
error variances constrained 
to be equal; Covariance of 
latent Obj. with Intercept 
and Slopes constrained to be 
equal. 















Regressions constrained to 
be equal; Observed BMI 
error variances constrained 
to be equal. 
                                  
                 
N=12,300. 
Results based on casewise maximum likelihood (also called FIML) estimation to account for missing data,  
with robust (Huber-White) standard errors. 




Table 4.4 shows coefficient estimates from the AR model for both measures, demonstrating how 
both subjective and objective weight exhibit a high degree of inertia or path dependency on the basis of 
the autoregressive coefficients. Namely, the subjective weight model has relatively high autoregressive 
coefficients between the latent variables for subjective weight (W1→W2 0.921; W2→W3 0.775; 
W3→W4 0.878), as well as fairly high R-square values for the endogenous latent variables (W2 0.870; 
W3 0.620; W4 0.758) suggesting that the majority of variance in subjective weight status is explained by 
its previous value. The R-squared for the observed measures of perceived weight provide an estimate their 
reliability; there is clear evidence of nonnegligible measurement error, as approximately one-third to one-







Table 4.4 Coefficient Estimates for Autoregressive Models of Subjective Weight (SUBJ.) and Objective Weight (OBJ.)  
                     
Perceived Weight   Body Mass Index 
Parameters     Estimate   
Std. 
Err. 
  P-value             Estimate   
Std. 
Err. 
  P-value 
                     
Regressions        Regressions        
 Wave IV SUBJ. ←          
            Wave V OBJ. ←      
  Wave III SUBJ. 0.921 
 0.017  0.000    Wave IV OBJ. 0.936 
 0.015  0.000 
 Wave III SUBJ. ←          
            Wave IV OBJ. ←      
  Wave II SUBJ. 0.775 
 0.015  0.000    Wave III OBJ. 1.072 
 0.013  0.000 
 Wave II SUBJ. ← 
       Wave III OBJ. ←      
  Wave I SUBJ. 0.878 
 0.016  0.000    Wave II OBJ. 1.104 
 0.013  0.000 
          
  Wave II OBJ. ←      
          
  
 Wave I OBJ. 1.086 
 0.013  0.000 
                     
Intercepts   
      Intercepts   
     
 Wave I SUBJ. 3.190 
 0.007  0.000   Wave I OBJ. 22.610  0.041  0.000 
 Wave II SUBJ. 0.399 
 0.052  0.000   Wave II OBJ. -1.332  0.286  0.000 
 Wave III SUBJ. 0.870 
 0.048  0.000   Wave III OBJ. 1.154  0.290  0.000 
 Wave IV SUBJ. 0.560 
 0.058  0.000   Wave IV OBJ. 0.409  0.340  0.229 
     
       Wave V OBJ. 3.494  0.410  0.000 
                     
Variances   
      Variances   
     
 Wave I PW 0.161 
 0.007  0.000   Wave I BMI 1.907  0.171  0.000 
 Wave II PW 0.161 
 0.007  0.000   Wave II BMI 1.907  0.171  0.000 
 Wave III PW 0.233 
 0.009  0.000   Wave III BMI 4.112  0.392  0.000 
 Wave IV PW 0.233 
 0.009  0.000   Wave IV BMI 5.158  0.753  0.000 
      
 
 
    Wave V BMI 5.158  0.753  0.000 
 Wave I SUBJ. 0.474 
 0.011  0.000   Wave I OBJ. 18.544  0.458  0.000 
 Wave II SUBJ. 0.054 
 0.011  0.000   Wave II OBJ. 2.147  0.310  0.000 
 Wave III SUBJ. 0.154 
 0.007  0.000   Wave III OBJ. 8.667  0.355  0.000 
 Wave IV SUBJ. 0.110 
 0.014  0.000   Wave IV OBJ. 9.203  0.624  0.000 
     
       Wave V OBJ. 10.280  1.128  0.000 







R-Square   
      R-Square   
     
 Wave I PW 0.746 
      Wave I BMI 0.907     
 Wave II PW 0.722 
      Wave II BMI 0.926     
 Wave III PW 0.636 
      Wave III BMI 0.902     
 Wave IV PW 0.661 
      Wave IV BMI 0.911     
      
      Wave V BMI 0.916     
 Wave II SUBJ. 0.870 
      Wave II OBJ. 0.911     
 Wave III SUBJ. 0.620 
      Wave III OBJ. 0.771     
 Wave IV SUBJ. 0.758 
      Wave IV OBJ. 0.826     
     
       Wave V OBJ. 0.818     
                                          
                     
N=12,300. 
Results based on casewise maximum likelihood (also called FIML) estimation to account for missing data,  
with robust (Huber-White) standard errors. 
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Likewise, in the AR model for objective weight there is evidence of a strong and consistent effect 
from one wave to the next, with AR coefficients very close to, or exceeding a value of 1.000 (sometimes 
described as “explosive autoregression” [Phillips 1987]): BM1→BMI2 = 1.086; BMI2→BMI3 = 1.104; 
BMI3→BMI4 = 1.072; BMI4→BMI5 = 0.936). This model also explains a very large proportion of the 
variation in objective weight, with high R-square values for all endogenous latent variables (BMI2 0.911; 
BMI3 0.771; BMI4 0.826; BMI5 0.818). Interestingly, the reliability estimates suggest relatively little 
measurement error in BMI – in either the self-report or measured observed variables – with R-square 
values ranging from 0.902 to 0.926. However, this does not mean that the measurement error is 
negligible; when estimating a model where BMI is assumed to be a perfect indicator of the latent variable 
(i.e., reliability = 1.000) there is a considerable decline in model fit, suggesting that the correction for 
error is preferable.  
Lacking any formal guidance or clear theory on how the trajectories of subjective and objective 
weight are interrelated over time, I proceed with testing plausible combinations of the different features 
one may expect to include based on the temporal ordering of effects within and across waves. The full set 
of plausible pathways is shown in Figure 4.2, serving as the basis for including or excluding different 
effects and correlations in the hypothesized models shown in Table 4.5. Specifically, in the “Correlated 
Only” model, I assume that the two trajectories are independent in terms of direct influences, but allow 
for objective and subjective weight to be correlated within waves – as would be expected given their 
being assessed at the same point in time. The “Within-wave Obj. on Subj. Only” model assumes that the 
primary information individuals draw on when assessing their subjective weight (in addition to their past 
response) is their objective weight or body size at that same point in time. By contrast, the “Cross-lagged 
Only” model assumes individuals’ subjective weight influences their later life objective weight and their 
current objective weight influences later life subjective weight. This is consistent with the logic that 
current beliefs about weight influence later life weight-related behaviors and that individuals’ beliefs   
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about their weight may be influenced by objective weight in the time period up to the moment they are 
asked. In addition to these three models, I combine various aspects of these models to account for more 








L(obj)j = Latent objective weight at Wave j; j = 1,2,3,4. 
L(subj)j = Latent subjective weight at Wave j; j = 1,2,3,4. 
BMIj = Measures of Body Mass Index at Wave j; j = 1,2,3,4. 
PWj = Measures of Perceived Weight at Wave j; j = 1,2,3,4. 
Open arrows indicate error terms. 
Double headed arrows indicate correlated errors. 
 
Figure 4.2 Plausible Pathways Linking Trajectories of Objective and Subjective Weight 
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The CFI, TLI, and 1-RMSEA criteria suggest excellent fit for all of the models; fortunately, the 
BIC provides more nuance in differentiating across these nested comparisons. The correlated and cross-
lagged and cross-lagged and within-wave models have the best fit, with identical large and negative BIC 
values (-20.331). These are known as chi-square equivalent, or just “equivalent,” models, due to the fact 
that the same parameters can be identified with the same elements of the covariance matrix (Raykov and 
Penev 1999). Equivalent models are not uncommon in cross-lagged models where the directionality of the 
relationship among variables is not clear; in these cases, researchers’ substantive knowledge can be used 
to identify the more appropriate model structure (Raykov and Penev 1999). Thus, it seems more 
appropriate to allow for direct within-wave effects – as one would expect individuals’ objective body size 








Table 4.5 Comparison of Intersecting Longitudinal Models for Subjective and Objective Weight 
               













               
Correlated Only 
 
246.894  14  115.051  0.995  0.989  0.957  
               
Within-wave Obj. on Subj. Only 
 
727.650  14  595.807  0.983  0.967  0.924  
               
Cross-lagged Only 
 
212.091  11  108.500  0.996  0.989  0.955  
               
Correlated and Within-wave Obj. 
on Subj. 
 
116.962  12  3.954  0.997  0.993  0.966  
               
Correlated and Cross-lagged 
 
55.008  8  -20.331  0.999  0.998  0.980  
               
Cross-lagged and Within-wave 
 
55.008  8  -20.331  0.999  0.997  0.975                                
                              
               
N=12,300. 




Before interpreting the coefficients in the best fitting model of both subjective and objective 
weight, it is important to acknowledge recent research on the utility of random intercept cross-lagged 
panel models (RICLPM) to address potential issues in how the relative “stability” of longitudinal 
measures is accounted for in traditional cross-lagged models (Hamaker et al. 2015; Usami et al. 2019), 
similar to the models used in these data. Namely, Hamaker and colleagues emphasize the importance of 
accounting for “stable, trait-like differences” exclusively in relation to “within-unit fluctuations” by using 
random intercepts to account for the part of the variance in a measure attributable to this “long-run” 
influence (Mulder and Hamaker 2021: 1). Their research suggests RICLPMs typically have better fit, and 
lead to more accurate autoregressive and cross-lagged estimates that are more appropriate for causal 
interpretation.  
The RICLPM model is not explicitly tested along with those presented above, on account of the 
fact that it does not model measurement error in a manner that allows for estimates of reliability; rather, 
the RICLPM model assumes that observed variables are perfect indicators of the underlying latent 
variable, with the latent time-invariant intercepts having a direct influence on these observed variables. 
Nevertheless, Hamaker et al.’s concerns about stability in cross-lagged models are pertinent to this 
analysis, and I proceed with fitting the proposed RICLPM. The resulting model has considerably worse fit 
relative to the more ‘traditional’ CLPM corrected for measurement error (BIC = 84.647); there are also 
issues in the estimation with respect to negative variances. Thus, I feel confident that the CLPM – 
modified to include direct effects, rather than cross-lagged effects – is most appropriate to these data. 
Figure 4.3 shows this cross-lagged model with all estimated pathways, accounting for 
longitudinal survey weights; both unstandardized coefficients (with standard errors) and standardized 
coefficients (in italics) are shown, on account of the fact that these two measures have different scales. 
Indeed, observed BMI was divided by 10 to bring variances among observed variables closer to one 
another and help with model convergence; though this makes interpreting unstandardized coefficients less 
clear, it does not   
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affect model fit. Thus, with the exception of the autoregressive coefficients, I focus on the standardized 
estimates as they are useful for comparing the relative effect of measures in cross-lagged models (Kuiper 









Model fit statistics: χ2 = 23.558, DF = 8, SBIC = -47.390, CFI = 0.999, TLI = 0.995, 1-RMSEA = 0.983.  
BMI divided by 10 to reduce variance and help with model convergence. 
L(obj)j = Latent objective weight at Wave j; j = 1,2,3,4. 
L(subj)j = Latent subjective weight at Wave j; j = 1,2,3,4. 
BMIj = Measures of Body Mass Index at Wave j; j = 1,2,3,4. 
PWj = Measures of Perceived Weight at Wave j; j = 1,2,3,4. 
Open arrows indicate error terms. 
Double headed arrows indicate correlated errors. 
Standardized coefficients in italics. 
*** p<0.001, ** p<0.01, * p<0.05, n.s. p≥0.05. 
 
Figure 4.3 Intersecting Pathways of Objective and Subjective Weight from Adolescence to Early Adulthood 
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The previously described large, autoregressive coefficients for the two trajectories are largely 
unchanged in the full model, though there is some attenuation across all estimates. Notably, the 
autoregressive effect between Waves II and III for SWS is reduced to 0.470, but it is still statistically 
significant. There is evidence of a consistent, negative cross-lagged effect between objective weight at 
one wave and subjective weight in the next, such that greater objective weight in the prior wave is 
associated with lower perceived subjective weight in the next. This cross-lagged effect is greatest between 
objective weight at Wave III and subjective weight at Wave IV, with a standardized estimate of -0.791; 
the effect is smaller, but also negative and statistically significant in prior waves, with standardized 
estimates close to -0.3. By contrast, the cross-lagged effect of subjective weight at prior wave to objective 
weight at the subsequent wave is positive but smaller. Both unstandardized and standardized estimates 
from Wave I subjective weight to Wave II objective weight and Wave III subjective weight to Wave IV 
objective weight are not significantly different from 0. However, there is a larger and significant, positive 
effect from Wave II subjective weight to Wave III objective weight (0.231 standardized) – a time when 
most respondents finish high school and are either in college or have completed their education – such 
that greater perceived weight is associated with larger body size. This likely explains some of the 
attenuation in the autoregressive subjective weight coefficient between these two time periods. Finally, 
there is a consistent positive and significant within-wave effect from objective weight to subjective 
weight, such that having a larger body size is associated with perceiving oneself as being overweight at a 
given point in time. Based on the standardized coefficients, this direct effect appears greater in Waves III 
(0.788) and IV (0.839) compared to Waves I (0.661) and II (0.334). Interestingly, the R-squared values 
are generally unchanged compared to the prior autoregressive models; however, about 50% of the 
variance in Wave I subjective weight is explained by Wave I objective weight, given that this is the only 
term influencing Wave I subjective weight in the model. 
Table A.11 shows the same estimates for this model in the full, unweighted sample of 12,300 
Wave V adults, yielding comparable estimates. A key difference is that this model was able to converge 
without dividing BMI by 10, hence the larger estimates for the unstandardized cross-lagged coefficients. 
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Given the interest in looking at gender differences in the relationship between these trajectories – as well 
as how they are related to adult health – Table A.12 presents coefficient estimates from a model testing 
for configural invariance. The fit for this model – where the structure is the same for males and females, 
but parameters are free to vary – is very good, with a large and negative BIC of -117. The general patterns 
noted above are observed in both female and male respondents, with no apparent differences in the 
autoregressive, cross-lagged, or direct relationships. That said, latent variable means and intercepts differ, 
as might be expected based on descriptive statistics, with consistently higher estimated values for females 
perceiving themselves as overweight over time. 
In the final stage of the analysis, Wave V physical and mental health outcomes are regressed on 
Wave IV subjective and objective weight, accounting for their intersecting trajectories. The overall fit of 
the model is excellent, with CFI, TLI, and 1-RMSEA all very close to 1 and a large and negative BIC of -
1273. Once again, I primarily focus on standardized coefficients given that the scale of the variables 
differs across health outcomes, with Wave V BMI, SBP, DBP, and CRP all divided by 10 to ensure 
similar variances among all variables in the model.  
There are notable differences in the association between subjective and objective weight and the 
different outcomes, as seen in Table 4.6. Unsurprisingly, Wave IV objective weight continues to have a 
large, positive association with Wave V BMI, as befitting the autoregressive trajectory, and Wave IV 
subjective weight continues to have a small and nonsignificant cross-lagged association with subsequent 
BMI. Wave IV objective weight is also positively associated with higher latent SBP (0.828) and latent 
DBP (0.681), though Wave IV subjective weight exhibits a significant negative association with both (-
0.506 for SBP, -0.408 for DBP), on average. Likewise, Wave IV objective weight is associated with 
higher risk of measured hypertension or being on anti-hypertensive medicine (0.592), whereas there is a 
negative association with Wave IV subjective weight (-0.198). By contrast, CRP is positively associated 




Table 4.6 Coefficient Estimates for Health Outcomes Regressed on Subjective Weight (SUBJ.) and 
Objective Weight (OBJ.) 
Parameters     Estimate   
Std. 
Err. 
  P-value   
Stdz. 
Est. 
            
Latent Variables        
 Systolic Blood Pressure 
→ 
       
 
 Reading #1 1.000 
      
 
 Reading #2 1.000 
      
 
 Reading #3 0.964 
 0.014  0.000   
 Diastolic Blood Pressure →       
 
 Reading #1 1.000 
      
 
 Reading #2 1.000 
      
 
 Reading #3 0.957 
 0.017  0.000   
 Depression →    
    
 
 Felt Depressed 1.000 
      
 
 Had Blues 0.824 
 0.015  0.000   
 
 Felt Sad 0.747 
 0.018  0.000   
            
Health Outcome Regressions        
 Wave V BMI ←        
 
 Wave IV OBJ. 0.963  0.050  0.000  0.842 
 
 Wave IV SUBJ. -0.008  0.061  0.893  -0.006 
 SBP ←   
     
  
 
 Wave IV OBJ. 1.554  0.156  0.000  0.828 
 
 Wave IV SUBJ. -1.118  0.193  0.000  -0.506 








 Wave IV OBJ. 0.957  0.114  0.000  0.681 
 
 Wave IV SUBJ. -0.674  0.142  0.000  -0.408 
 
Measured Hypertension/Rx ← 
    
  
 
 Wave IV OBJ. 0.788  0.113  0.000  0.592 
 
 Wave IV SUBJ. -0.310  0.141  0.028  -0.198 
 CRP ←   
     
  
 
 Wave IV OBJ. 0.164  0.031  0.000  0.193 
 
 Wave IV SUBJ. 0.165  0.037  0.000  0.164 
 Latent Depression ←        
 
 Wave IV OBJ. -0.072  0.038  0.062  -0.083 
 
 Wave IV SUBJ. 0.132  0.043  0.002  0.130 
 
Depression Dx ← 
     
  
 
 Wave IV OBJ. -0.419  0.074  0.000  -0.315 
 
 Wave IV SUBJ. 0.656  0.087  0.000  0.419 
 Anxiety Dx ←        
 
 Wave IV OBJ. -0.503  0.076  0.000  -0.378 
 
 Wave IV SUBJ. 0.682  0.099  0.000  0.436 
 Trouble Sleeping ←        
 




 Wave IV SUBJ. 0.340  0.096  0.000  0.161             
SWS and BMI Regressions        
 Wave IV OBJ. ←        
 
 Wave III OBJ. 0.998 
 0.044  0.000  0.836 
 
 Wave III SUBJ. 0.087 
 0.049  0.079  0.073 
 Wave III OBJ. ←                                 
 
 Wave II OBJ. 0.854 
 0.032  0.000  0.685 
 
 Wave II SUBJ. 0.193 
 0.024  0.000  0.207 
 Wave II OBJ. ←                  
               
 
 Wave I OBJ. 1.047 
 0.052  0.000  0.897 
 
 Wave I SUBJ. 0.037 
 0.023  0.112  0.051 
 Wave IV SUBJ. ←               
 
 Wave III SUBJ. 1.008 
 0.059  0.000  1.000 
 
 Wave III OBJ. -0.964 
 0.111  0.000  -0.950 
 
 Wave IV OBJ. 0.793 
 0.087  0.000  0.933 
 Wave III SUBJ. ←                               
 
 Wave II SUBJ. 0.482 
 0.023  0.000  0.515 
 
 Wave II OBJ. -0.402 
 0.067  0.000  -0.320 
 
 Wave III OBJ. 0.799 
 0.065  0.000  0.793 
 Wave II SUBJ. ←                               
 
 Wave I SUBJ. 0.880 
 0.044  0.000  0.902 
 
 Wave I OBJ. -0.771 
 0.320  0.016  -0.492 
 
 Wave II OBJ. 0.754 
 0.263  0.004  0.562 
 Wave I SUBJ. ←                               
 
 Wave I OBJ. 1.063 
 0.046  0.000  0.663             
R-Square   
       
 Wave I BMI 0.767       
 Wave II BMI 0.818       
 Wave III BMI 0.762       
 Wave IV BMI 0.820       
 Wave I PW 0.747       
 Wave II PW 0.737       
 Wave III PW 0.607       
 Wave IV PW 0.611       
 Wave II OBJ. 0.868       
 Wave III OBJ. 0.707       
 Wave IV OBJ. 0.812       
 Wave I SUBJ. 0.439       
 Wave II SUBJ. 0.923       
 Wave III SUBJ. 0.904       
 Wave IV SUBJ. 0.850       
 Wave V BMI 0.699       
 L-SBP   0.200 
      
 SBP #1   0.762 
      
 SBP #2   0.812 
      
 SBP #3   0.801 
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 L-DBP   0.138 
      
 DBP #1   0.806 
      
 DBP #2   0.834 
      
 DBP #3   0.805 
      
 Measured 
Hypertension/Rx 
0.182      
 
 CRP   0.120 
      
 L-Depression 0.005       
 Feel Depressed 0.860       
 Had Blues  0.597 
      
 Feel 
Sad   
0.518       
 Depression Dx 0.041       
 Anxiety 
Dx  
0.041       
 Trouble Sleeping 0.008       
                        
            
N=7,105. 
Observed BMI, observed SBP and DBP, and observed CRP  
divided by 10 to reduce variance and help with model convergence. 
Covariances, means and intercepts, and variances omitted for parsimony. 
Results based on casewise maximum likelihood (also called FIML) estimation to 
account for missing data, with diagonal weighted least squares standard errors due 
to binary outcome variables. 
Weighted estimates account for person-level longitudinal survey weights (WI-V), 
school-level clustering, and regional strata. 
Model fit statistics: χ2 = 225.147, DF = 169, BIC = -1273.639, CFI = 0.997,  
TLI = 0.996, 1-RMSEA = 0.993. 
 
With respect to mental health related outcomes, Wave IV objective weight is not significantly 
associated with latent depression, whereas there is a positive association with Wave IV subjective weight 
(0.130). Wave IV objective weight has a significant negative association with both diagnosed depression 
(-0.315) and anxiety (-0.378), compared to significant positive associations with Wave IV subjective 
weight (0.419 and 0.436, respectively). Finally, there a significant, but smaller negative association 
between BMI and trouble sleeping (-0.090) and a significant positive association between Wave IV 
subjective weight and trouble sleeping (0.161). The R-squared values provide important context for this 
model and its explanatory power across the different physical and mental health outcomes; critically, it is 
apparent that objective and subjective weight alone do not explain much of the variation in either physical 
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and mental health. Aside from Wave V BMI, objective and subjective weight only explain about 10-20% 
of the variation in blood pressure, hypertension, and CRP. The R-squared values are considerably lower 
for mental health, where over 95% of the variation is unexplained. 
Prior to comparing gender differences in the associations between Wave IV subjective and 
objective weight and Wave V health outcomes, I provide the caveat that I could not definitively 
demonstrate that this model has configural invariance across both genders. Formal tests of measurement 
invariance encountered convergence issues, though I believe this is largely attributable to the complexity 
of the model rather than misspecification. Indeed, the model fit is excellent when assessed separately by 
gender, with CFI, TLI, and 1-RMSEA near 1 and equally large and negative BICs (-1204 for female 
respondents; -1160 for male respondents). Thus, coupled with evidence of configural invariance from the 
previous model without health outcomes, one might expect that the estimates provided in Table 4.7 are 
valid. 
The general pattern for the associations between objective and subjective weight and physical 
health is very similar for both females and males. Wave IV objective weight continues to be strongly, 
positively associated with Wave V BMI, while Wave IV subjective weight is not. Wave IV objective 
weight is also positively associated with SBP and DBP and measured hypertension or use of 
antihypertensive medication, while these same measures are negatively associated with Wave IV 
subjective weight. However, it appears that the association between blood pressure and objective weight 
is somewhat weaker for females as compared to males (0.631 vs. 0.759 for SBP; 0.390 vs. 0.654 for DBP; 
0.347 vs. 0.468 for measured hypertension or medication). Likewise, the positive association between 
CRP and Wave IV objective weight is greater among male respondents as compared to females (0.634 vs. 
0.312), but the relationship between CRP and Wave IV subjective weight is not significant among 
females and negative among males (-0.352). Conversely, the associations between mental health and 
objective and subjective are more pronounced for female respondents as compared to males.   
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There is no significant relationship with latent depression for either group, but Wave IV subjective weight 
is significantly associated with greater diagnosed depression among females (0.271), as well as greater 







Table 4.7 Coefficient Estimates for Health Outcomes Regressed on Subjective Weight Status (SWS) and Body Mass Index (BMI);  
Female vs. Male 
                    
     Female  Male 


















                    
Latent Variables                
 Systolic Blood Pressure →         
       
 
 Reading #1 1.000 
      
 1.000 
      
 
 Reading #2 1.000 
      
 1.000 
      
 
 Reading #3 0.976 
 0.022      0.958 
 0.022  0.000   
 Diastolic Blood Pressure →        
       
 
 Reading #1 1.000 
      
 1.000 
      
 
 Reading #2 1.000 
      
 1.000 
      
 
 Reading #3 0.958 
 0.023      0.955 
 0.026  0.000   
 Depression →    
    
    
    
 
 Felt Depressed 1.000 
      
 1.000 
      
 
 Had Blues 0.826  0.024 
 0.000    0.832 
 0.024  0.000   
 
 Felt Sad 0.749  0.027 
 0.000    0.724 
 0.028  0.000   
                    
Health Outcome Regressions                
 Wave V BMI ←         
     
  
 
 Wave IV OBJ. 1.043  0.082  0.000  0.929 
 1.010  0.110  0.000  0.870 
 
 Wave IV SUBJ. -0.149  0.109  0.172  -0.096 
 -0.058  0.110  0.596  -0.052 
 SBP ←   
     
  
      
  
 
 Wave IV OBJ. 1.007  0.186  0.000  0.631 
 1.561  0.329  0.000  0.759 
 
 Wave IV SUBJ. -0.498  0.257  0.053  -0.225 
 -0.805  0.324  0.013  -0.402 














 Wave IV OBJ. 0.476  0.132  0.000  0.390 
 1.028  0.273  0.000  0.654 
 
 Wave IV SUBJ. -0.046  0.183  0.803  -0.027 
 -0.595  0.270  0.028  -0.389 
 
Measured Hypertension/Rx ← 
    
  
      
  
 
 Wave IV OBJ. 0.420  0.151  0.005  0.347 
 0.704  0.232  0.002  0.468 
 
 Wave IV SUBJ. 0.193  0.213  0.364  0.115 







 CRP ←   
     
  
      
  
 
 Wave IV OBJ. 0.279  0.054  0.000  0.312 
 0.443  0.062  0.000  0.634 
 
 Wave IV SUBJ. 0.041  0.078  0.595  0.033 
 -0.239  0.062  0.000  -0.352 
 Latent Depression ←        
      
  
 
 Wave IV OBJ. -0.016  0.064  0.801  -0.020 
 -0.069  0.083  0.406  -0.074 
 
 Wave IV SUBJ. 0.137  0.084  0.103  0.121 
 0.040  0.086  0.641  0.044 
 
Depression Dx ← 
     
  
      
  
 
 Wave IV OBJ. -0.158  0.100  0.115  -0.131 
 -0.339  0.213  0.111  -0.225 
 
 Wave IV SUBJ. 0.456  0.143  0.001  0.271 
 0.292  0.204  0.152  0.199 
 Anxiety Dx ←        
      
  
 
 Wave IV OBJ. -0.353  0.118  0.003  -0.291 
 -0.407  0.212  0.055  -0.271 
 
 Wave IV SUBJ. 0.579  0.179  0.001  0.344 
 0.378  0.207  0.068  0.258 
 Trouble Sleeping ←        
      
  
 
 Wave IV OBJ. -0.050  0.119  0.677  -0.030 
 0.083  0.149  0.577  0.042 
 
 Wave IV SUBJ. 0.302  0.167  0.071  0.133 
 -0.105  0.149  0.479  -0.055                     
SWS and BMI Regressions                
 Wave IV OBJ. ←         
     
  
 
 Wave III OBJ. 0.954 
 0.061  0.000  0.803  1.109 
 0.129  0.000  0.926 
 
 Wave III SUBJ. 0.125 
 0.079  0.112  0.091  -0.014 
 0.117  0.904  -0.014 
 Wave III OBJ. ←                              
                       
 
 Wave II OBJ. 0.882 
 0.042  0.000  0.667  0.668 
 0.067  0.000  0.599 
 
 Wave II SUBJ. 0.263 
 0.033  0.000  0.248  0.256 
 0.042  0.000  0.304 
 Wave II OBJ. ←                
                                  
               
 
 Wave I OBJ. 1.052 
 0.063  0.000  0.870  0.911 
 0.099  0.000  0.816 
 
 Wave I SUBJ. 0.049 
 0.032  0.127  0.062  0.087 
 0.046  0.062  0.118 
 Wave IV SUBJ. ←                
              
 
 Wave III SUBJ. 1.019 
 0.092  0.000  1.025  0.868 
 0.213  0.000  0.817 
 
 Wave III OBJ. -0.794 
 0.098  0.000  -0.927  -1.292 
 0.317  0.000  -1.050 
 
 Wave IV OBJ. 0.654 
 0.076  0.000  0.908  1.196 
 0.218  0.000  1.165 
 Wave III SUBJ. ←                                        
                         
 
 Wave II SUBJ. 0.373 
 0.032  0.000  0.407  0.306 
 0.056  0.000  0.314 
 
 Wave II OBJ. -0.475 
 0.086  0.000  -0.417  -0.353 
 0.106  0.001  -0.273 
 
 Wave III OBJ. 0.849 
 0.081  0.000  0.985  1.054 







 Wave II SUBJ. ←                                        
                         
 
 Wave I SUBJ. 0.848 
 0.055  0.000  0.870  0.819 
 0.049  0.000  0.844 
 
 Wave I OBJ. -0.275 
 0.214  0.178  -0.183  -0.225 
 0.227  0.322  -0.152 
 
 Wave II OBJ. 0.345 
 0.171  0.078  0.277  0.361 
 0.197  0.066  0.272 
 Wave I SUBJ. ←                                        
                         
 
 Wave I OBJ. 0.989 
 0.054  0.000  0.641  1.075 
 0.072  0.000  0.704                     
R-Square   
       
 
       
 Wave I BMI 0.801        0.788 
      
 Wave II BMI 0.854        0.823 
      
 Wave III BMI 0.814        0.681 
      
 Wave IV BMI 0.860        0.753 
      
 Wave I PW 0.728        0.755 
      
 Wave II PW 0.717        0.744 
      
 Wave III PW 0.568        0.684 
      
 Wave IV PW 0.565        0.710 
      
 Wave II OBJ. 0.831        0.815 
      
 Wave III OBJ. 0.722        0.713 
      
 Wave IV OBJ. 0.786        0.835 
      
 Wave I SUBJ. 0.411        0.495 
      
 Wave II SUBJ. 0.870        0.873 
      
 Wave III SUBJ. 0.955        0.891 
      
 Wave IV SUBJ. 0.909        0.909 
      
 Wave V BMI 0.706        0.680 
      
 L-SBP   0.184 
      
 0.196 
      
 SBP #1   0.724 
      
 0.778 
      
 SBP #2   0.774 
      
 0.809 
      
 SBP #3   0.792 
      
 0.775 
      
 L-DBP   0.133 
      
 0.127 
      
 DBP #1   0.791 
      
 0.803 
      
 DBP #2   0.813 
      
 0.840 
      
 DBP #3   0.792 
      
 0.798 
      
 
Measured Hypertension/Rx 0.208 
     
  0.182 
     
 
 CRP   0.117 
      
 0.130 







 L-Depression 0.010        0.002 
      
 Feel Depressed 0.866        0.860 
      
 Had Blues  0.645 
      
 0.565 
      
 Feel Sad   0.536 
      
 0.480 
      
 Depression Dx 0.024        0.011 
      
 Anxiety Dx  0.016 
      
 0.016 
      
 Trouble Sleeping 0.011        0.001 
      
                                        
                    
N(Female)=4,152; N(Male)=2,953. 
Covariances, means and intercepts, and variances omitted for parsimony. 
Results based on casewise maximum likelihood (also called FIML) estimation to account for missing data,  
with diagonal weighted least squares standard errors due to binary outcome variables. 
Weighted estimates account for person-level longitudinal survey weights (WI-V), school-level clustering, and regional strata. 
Model fit statistics for Female respondents: χ2 = 203.767, DF = 169, BIC = -1204.230, CFI = 0.997, TLI = 0.995, 1-RMSEA = 0.993. 
Model fit statistics for Male respondents: χ2 = 190.529, DF = 169, BIC = -1159.878, CFI = 0.998, TLI = 0.996, 1-RMSEA = 0.993. 
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Tables A.13 and A.14, in the Appendix, demonstrate that the estimates and patterns noted above 
are largely unchanged when accounting for individuals’ age, race and ethnicity, and educational 
attainment (or parent’s educational attainment in Waves I and II). A key difference is that CRP is not 
positively associated with either objective and subjective weight in the overall model, but instead 
negatively associated with Wave IV subjective weight (-0.153). Also, the association between Wave IV 
subjective weight and latent depression is significant in both the overall model (0.120), and among 
females (0.209). The unstandardized coefficient estimates associated with the covariates are generally 
consistent with extant knowledge of how gender, race/ethnicity, and educational attainment are associated 
with health outcomes. Females have lower blood pressure and hypertension, whereas non-Hispanic Black 
adults have elevated blood pressure and a higher likelihood of hypertension relative to their non-Hispanic 
White counterparts. However, females have higher CRP, on average, as well as worse mental health with 
respect to diagnosed depression and diagnosed anxiety. These same measures of mental health are 
generally lower among all race/ethnic groups relative to non-Hispanic White adults, and the same pattern 
for gender and race/ethnicity is observed for trouble sleeping. College-educated respondents and children 
with parents who are more highly educated generally have lower BMIs. 
Finally, simply looking at the association between Wave IV objective and subjective weight and 
Wave V health outcomes does not necessarily provide a complete account of how the intersecting 
trajectories of objective and subjective weight are associated with adult health. Namely, the estimates 
between the Wave IV latent variables for weight and the various Wave V outcomes are net of the 
autoregressive, cross-lagged, and direct effects; the resulting coefficients are not indicative of how these 
pathways of subjective and objective weight interact in having both direct and indirect effects on adult 
health. This is not to suggest the estimates described above have no meaning – rather, they are not clearly 
interpretable given the complexity of negative and positive pathways preceding them, as they reflect 
exclusively “short-run” versus “long-run” effects (Zyphur et al. 2020). Thus, it is more instructive to 
consider how subjective and objective weight in Wave I are associated with Wave V health outcomes as a 
function of these intersecting trajectories, which can be accomplished by estimating the total effects, as in 
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past research using cross-lagged panel models (Kane et al. 2018; Zyphur et al. 2020). Moreover, it is 
interesting to compare how much of the total effect from either Wave I objective weight or subjective 
weight on a given Wave V outcome occurs through the “path dependent,” or autoregressive trajectory, as 
compared to how these measures are related to one another over time. With five waves of data linked 
through autoregressive, cross-lagged, and direct effects, one should not expect very large effects due to 
considerable attenuation over time on account of many multiplicative terms, but the general direction of 
the effect and relative magnitudes are of interest rather than the size (Adachi and Willoughby 2015). Both 
the total and path dependent effects for the different health outcomes are shown in Table 4.8, adjusting for 
age, gender, race and ethnicity, and educational attainment. 
Table 4.8 Total and Indirect Effects for Health Outcomes Regressed on Subjective Weight (SUBJ.) and 
Objective Weight (OBJ.), Adjusted for Age, Gender, Race/Ethnicity, and Education 
            
Parameters     Estimate   
Std. 
Err. 
  P-value   
Stdz. 
Est. 
            
 Wave V BMI ←        
  Wave I OBJ.  
Total Effect 
1.017  0.066  0.000  0.524 
  Wave I OBJ. Path 
Dependent Effect 
0.690  0.111  0.000  0.355 
  Wave I SUBJ.  
Total Effect 
0.307  0.051  0.000  0.251 
  Wave I SUBJ. Path 
Dependent Effect 
-0.013  0.022  0.548  -0.011 
 SBP ←   
     
  
  Wave I OBJ.  
Total Effect 
0.704  0.074  0.000  0.220 
  Wave I OBJ. Path 
Dependent Effect 
0.478  0.152  0.002  0.150 
  Wave I SUBJ.  
Total Effect 
0.212  0.066  0.001  0.105 
  Wave I SUBJ. Path 
Dependent Effect 
-0.010  0.055  0.855  -0.005 







  Wave I OBJ.  
Total Effect 
0.434  0.055  0.000  0.180 
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  Wave I OBJ. Path 
Dependent Effect 
0.300  0.118  0.011  0.124 
  Wave I SUBJ.  
Total Effect 
0.128  0.052  0.013  0.084 
  Wave I SUBJ. Path 
Dependent Effect 
-0.009  0.047  0.851  -0.006 
 
Measured Hypertension/Rx ← 
    
  
  Wave I OBJ.  
Total Effect 
0.597  0.062  0.000  0.247 
  Wave I OBJ. Path 
Dependent Effect 
0.252  0.107  0.018  0.104 
  Wave I SUBJ.  
Total Effect 
0.264  0.051  0.000  0.173 
  Wave I SUBJ. Path 
Dependent Effect 
0.077  0.046  0.098  0.050 
 CRP ←   
     
  
  Wave I OBJ.  
Total Effect 
0.307  0.025  0.000  0.207 
  Wave I OBJ. Path 
Dependent Effect 
0.276  0.047  0.000  0.186 
  Wave I SUBJ.  
Total Effect 
0.056  0.021  0.009  0.060 
  Wave I SUBJ. Path 
Dependent Effect 
-0.042  0.015  0.006  -0.044 
 Latent Depression ←        
  Wave I OBJ.  
Total Effect 
-0.014  0.021  0.522  -0.009 
  Wave I OBJ. Path 
Dependent Effect 
-0.071  0.037  0.056  -0.048 
  Wave I SUBJ.  
Total Effect 
0.029  0.016  0.066  0.031 
  Wave I SUBJ. Path 
Dependent Effect 
0.034  0.017  0.047  0.037 
 
Depression Dx ← 
     
  
  Wave I OBJ.  
Total Effect 
0.039  0.043  0.368  0.016 
  Wave I OBJ. Path 
Dependent Effect 
-0.134  0.080  0.096  -0.055 
  Wave I SUBJ.  
Total Effect 
0.099  0.036  0.007  0.065 
  Wave I SUBJ. Path 
Dependent Effect 
0.088  0.039  0.023  0.058 
 Anxiety Dx ←        
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  Wave I OBJ.  
Total Effect 
-0.052  0.046  0.265  -0.021 
  Wave I OBJ. Path 
Dependent Effect 
-0.222  0.086  0.009  -0.091 
  Wave I SUBJ.  
Total Effect 
0.086  0.041  0.034  0.056 
  Wave I SUBJ. Path 
Dependent Effect 
0.104  0.041  0.010  0.068 
 Trouble Sleeping ←        
  Wave I OBJ.  
Total Effect 
0.016  0.028  0.564  0.008 
  Wave I OBJ. Path 
Dependent Effect 
0.004  0.029  0.902  0.002 
  Wave I SUBJ.  
Total Effect 
0.040  0.036  0.270  0.013 
  Wave I SUBJ. Path 
Dependent Effect 
0.019  0.063  0.759  0.006 
                        
            
N=6,247. 
"Path Dependent" effect refers to autoregressive trajectory for OBJ. and SUBJ.:  
W1 → W2 → W3 → W4. 
Observed BMI, observed SBP and DBP, and observed CRP  
divided by 10 to reduce variance and help with model convergence. 
Results based on casewise maximum likelihood (also called FIML) estimation to 
account for missing data among endogenous variables, with diagonal weighted least 
squares standard errors due to binary outcome variables. 
Weighted estimates account for person-level longitudinal survey weights (WI-V), 
school-level clustering, and regional strata. 
Model fit statistics: χ2 =  361.617, DF = 274, SBIC = -2033.104, CFI = 0.994,  
TLI = 0.991, 1-RMSEA = 0.993. 
 
A one standard deviation (SD) increase in objective weight at Wave I continues to be positively 
associated with a 0.524 SD increase in BMI at Wave V, with approximately two-thirds of the effect 
attributable to path dependency in BMI. Though the path dependent effect of subjective weight on Wave 
V BMI is nonexistent, a one SD increase in Wave I subjective weight is associated with a 0.307 SD 
increase in Wave V BMI due to its intersecting association with objective weight over time. There is a 
similar pattern for SBP, DBP, and hypertension, such that a one SD increase in objective weight at Wave 
I is significantly associated with increased SBP, DBP, and hypertension at Wave V (0.220, 0.180, 0.247 
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SD, respectively). Approximately 70% of the total effect between Wave I objective and SBP and DBP is 
attributable to path dependency, compared to ~40% for hypertension or medication use. Subjective 
weight has no path dependent association with any of the blood pressure outcomes, but has a small 
positive association through objective weight (0.105, 0.084, 0.060 SD, respectively). The association 
between Wave I objective weight and Wave V inflammation, on the basis of CRP, is positive, such that a 
one SD increase in objective weight is associated with a 0.207 SD increase in CRP, with almost the 
entirety of the effect through BMI rather than objective weight (~90%). As before, there is no path 
dependent association between subjective weight and CRP, but there is a small and positive total effect 
(0.060 SD). 
The inverse pattern is observed for the total and path dependent effects between Wave I objective 
and subjective weight and Wave V mental health outcomes. There is no evidence of an association 
between objective weight and latent depression, but a small positive association between subjective 
weight and latent depression (0.031 SD), which would be larger if not for the association between 
subjective and objective weight over time (0.037 SD). Likewise, there is no association between objective 
weight and diagnosed depression, but a small positive association with Wave I subjective weight (0.065 
SD). Wave V anxiety diagnosis is also not associated with Wave I objective weight, though its path 
dependent effect has a small, negative and significant association (-0.091 SD); however, the association 
with Wave I subjective weight is small but positive (0.056 SD). There does not appear to be any 
significant association between either objective or subjective weight and trouble sleeping. 
Finally, I examine gender differences in these total and path dependent effects in Table 4.9. The 
similarity of the model structure for both female and male respondents appears to result in similar patterns 
in the direct and path dependent effects compared to the overall sample, with respect to both their general 
direction and magnitude. Nevertheless, key deviations from the overall pattern – indicative of important 
gender differences – are observed as well. Generally, the association between Wave I objective weight 
and both SBP and DBP is greater for males compared to females (0.276 vs. 0.190 SD; 0.216 vs. 0.146 
SD), especially on account of the path dependent effect. The association between CRP and Wave I 
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objective weight appears somewhat stronger for males compared to females, also on account of the path 
dependent effect. However, the total effect between CRP and Wave I subjective is positive and significant 
for females (0.096 SD) and not significant for males, for whom there is a significant negative path 
dependent effect (-0.083 SD). There is a clear gender difference in total effects for Wave I subjective 
weight on latent depression, wherein there is a positive total (0.074 SD) and path dependent effect (0.065 
SD) compared to seemingly no relationship for male respondents. The same finding is true of diagnosed 
depression and anxiety, where the effect from Wave I subjective weight on these outcomes is positive and 
significant for female respondents (0.108 and 0.096 SD, respectively) but not their male counterparts. 
Finally, while there were no significant effects from Wave I objective and subjective weight on trouble 
sleeping in the overall sample, the stratified results show that a one SD increase in Wave I objective 








Table 4.9 Total and Indirect Effects for Health Outcomes Regressed on Subjective Weight (SUBJ.) and Objective Weight (OBJ.), Adjusted for 
Age, Race/Ethnicity, and Education; Female vs. Male 
                    
     Female  Male 


















                    
 Wave V BMI ←                
  Wave I OBJ.  
Total Effect 
1.043  0.082  0.000  0.492  0.922  0.089  0.000  0.539 
  Wave I OBJ. Path 
Dependent Effect 
0.688  0.119  0.000  0.325  0.609  0.178  0.001  0.356 
  Wave I SUBJ.  
Total Effect 
0.315  0.064  0.000  0.230  0.319  0.085  0.000  0.282 
  Wave I SUBJ. Path 
Dependent Effect 
-0.040  0.033  0.227  -0.029  0.003  0.029  0.917  0.003 
 SBP ←   
     
   
     
  
  Wave I OBJ.  
Total Effect 
0.563  0.085  0.000  0.190  0.830  0.123  0.000  0.276 
  Wave I OBJ. Path 
Dependent Effect 
0.363  0.145  0.012  0.122  0.682  0.287  0.017  0.227 
  Wave I SUBJ.  
Total Effect 
0.176  0.071  0.013  0.092  0.237  0.107  0.027  0.119 
  Wave I SUBJ. Path 
Dependent Effect 
-0.016  0.069  0.818  -0.008  -0.055  0.068  0.421  -0.028 













  Wave I OBJ.  
Total Effect 
0.335  0.057  0.000  0.146  0.510  0.093  0.000  0.216 
  Wave I OBJ. Path 
Dependent Effect 
0.112  0.094  0.233  0.049  0.532  0.223  0.017  0.226 
  Wave I SUBJ.  
Total Effect 







  Wave I SUBJ. Path 
Dependent Effect 
0.062  0.051  0.224  0.042  -0.082  0.060  0.169  -0.053 
 
Measured Hypertension/Rx ← 
    
   
     
  
  Wave I OBJ.  
Total Effect 
0.549  0.082  0.000  0.228  0.645  0.083  0.000  0.279 
  Wave I OBJ. Path 
Dependent Effect 
0.220  0.119  0.065  0.091  0.324  0.176  0.066  0.140 
  Wave I SUBJ.  
Total Effect 
0.266  0.061  0.000  0.171  0.262  0.076  0.001  0.171 
  Wave I SUBJ. Path 
Dependent Effect 
0.076  0.061  0.207  0.049  0.046  0.057  0.416  0.030 
 CRP ←   
     
   
     
  
  Wave I OBJ.  
Total Effect 
0.342  0.035  0.000  0.195  0.246  0.032  0.000  0.232 
  Wave I OBJ. Path 
Dependent Effect 
0.219  0.052  0.000  0.125  0.299  0.090  0.001  0.282 
  Wave I SUBJ.  
Total Effect 
0.109  0.030  0.000  0.096  0.034  0.031  0.278  0.049 
  Wave I SUBJ. Path 
Dependent Effect 
-0.008  0.021  0.700  -0.007  -0.058  0.021  0.006  -0.083 
 Latent Depression ←         
     
  
  Wave I OBJ.  
Total Effect 
0.019  0.027  0.467  0.013  -0.050  0.031  0.106  -0.036 
  Wave I OBJ. Path 
Dependent Effect 
-0.082  0.046  0.072  -0.054  -0.045  0.053  0.397  -0.032 
  Wave I SUBJ.  
Total Effect 
0.073  0.024  0.002  0.074  -0.013  0.019  0.484  -0.014 
  Wave I SUBJ. Path 
Dependent Effect 
0.064  0.025  0.010  0.065  0.005  0.019  0.802  0.005 
 
Depression Dx ← 
     
   








  Wave I OBJ.  
Total Effect 
0.144  0.058  0.014  0.060  -0.111  0.071  0.116  -0.048 
  Wave I OBJ. Path 
Dependent Effect 
-0.082  0.090  0.366  -0.034  -0.228  0.156  0.143  -0.099 
  Wave I SUBJ.  
Total Effect 
0.168  0.053  0.001  0.108  0.020  0.042  0.639  0.013 
  Wave I SUBJ. Path 
Dependent Effect 
0.115  0.051  0.024  0.074  0.066  0.049  0.177  0.044 
 Anxiety Dx ←         
     
  
  Wave I OBJ.  
Total Effect 
0.010  0.051  0.843  0.004  -0.161  0.075  0.032  -0.070 
  Wave I OBJ. Path 
Dependent Effect 
-0.203  0.092  0.028  -0.084  -0.311  0.161  0.053  -0.135 
  Wave I SUBJ.  
Total Effect 
0.151  0.058  0.009  0.096  0.021  0.050  0.673  0.014 
  Wave I SUBJ. Path 
Dependent Effect 
0.143  0.056  0.010  0.091  0.088  0.052  0.091  0.058 
 Trouble Sleeping ←         
     
  
  Wave I OBJ.  
Total Effect 
0.136  0.052  0.009  0.043  -0.044  0.057  0.440  -0.015 
  Wave I OBJ. Path 
Dependent Effect 
0.041  0.081  0.617  0.013  0.047  0.097  0.626  0.016 
  Wave I SUBJ.  
Total Effect 
0.076  0.046  0.096  0.037  -0.044  0.033  0.183  -0.022 
  Wave I SUBJ. Path 
Dependent Effect 
0.029  0.045  0.523  0.014  -0.033  0.035  0.350  -0.017 
                                        
                    
N(Female)=4,152; N(Male)=2,606. 
"Path Dependent" effect refers to autoregressive trajectory for OBJ. and SUBJ.: W1 → W2 → W3 → W4. 







Results based on casewise maximum likelihood (also called FIML) estimation to account for missing data among endogenous variables, 
with diagonal weighted least squares standard errors due to binary outcome variables. 
Weighted estimates account for person-level longitudinal survey weights (WI-V), school-level clustering, and regional strata. 
Model fit statistics for Male respondents: χ2 = 295.971, DF = 268, SBIC = -1812.002, CFI = 0.996, TLI = 0.993, 1-RMSEA = 0.994. 
Model fit statistics for Female respondents: χ2 = 369.979, DF = 268, SBIC = -1827.625, CFI = 0.990, TLI = 0.983, 1-RMSEA = 0.990. 
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Discussion and Conclusion 
This project seeks to broaden conceptualization and measurement in health research by 
emphasizing the utility of both objective and subjective measures when examining the relationship 
between body size and health. Researchers should be cognizant of reporting issues and biases associated 
with subjective measures; however, “self-reported data should not axiomatically be characterized as 
inferior solely because they come from respondents” (Ferraro and Farmer 1999: 313). Indeed, Goldman et 
al. (2004) suggest that “rather than enhance our efforts to collect so-called objective measures through 
physicians’ reports and biomarkers, we may need to focus on aspects of well-being that are notoriously 
difficult to measure, such as mental and emotional health limitations imposed by health conditions” 
(p.56). In obesity research, the body mass index continues to be the “gold standard” for objective weight 
and health (Gutin 2018; Nicholls 2013); yet much of the poor health and physiological dysregulation that 
we associate with obesity and body weight is not necessarily captured by this measure (Tomiyama et al. 
2018). Giving priority to this “objective” measure might be unwarranted, as would dismissing 
individuals’ perceptions of and feelings about their body weight, in a society where social and health 
norms about the body and its appearance are so highly intertwined (Gutin 2021). 
Indeed, much of the extant research on perceived weight has focused on its relationship with 
objective body size, rather than considered the extent to which it provides key insights on the 
psychosocial aspects of body size and weight. Sociological research on the function of the body in society 
(Bourdieu 1984; Fox 2012), and the stigma attached to overweight bodies as “deviant” (Cahnman 1968; 
Maddox et al. 1968), suggests that individuals’ subjective weight taps into the social experiences 
associated with overweight and obesity, and thus requires further scrutiny. In line with past research on 
the importance of subjective measures, this study considers the longitudinal measurement properties of 
subjective weight and then uses this knowledge to provide estimates of its relationship with key adult 
health outcomes while accounting for the complex and intersecting relationship with objective weight 
over time. As such, the primary takeaways from this study – and their substantive implications – consider 
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how subjective weight is both separate from and related to objective weight over time, as well as how 
these two trajectories both influence adult physical and mental health. 
Firstly, this study provides needed context on past research describing “misperception” in the 
extent to which individuals’ subjective and objective weight track with one another. Namely, this lack of 
one-to-one correspondence is not surprising given the relatively stability of subjective weight over time, 
and its strong wave-to-wave predictive power, even across observations separated by multiple years. 
Indeed, the strong autoregressive relationship largely persists after accounting for how subjective weight 
intersects with objective body weight. While a true notion of stability would be more consistent with 
evidence of some kind of enduring latent influence (Bollen and Gutin [Forthcoming]), a “time-invariant” 
model including such a latent intercept did not have better fit to the Add Health data. Yet, the best-fitting 
autoregressive model suggests that individuals’ subjective weight is largely influenced by their prior, or 
pre-existing, views of their weight – as indicated by the large proportion of variance in latent subjective 
weight explained by this model. Based on this model, one may assume that individuals’ weight 
“identities” form fairly early in life and largely persist throughout the life course (Blaxter 2004; Fox and 
Ward 2008; Sobal and Maurer 2017; Whyte 2009), consistent with past research on relative stability in 
the measure and the notion that weight perceptions may have a heritable component (Wedow et al. 2016; 
Wedow et al. 2018). Subjective weight is clearly associated with individuals’ objective weight – as 
evidenced by the large direct effect of objective weight on subjective weight within waves – but this 
association is not the driving factor underlying the longitudinal trajectory of subjective weight. 
However, the strong predictive power of the autoregressive model does not imply that the wave-
to-wave relationship between subjective weight and both itself and objective weight is consistent over 
time; there are notable deviations in the autoregressive estimates, as well as the cross-lagged and direct 
relations. Although a “growth”-based model, consistent with a life course pattern, was not a good fit for 
the data, the autoregressive model exhibits less stability – for both women and men – in the 
“transitionary” stage in life between Waves II and III when many respondents are leaving their homes, 
completing their education, and starting both careers and families (Elder et al. 2003; Shanahan 2000). The 
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lagged effect of subjective weight is weaker, while there is a significant positive cross-lagged effect from 
subjective weight to objective weight, suggesting that perceiving oneself as overweight is associated with 
future weight gain. Indeed, the more interlinked relationship between the two measures between these two 
waves is consistent with research showing how many of the social institutions that rise to prominence at 
this point in the life course are subject to different forms of weight bias and discrimination, which may 
affect how much influence subjective and objective weight have on one another. For instance, a large 
body of research documents weight discrimination and bias in educational and workplace environments, 
as well as in romantic relationships and marriage (Puhl and Heuer 2010; Puhl et al. 2008; Varney 2014). 
Individuals’ awareness of their bodies and their weight – and the stress associated with having the wrong 
body or body weight – may be exacerbated at these ages, leading to the “paradoxical” relationship 
between believing oneself to be overweight and gaining weight observed in past research (Daly et al. 
2017; Tomiyama et al. 2018; Unger et al. 2017). Of course, the available evidence in this study is only 
suggestive of these explanations, and the inclusion of relevant contextual variables at these ages would be 
required to substantiate these claims.  
The significant negative association between objective weight and future subjective weight – 
implying that higher body size is associated with a lower perception of one’s weight – provides additional 
context on the complex relationship between these two measures over time. Indeed, this finding speaks to 
extant literature on the “normalization” of weight over the life course, as individuals may acclimate to 
having a larger body size and weight as they age (Smith and Holm 2011). Given broader trends of 
population-wide weight gain over the life course (Lee et al. 2010; Mizuno et al. 2004) – especially among 
this cohort of adults (Gordon-Larsen et al. 2010) – it is possible that normalization is not exclusively a 
function of individual’s weight, but also a function of their peers and those in their community (Burke 
and Heiland 2007; Burke and Heiland 2018; Christakis and Fowler 2007; Robinson 2017; Wedow et al. 
2018). Once again, additional information would be necessary to further explore these claims. However, it 
is important to note that the total effect of objective weight on subsequent subjective weight is positive, as 
this direct, negative cross-lagged effect is offset by a larger indirect positive effect through prior 
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subjective weight and subsequent objective weight. Namely, even if individuals may “get used to” having 
a larger body – on the basis of individual or social acclimation, or both – this does not counteract the 
strong lagged influence of subjective weight, or how lagged objective weight continues to influence 
subsequent subjective weight. 
Importantly, the high degree of stability in both subjective and objective weight challenges the 
premise of many public health interventions seeking to increase individuals’ “awareness” of their being 
overweight (Daly et al. 2017; Daly et al. 2019; Haynes et al. 2018; Robinson et al. 2017). The underlying 
logic is that that awareness engenders better health behaviors and lifestyles that lead to weight loss and 
better health; however, this approach is ignorant of evidence in this study – and others – suggesting that 
subjective and objective weight represent separate constructs that follow independent, lagged trajectories.  
One key implication from this study is that such interventions are likely to be ineffective, as 
individuals’ subjective weight has minimal to no influence on their future objective weight or – in the 
previously described transition from Waves II to III – is actually associated with weight gain. Namely, a 
key obstacle to population-wide weight loss is not a lack of awareness but individuals’ inability to act on 
this knowledge should they choose to. Decades of research on obesity conclusively demonstrate that it the 
product of structural issues in the United States, wherein change requires modifications to individuals’ 
environments that engender organic action as a function of accessible and easily integrated everyday 
activities and behaviors (Novak and Brownell 2011; Novak and Brownell 2012; Schwartz and Brownell 
2007), rather than as a function of individuals’ agency (Adams et al. 2016). Indeed, the misplaced focus 
on individuals’ perceptions of their weight is an important consideration in the harmful and 
counterproductive framing of obesity as a function of individuals’ lack of willpower, poor choice, and 
ignorance of healthful knowledge and practices (Brownell et al. 2010; Ciciurkaite and Perry 2018; Puhl 
and Brownell 2003; Saguy 2012; Shugart 2016) – beliefs that have been shown to reduce support for 
obesity-related public policy (Barry et al. 2009). Emphasis on misperception perpetuates the focus on the 
individual and their personal failures, despite broad consensus that most U.S. adults are at the whim of 
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macro-level social, economic, and political forces acting on their weight and health that are difficult – if 
not impossible – to fully disengage from at the individual level. 
Indeed, acknowledgement of subjective and objective weight as separate entities speaks to the 
larger issue of how researchers conceptualize individuals’ health as a function of both the physiological 
and psychosocial aspects of body weight. Substantiating past research on the subject (Daly et al. 2017; 
Daly et al. 2019; Haynes et al. 2018; Haynes et al. 2019; Frisco et al. 2010; Robinson et al. 2017; 
Tomiyama et al. 2018; Unger et al. 2017), this study demonstrates that individuals’ perceptions of their 
weight are tied to multiple negative health outcomes independent of their body mass index. However, this 
study builds on past work in accounting for measurement error and the longitudinal and intersecting 
nature of the relationship between subjective and objective weight. Consequently, this study underscores 
a key distinction between these different aspects of weight and their associations with physiological and 
psychosocial outcomes, as well as gender differences in these associations.  
Unsurprisingly, objective body size continues to be associated with many of the negative 
physiological health outcomes identified in past research, such as elevated blood pressure and 
inflammation. However, there is no evidence of a strong association between objective weight and worse 
mental health, as these dimensions of health appear to be more closely associated with subjective weight 
and how dissatisfaction with one’s weight – or knowledge that it is not “right” – takes a toll on one’s 
health. Given the gendered context for body weight and image in the United States, the negative mental 
health associated with subjective weight is most apparent for female respondents, both in terms of 
magnitude and statistical significance. However, the intersecting trajectories of objective and subjective 
weight throughout the life course provides evidence that subjective weight is indirectly associated with 
worse physiological health through its relationship with objective weight. 
These results clearly show that both aspects of weight – the objective reality of having a higher 
body weight, and the subjective experience of perceiving oneself as overweight – are key determinants of 
individuals’ overall health and wellbeing. However, extant perspectives on overweight and obesity as 
public health issues often fall into two, opposing ideological camps. Emphasis on body size as an 
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indicator of health, and obesity as a disease, makes body weight the direct target of interventions aimed at 
reducing individuals’ BMIs; by contrast, emphasis on body size as a socially defined measure of 
“normality” champions body positivity and Health at Every Size, arguing that a focus on weight loss 
should not come at the expense of other dimensions of individuals’ physical and mental health (Bacon 
and Aphramor 2011; Gutin 2021; Kraschnewski et al. 2010; Mann et al. 2007). Many obesity researchers 
recognize body weight as both a physiological and social source of stress; yet, strategies aimed at 
targeting one pathway may not account for lingering effects brought on by the other. Indeed, the fact that 
body size is both a physical and social trait means that an “either/or” binary towards improving 
individuals’ physiological or psychosocial health is inappropriate, and potentially counterproductive. 
While this complicates the narrative of addressing body weight at both the individual and population 
level, intervening on both the physical and social aspects of body weight is likely to produce more lasting 
and comprehensive change than interventions premised on the notion that lower body weight is a 
guarantee to better health or that a higher body weight is not consequential to one’s health.  
Namely, there is truth in both perspectives, but less acknowledgement of how they reflect 
different sets of individual and structural solutions, especially in the case of subjective weight. On the one 
hand, BMI is not a definitive marker of health (Gutin 2018), and obesity is not a monolithic state of 
disease or impairment, such that the qualitative labels attached to objective weight can cause more harm 
than good (Greenhalgh 2015; Jutel 2011; Jutel 2014). Yet, it is important to recognize and respond to the 
fact that many individuals stand to benefit from losing weight and seeing improvement in their health. 
Unfortunately, physicians and researchers often have a limited view of body size as a measure or marker 
of health, lacking important social or psychological context for what body size means to a given 
individual and how that subjective meaning is implicated in current and future health. For instance, many 
clinicians and researchers advocate for expanding the set of physiological indicators used to assess 
individuals’ health in relation to their body weight, thus providing greater nuance in distinguishing 
between real and misplaced concern about overweight and obesity as health risks (Garvey et al. 2014; 
Guo and Garvey 2016; Guo et al. 2014). Should individuals’ psychosocial contexts and subjective 
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experiences be taken into consideration as well? This is largely a rhetorical question, as diagnostic 
protocol is governed by its own set of structural constraints and guidelines (Jutel 2014; Rosenberg 2002). 
Nonetheless, the findings in this study and elsewhere suggest that subjective weight is an 
underappreciated factor in  how researchers and care providers evaluate the costs and benefits associated 
with weight loss focused interventions.  
This is not to suggest that the subjective experience and psychosocial ramifications of body 
weight are entirely absent in discourse on overweight and obesity. However, the growing call for greater 
body positivity and body diversity in relation to health has largely been framed in the language of 
advocacy (Cohen et al. 2020; Cwynar-Horta 2016; Friedman et al. 2019; Lazuka et al. 2020; Webb et al. 
2017), rather than acknowledged as a legitimate effort to recognize the health implications of individuals’ 
bodies as a source of stigma that is implicated in the physiological and psychosocial consequences of 
obesity.  
In recognizing the difficulty – if not outright futility – of sustainable, long-term weight loss for 
much of the population (Puhl et al. 2020), many researchers now stress the importance of intervening on 
the social mechanisms leading to worse health and wellbeing among children and adults with overweight 
and obesity. Puhl and colleagues have spent decades chronicling the myriad social pathways and factors 
in the workplace, educational settings, healthcare, interpersonal relationships, and media lead to worse 
treatment and fewer rewards for individuals with overweight and obesity (Pearl 2018; Pearl and Puhl 
2018; Puhl and Brownell 2001; Puhl and Brownell 2003; Puhl and Heuer 2009; Puhl and Heuer 2010; 
Puhl et al. 2005; Puhl et al. 2020), directly impacting their socioeconomic prospects, quality of life, and 
health. These various forms of weight stigma, bias, and discrimination represent psychosocial 
mechanisms that cannot – and should not – be addressed by interventions premised on individual weight 
loss. Rather, they represent institutional sources of injustice and inequity that require institutional-level 
action, such as legislation, policies, and education or training that targets hiring and pay discrimination 
among employers, bullying and unfair treatment by both peers and teachers in educational settings, 
implicit bias and negligence among physicians, and inaccurate or defamatory news coverage, among 
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many other plausible interventions (Pearl 2018; Pearl et al. 2017; Puhl et al. 2020). Critically, public 
health messaging that avoids equating weight loss with individuals’ health – or avoids implicating 
individuals’ as being flawed due to their having overweight or obesity – is shown to be more effective in 
encouraging healthy behaviors and lifestyles (Pearl 2018).  
Limitations 
Prior to concluding, I note some limitations of the study, and how addressing them can help 
advance research on subjective weight, weight-related stigma, and broader questions surrounding body 
weight and health. As mentioned, the key variable of interest – individuals’ perceptions of their weight – 
is an imperfect measure of the much broader constructs of body image and body satisfaction that are 
relevant to this study (Durso and Latner 2008; Lillis et al. 2010; Sandoz et al. 2013). Though the use of 
perceived weight in this analysis is consistent with past work, a multi-dimensional perceptual measure 
would allow for a more comprehensive assessment of subjective weight and its implications for 
psychosocial wellbeing, as well as how it tracks with objective weight and body size over time. This may 
be especially important in the case of explaining differences between female and male respondents, as 
past work has shown that weight, in and of itself, is a less focal issue for men as compared to body 
composition and muscularity (Grogan 2007; Pope et al. 2000). It is understandable that a large, 
longitudinal data set like Add Health has limited space for additional questions; however, the inclusion of 
questions about weight discrimination in Waves IV and V offers an interesting opportunity to examine 
them as key mediators, or additional pathways, connecting subjective and objective weight and how they 
are associated with Wave V health outcomes. Indeed, preliminary analyses from these data suggest that 
individuals’ experiences of discrimination on the basis of their weight are strongly associated with both 
objective and subjective weight, as well as a number of physical and mental health outcomes. More 
explicit consideration of weight-based discrimination – as well discrimination on the basis of physical 
appearance – is an important line of future research 
There are also some limitations in the flexibility with which trajectories could be modeled in the 
analysis. The Add Health data are advantageous in covering different periods of the life course and 
 
197 
having high-quality health data; however, the number of waves is somewhat limited when assessing more 
complex longitudinal models, such as those including non-linear slopes (Bauldry and Bollen 2018). 
Moreover, the spacing between waves is inconsistent, which makes the interpretability of the 
autoregressive coefficients challenging (Kuiper and Ryan 2018). The comparison of models in these 
analyses was fairly definitive with respect to the choice of autoregressive models for both subjective and 
objective weight, but additional research can be done to validate these conclusions. To my knowledge, the 
NLSY97 is the only other comparable data set that tracks these two measures over a similar period in the 
life course, with fewer years separating waves. Even though the NLSY97 data are self-reported and lack 
as comprehensive a set of health outcomes, they can help demonstrate if the lagged effects trajectory 
continues to perform well with more time points and fewer years between measures. Past research 
suggests the autoregressive model would continue to have excellent fit, likely having higher 
autoregressive coefficients and greater explanatory power, but additional data would allow for better 
assessments of autoregressive latent trajectory models (Bollen and Gutin [Forthcoming]). 
Finally, additional work should be done to examine these trajectories, their associations, and their 
relation to outcomes among other groups. For one, this sample is age-limited, and some of the more 
adverse physiological outcomes associated with both subjective and objective weight measures are yet to 
manifest. The Health and Retirement Study also asks respondents about their subjective weight (Wedow 
et al. 2018), though the older starting age of the sample precludes the ability to assess how a more lifelong 
trajectory of subjective weight is associated with adult health.  
More importantly, this study only examined gender differences, on account of the gendered 
reality of body size and associated norms of what is an appropriate weight and appearance (Bordo 2004; 
Grogan 2007). However, these norms are by no means limited to women and men, as there is also 
evidence of differences in body weight norms and perceptions on the basis of race and ethnicity, as well 
as individuals’ socioeconomic status (Akan and Grilo 1995; Bennett and Wolin 2006; Cachelin et al. 
2002; Dorsey et al. 2009; Fitzgibbon et al. 2000; Gregory et al. 2008; Kronenfeld et al. 2010; Paeratakul 
et al. 2002; Vaughan et al. 2008; Webb et al. 2014). These are all incredibly important axes through 
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which to examine these issues, as are additional intersectional frameworks (Ciciurkaite and Perry 2018; 
Cole 2009; Himmelstein et al. 2017; Watson et al. 2019; Wildes et al. 2001). Social norms about beauty, 
fitness, and body size are often targeted towards specific groups. Indeed, many have noted that the “thin, 
fit ideal” in the United States is really a “White, female” ideal (Arciszewski et al. 2012; Greenhalgh 2015; 
Saguy 2012).  
In turn, there is an open question about the health consequences associated with the intersection 
of these ideals and identities with one’s BMI and perception of weight, given that much of what is 
understood about body image derives from work focused on White women (Cole 2009). On the one hand, 
it is plausible that a social comparative framework offers some degree of protection from the harm 
associated with not adhering to these societal ideals – as individuals largely draw on “within” group 
comparisons that lead them to be more satisfied with their weight and avoid any ensuing psychosocial 
consequences. Conversely, greater distance from social norms – even those that are targeted towards a 
group one is not a “member” of – can be more harmful, especially if individuals are actively judged by 
others who compare them to these unattainable ideals, which in turn informs individuals’ own 
assessments of their weight. 
These are important and compelling lines of inquiry, requiring careful examination within this 
SEM framework. As seen in these analyses, the relative complexity of the models makes formal tests of 
measurement invariance quite difficult, which proves limiting in making formal comparisons across 
groups. Indeed, additional consideration of invariance across race and ethnic groups failed to converge in 
these analyses, suggesting that examination of these differences requires a more systematic approach to 
model-building wherein group-specific trajectories and intersections between trajectories need to be 
identified. This work can be integrated with “contextual” data on weight perception – as seen in past 
research using Add Health data (Wedow et al. 2018) – to better understand the social origins and social 




Amid high and rising rates of obesity in the United States, it is reasonable for population health 
researchers to speculate that shifting norms about what constitutes a healthy and normal body size and 
weight may be implicated as a key contributing cause (Burke et al. 2010). Yet the understanding of how 
objective and subjective weight are related to one another throughout the population is incomplete 
without accounting for individuals’ tendency to exhibit some degree of stability – or path dependency – in 
various aspects of their health and perceptions of their health over time; moreover, the relationship 
between objective and subjective health is likely complex and variable over the life course. Thus, one 
cannot expect that individuals’ objective and subjective weight perfectly track with one another, such that 
modifying one or the other will result in both a ‘healthier’ weight and greater satisfaction with one's 
weight. Rather, subjective and objective weight need to be understood as separate constructs and 
longitudinal processes, requiring independent study that can help facilitate more nuanced and actionable 
policies and interventions. 
Population health research is cognizant of the importance of subjective measures of health, and 
this should be no different in the case of subjective weight. Individuals’ weight status is a key source of 
social stigma in the United States (Greenhalgh 2015; Puhh and Heuer 2010); more broadly, individuals’ 
health status – and others’ perceptions of or assumptions about individuals’ health – is a key determinant 
of one’s social standing and worth (Cockerham 2005; Dew 2012). Health and social norms are 
inextricably intertwined, with body size and obesity as arguably the most illustrative example. Health is 
something that individuals experience at both a physiological and psychosocial level yet this is rarely 
taken into consideration in the study of body weight. Individuals’ perceptions of their weight may offer 
key insight on these psychosocial mechanisms, yet they are often used to gauge whether and how wrong 
individuals are about their weight. In framing this as an issue of misperception, researchers should take a 
moment to consider the social and cultural biases that lead to such a conclusion – especially in reinforcing 
the narrative of personal responsibility, knowledge, and decision-making as driving factors underlying 
overweight and obesity (Brownell et al. 2010; Puhl and Brownell 2003; Saguy 2012; Shugart 2016). 
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Instead, researchers should consider how and why this discordance occurs, and whether it is truly 
discordance at all. These more open-ended lines of inquiry allow for future research and theory akin to 
past work on self-rated health (Jylhä 2009), asking if individuals’ responses are based on whether they 
believe that their body allows them to have a satisfying and healthy life, above and beyond the limited 
insight provided by height and weight. 
Indeed, this study suggests that many of the pathways through which subjective weight affects 
individuals’ health are likely a function of distorted and discriminatory social norms about “healthy,” 
“normal,” and thus “good” bodies (Dew 2012; Greenhalgh 2015; Saguy 2012). While excess weight can 
be and often is detrimental to one’s health, it is important to consider how the negative identities and 
beliefs individuals form in relation to their body weight are consequential as well. The United States, as 
well as many other countries (Puhl et al. 2015), is a highly weight-conscious nation, with institutional and 
interpersonal biases against individuals who do not conform to certain expectations of an appropriate 
and/or desirable body and appearance (Jutel and Beutow 2007). In that sense, body weight is not unlike 
other axes of inequality that shape individuals’ day-to-day lives based on the stereotypes and assumptions 
that others have based on how a person looks (Gutin 2021), and the social and cultural messages that 
amplify these beliefs. The prevailing message that individuals simply need to lose weight – and conform 
to these ideals – cannot and should not be the solution to mitigating weight stigma as a harmful and 
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CHAPTER 5: CONCLUSION 
Sociologists, public health scientists, and numerous other researchers engaged in the study of 
population health are in an unenviable position when it comes to understanding body weight and health. 
The work is important and necessary: body weight continues to be a key determinant of individuals’ 
health and obesity remains a key population health challenge. Yet body weight is also key aspect of 
individuals’ identities, influencing both how they perceive themselves and how they are perceived and 
treated by others in a highly weight-conscious and body-normative society like the United States (Puhl 
and Heuer 2010; Saguy 2012). In turn, body weight and size carry many different meanings and 
assumptions depending on the context in which it is being used or discussed, and the various stakeholders 
involved (Gutin 2021). This enormity of different ways of thinking about body weight and size – and the 
numerous biological, physiological, psychological, and social factors and pathways that they reflect – 
makes population health research particularly challenging, especially when using an imprecise measure 
like BMI (Gutin 2018). 
This dissertation does not represent an effort to resolve this complexity by suggesting there is a 
single, or most valid, or definitive way of conceptualizing and using body weight in research on health. 
Rather, it makes a case for taking advantage of and examining the ambiguity in the relationship between 
body weight and health to obtain novel insights on body weight as both a physical trait and a social 
identity, situated at the nexus of health, morality, and normality. By synthesizing research and theory 
across the many different disciplines and contexts in which body weight is studied, I demonstrate that it 
represents a complex individual and population health issue that requires an equally complex and 
comprehensive approach to empirical research. Namely, this dissertation explores three key contexts in 
which ambiguity surrounding body weight as a health and social issue is paramount, to the extent that 
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body weight is a focal issue in clinical settings, epidemiological assessments of the population, and 
individuals’ subjective experiences and day-to-day lives. These are arguably the most important contexts 
shaping collective understanding of weight as a health issue, reflecting different underlying beliefs about 
the relationship between weight and health and how it should be addressed. However, this dissertation 
further demonstrates that these contexts are not without their own sources of ambiguity in how body 
weight is interpreted and used, underscoring the complexity of this ostensibly simple and parsimonious 
measure.  
With respect to the conceptualization and use of body weight in clinical practice, the first chapter 
finds that uncertainty about what body weight represents in early life is an integral part of the diagnostic 
process for childhood obesity. Indeed, health practitioners working with children and adolescents and 
their families often avoid formal diagnostic or medical language and labels out of concern for what terms 
like “overweight” or “obese” convey about a child’s level of unhealthiness and, in turn, how they 
influence patients’ perceptions of themselves and families’ perceptions of their children. Instead, I 
observe a consistent emphasis on framing childhood obesity in the language of prognosis – and locating a 
child on a trajectory of health and wellbeing – that avoids making definitive pronouncements about a 
child’s current condition. This prognostic framework is linked to clinicians’ underlying uncertainty about 
the utility and validity of existing diagnostic tools (Timmermans and Stivers 2018), especially when it 
comes to interpreting and reacting to patients’ BMIs. 
In the context of epidemiologic research on body weight and population health, the second 
chapter documents considerable heterogeneity in how obesity and poor cardiometabolic health co-occur 
in the U.S. adult population. Namely, obesity is not a monolith when it comes to its association with poor 
cardiometabolic health and increased mortality risk. There is much more nuance to the broad category of 
obesity; many adults with obesity have good cardiometabolic health, and the majority have a 
cardiometabolic health profile and mortality risk that is indistinguishable from an equally large subset of 
adults without obesity. However, the patterning of these different profiles of body size and 
cardiometabolic health is clearly social, rather than biological: college-educated adults are much more 
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likely to be free of any of the risks associated with either higher body weight or cardiometabolic 
impairment – reaffirming the fact that the health-advantages enjoyed by higher-SES adults cannot be 
reduced to a single source of risk (Freese and Lutfey 2011; Link and Phelan 1995; Phelan et al. 2010).  
The third chapter shows the importance of understanding how the relationship between 
individuals’ body weight and their health is a function of both the physiological and psychosocial aspects 
of body weight as an objective and subjective construct, respectively. Echoing a growing body of 
literature on this topic (Daly et al. 2017; Daly et al. 2019; Haynes et al. 2018; Haynes et al. 2019; Frisco 
et al. 2010; Robinson et al. 2017; Tomiyama et al. 2018; Unger et al. 2017), this chapter demonstrates that 
individuals’ perceptions of their weight are tied to multiple negative health outcomes over and above their 
body mass index. Objective body size has a clear physiological toll on adult health – as evidenced by 
increased blood pressure and inflammation – but there is no evidence of an association with worse mental 
health. Rather, increased depression and anxiety is related to individuals’ subjective assessments of 
themselves as being overweight, and the extent to which that suggests dissatisfaction with one’s body and 
weight. Critically, objective and subjective weight affect one another from early life into adulthood, such 
that subjective weight is indirectly associated with worse physiological health. In sum, these results show 
that the objective reality of having a higher body weight and the subjective experience of perceiving 
oneself as overweight are strongly associated with multiple dimensions of individuals’ health and 
wellbeing. 
This dissertation is not without a number of limitations specific to each of these chapters; there 
are also key questions left unanswered across these studies that serve as the basis for multiple future 
studies using these and other data. The interview data used in the first chapter may be subject to some 
degree of selection bias, as they come from a sample of childhood obesity practitioners whose 
professional interests coincide with the more critical and self-reflexive questions about conceptualization, 
definition, measurement, and diagnosis being asked in this study. Namely, their views may not be 
representative of the much broader population of clinicians and health professionals who encounter issues 
surrounding childhood obesity on a day-to-day basis; nor can these views be safely extrapolated to the 
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much broader issue of weight and health in other clinical settings. Representativeness is not a prerequisite 
of qualitative research in medical settings (Britten 1995), but it is important to acknowledge the 
possibility of variation in diagnosis and communication on childhood obesity across different settings and 
populations, as well as what determines this variation. Future work on childhood obesity as a diagnosis – 
and any ambiguity or uncertainty therein – should also incorporate the perspectives of patients and 
families on the receiving end of this diagnosis, as they represent key stakeholders in the “social 
diagnosis” framework (Brown et al. 2011). Practitioners and patients often reach different conclusions 
about the success or failure of a clinical encounter (Lutz 2019), and it is important to understand how 
aligned their views are in the context of childhood obesity. Though practitioners emphasize the 
importance of mutual understanding, it is unclear to what extent their patients and families experience 
their relationship as a partnership. For instance, directly observing clinical encounters could reveal 
important discrepancies in how practitioners recall their diagnostic language and advice as compared to 
what they actually say and do in describing patients’ weight and health. Moreover, given clear social 
disparities in childhood obesity, it may be especially valuable to see how patients’ backgrounds – such as 
their race and ethnicity or socioeconomic status – influence the degree of concordance between 
practitioners and patients’ experiences of a clinical visit, and how that influences the long-term trajectory 
of care and outcomes. 
With respect to the second chapter, it is important to acknowledge that both the data and methods 
used to identify multimorbidity and the co-occurrence of obesity with other cardiometabolic risks 
represent one of many possible approaches to addressing the same question, as evidenced by the large 
body of past work in this area (Blüher 2020; Primeau et al. 2011; Stefan et al. 2008; Tomiyama et al. 
2016; Wildman et al. 2008). Though I examine the sensitivity of the results to alternate specifications and 
choice of variables, I could not consider all possible combinations of relevant anthropometric and 
cardiometabolic variables and corresponding cutoffs for “high risk,” which could lead to substantively 
different class solutions. Likewise, latent class analysis is one of multiple options researchers have for 
identifying data-driven patterns, and it is important to validate these results using alternate methods. 
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Beyond these concerns about the robustness of the findings, further work with more recent restricted-use 
mortality data would allow researchers to include more refined cause-specific analyses and consider 
important group differences. Results from this study clearly show how the cause of death under 
consideration leads to different estimates of the associations between groupings of body size and 
cardiometabolic health and mortality risk, as well as the percent mediation in the educational gradient of 
mortality risk. Looking at all-cause mortality may be less appropriate than examining causes of death 
more closely linked to body weight and cardiometabolic dysregulation, as in past research with vital 
statistics (Masters et al. 2018). These additional restricted data – with a longer follow-up period for 
mortality – would also facilitate additional group comparisons not examined in this study. Ideally, 
researchers could identify group-specific latent class solutions and assess their association with mortality 
risk, given important intersectional differences in key metrics of population health (Bauer 2014; Bowleg 
2012). Finally, the availability of rich biomarker data in longitudinal data provides opportunities to 
examine not only the presence of latent classes but also transitions from one class to another as 
individuals age. This latter analysis would be particularly insightful for understanding how and why the 
latent classes identified in this study come to be associated with varying levels of mortality risk over time. 
The key variable of interest in the third chapter – individuals’ perceived weight – is not a 
comprehensive measure of negative body image, body dissatisfaction, internalized weight bias, weight 
stigma, weight discrimination, or the many other hypothesized mechanisms thought to explain how and 
why subjective weight is associated with worse health over and above body mass index (Durso and Latner 
2008; Lillis et al. 2010; Puhl and Huer 2010; Sandoz et al. 2013). At present, this study is limited by the 
availability of more comprehensive subjective measures of the body and weight in longitudinal data, let 
alone with a large sample size and well-measured physical and mental health outcomes. Thus, I cannot 
definitively identify the mechanisms underlying the association between subjective weight and worse 
health, or how it is associated with objective weight over time. Better measurement of the 
multidimensionality of subjective weight is critical for future work examining additional group 
differences in both the relationship between subjective and objective weight over time, and how both 
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measures are associated with adult health. This study emphasizes the importance of gender differences, 
but there is evidence of differences in body weight norms and perceptions based on individuals’ race and 
ethnicity and socioeconomic status, as well as how they differ based on gender (Bennett and Wolin 2006; 
Cachelin et al. 2002; Ciciurkaite and Perry 2018; Cole 2009; Dorsey et al. 2009; Fitzgibbon et al. 2000; 
Gregory et al. 2008; Himmelstein et al. 2017; Kronenfeld et al. 2010; Paeratakul et al. 2002; Vaughan et 
al. 2008; Watson et al. 2019). While there does not appear to be a longitudinal dataset that allows for a 
full accounting of the many dimensions of subjective weight identified in psychological research, further 
work with Add Health may consider how individuals’ desire to modify their weight or their experiences 
with weight discrimination can be incorporated into this structural equation modeling framework. 
Moreover, the stepwise modeling strategy outlined in this third chapter can serve as a guide for 
identifying the appropriate group-specific trajectories and intersecting relationships between subjective 
and objective body weight. 
Limitations aside, the results from this dissertation have important substantive implications for 
the conceptualization and use of body weight in clinical and epidemiologic research and settings, as well 
as the kinds of interventions and policies that are designed to address the inverse relationship between 
individuals’ weight and their health. For one, these results provide empirical support for the theory that 
acceptance, rather than avoidance, of uncertainty in diagnosis and clinical decision-making represents a 
key pathway by which practitioners engage with the various social and non-medical factors that affect 
patients’ lives and health (Brown et al. 2011; Croft et al. 2015). Despite growing awareness of the social 
determinants of health in the medical field, clinicians have few opportunities to directly engage with their 
patients’ health at this “social” level beyond having greater awareness and empathy for extenuating 
circumstances in patients’ lives (Metzl and Hansen 2014). However, clinicians play a key role in affecting 
change at the social, rather than the biomedical, level. Reich et al. (2016) provide an actionable 
framework for integrating fundamental cause theory into medical care, towards the goal of implementing 
“fundamental interventions.” While there are many reasons why viewing a patient through a biomedical 
lens is appropriate in a given situation (Reich et al. 2016), both this study and Reich et al. demonstrate 
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how broader consideration of patients’ social circumstances is often more informative. Clinicians cannot 
directly intervene on these social factors as they might with other aspects of a patient’s health, but they 
are a prominent voice in advocating for social policy with direct implications for individuals’ health 
(Reich et al. 2016), such as legislation on housing, infrastructure, minimum wage, and many other factors 
that influence obesity and health more broadly. Echoing the sentiment of many participants in this study, 
Reich et al. (2016) also describe the plausibility of “needs-based assessments” during clinical visits, that 
help screen for the social factors that have a direct bearing on clinical care and future health. Ideally, 
clinicians would be part of a wide network of social workers and community health professionals, such 
that patients and families are connected to individuals and resources that allow them to better adhere to 
and act on the advice that clinicians provide during a patient visit. 
Better assessment of risk is also crucial at the population level, especially when using fairly 
imprecise measures like BMI or obesity to study health disparities. As the second chapter shows, there is 
a wide range of substantive groupings of body size and cardiometabolic risks among U.S. adults, such 
that no single combination of body size and cardiometabolic risk fully explains the educational gradient in 
mortality. However, certain risk profiles are clearly more concerning than others; obesity is often one of 
many risk factors of concern and, in some cases, appears to present no additional risk in and of itself. This 
more nuanced understanding of body size, health, and overall risk raises questions about the continued 
emphasis on obesity as a key source of social disparities in mortality in the United States. Undoubtedly, 
obesity is a contributing factor, but it is important to recognize that obesity is primarily a concern when 
we have more direct evidence of its being the cause of poor health (Sharma and Campbell-Scherer 2017). 
One of the primary justifications for the continued reliance on BMI to define obesity in population health 
research is its easy of data collection and interpretation (Gutin 2018); these are valuable attributes of any 
measure, but they should not come at the expense of having an incomplete understanding of population 
health. Medical researchers have advocated for a more nuanced diagnosis of obesity that integrates other 
dimensions of individuals’ health (Sharma and Kushner 2009). In turn, epidemiologic, population-level 
research can provide support for these concerns, providing the critical “evidentiary” basis needed to 
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reevaluate and change clinical standards and protocols (Timmermans and Berg 2003). More broadly, 
population researchers and policymakers should invest in data collection and design that facilitate for a 
more holistic understanding of individuals’ health and allow for a more comprehensive evaluation of the 
success of a given intervention or policy beyond a narrow focus on weight loss. 
Likewise, the third chapter underscores the importance of expanding population and public health 
understanding of body weight and obesity as a health concern to be more inclusive of the subjective and 
psychosocial experience of being “overweight” in a society that values thinness and equates fitness with 
being a “good” person (Greenhalgh 2015). Obesity researchers recognize that body weight is often both a 
physiological and social source of stress; however, extant approaches to intervening on the negative 
health outcomes associated with higher body weight often focus on body weight itself as the target of the 
intervention and the metric of success. Yet long-term weight loss is unsustainable for the majority of 
adults (Bacon and Aphramor 2011; Puhl et al. 2020); nor is weight loss the appropriate solution for the 
many social explanations underlying worse health and wellbeing among children and adults with 
overweight and obesity. Body weight is a key source of stigma in the United States, and a key factor 
underlying worse experiences and outcomes in the workplace, educational settings, and healthcare, 
among many other settings (Puhl et al. 2020). The many forms of weight bias and discrimination that 
individuals with overweight and obesity encounter represent psychosocial mechanisms for which weight 
loss is not a panacea. Rather, these are institutional sources of inequality that require institutional-level 
action, such as legislation, policies, and education or training that targets hiring and pay discrimination 
among employers, bullying and unfair treatment by both peers and teachers in educational settings, 
implicit bias and negligence among physicians, and various other targeted interventions (Pearl 2018; Pearl 
et al. 2017; Puhl et al. 2020). At a more fundamental – and much simpler – level, population researchers 
studying obesity should avoid the uncritical conflation of elevated risk associated with higher weight and 
unhealthiness as a state of being (Gutin 2021); this mentality and language is often inaccurate and 
counterproductive, perpetuating the notion that overweight and obesity represent flawed or deviant 
identities (Pearl 2018; Puhl and Heuer 2010). 
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Ultimately, all three projects speak to the broader issue of how researchers, policymakers, and the 
public at large think about body weight and its relation to health; indeed, the overarching goal of this 
dissertation is to encourage more critical and reflexive thinking on how social and health norms are 
intertwined in society, and how that structures negative beliefs and biases towards individuals on the basis 
of what a number suggests about their health, or what their appearance implies about their standing in 
society. These biases are pervasive in research and society-at-large; moreover, they are almost entirely 
superficial in the sense that individuals’ weight or appearance provides limited insight on who they are, 
how they live their lives, or what their health is like. 
This kind of superficiality – and its relation to broader issues of inequality and stratification – is 
well established in sociological research. The notion that phenotypic attributes become imbued with 
social meaning – and thus become health-relevant traits – is not a novel concept (Link and Phelan 2001). 
Directly equating body size with race is too strong a comparison, to the extent that race is tied to endemic 
legacies and systems of oppression (Phelan and Link 2015), but one should not ignore how BMI and race 
exemplify how one’s phenotype affects health though non-biophysiological pathways. The issues 
surrounding race as an essentialized concept provide a clear illustration of how phenotypic traits are 
conflated with their social consequences (Frank 2007; Gutin 2019; Morning 2011), wherein race, itself, is 
assumed to be the innate, causal mechanism underlying poor health. Yet, decades of research prove that 
the relationship between race and health is attributable to race being a proxy for the many social ills 
inflicted upon non-White persons via interpersonal and institutional forms of discrimination and 
disenfranchisement (Phelan and Link 2015). Unfortunately, this message fails to resonate in a society 
where health is actively used to gauge individuals’ social standing (Scambler 2009); the moral judgment 
attached to healthiness substantiates the belief that those who are unhealthy are ‘bad’ members of society. 
This gives rise to a vicious cycle by which the poor health of a marginalized group is used to justify their 
marginalization, likely leading to worse health in the future. A comparable process of essentializing BMI 
has been at work for decades, legitimizing BMI as a surrogate marker of biophysiological health, while 
ignoring the psychosocial implications of its being a marker of appearance and status. Once again, 
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tautological reasoning is partially to blame; a person becomes unhealthy upon attaining an unhealthy 
BMI, implying some kind of transition in their latent health. 
Decades of sociological research reveal the importance of moving past such superficial biases to 
uncover the deeper social and institutional mechanisms at work, for which appearance or phenotype is 
merely a proxy. More broadly, BMI is a marker for health in the same way phenotypic attributes like race 
and gender are determinants of health; they gauge future risk rather than serve as measures of current 
health. Certainly, BMI is distinctive – and challenging – as it is not exclusively a marker of appearance 
and has real biophysiological consequences. Studying the relationship between body size and health is 
important, but there is a need to better acknowledge uncertainty in what body size represents. The 
conceptualization of race in health research continues to serve as a useful parallel; there are legitimate 
concerns about how race being used to perpetuate biogenetic explanations (Bliss 2012; Shim 2002), but 
recognition that race is a socially-meaningful category is vital for advancing justice and equity (Epstein 
2008). Thus, rather than limit discussion to biophysiological explanations for why BMI is associated with 
adverse health, the inequality framework allows for a broader set of psychosocial pathways and 
interventions. Again, a direct parallel is inappropriate, but it is informative in showing how limited the 
understanding of the relationship between body weight and health may be due to these implicit biases in 
how the association is described and examined.  
Conceptualizing body weight in terms of inequality, and advocating for weight neutrality, is more 
than just a rhetorical device. A weight neutral approach to research recognizes the importance of 
examining a wide variety of plausible mechanisms and explanations in the association between body 
weight and health. At present, the physiological and psychosocial mechanisms are often explored 
independent of one another; there is a critical gap in scholarship on how these two perspectives can be 
integrated to further collective knowledge of body weight and health, and improve body weight-related 
policy – especially when it is apparent that current efforts to address obesity and improve quality of life 
among adults with obesity are not effective. This dissertation shows that addressing all plausible 
explanations for how and why body weight is associated with poor health is not feasible in the context of 
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a single study. However, acknowledging these alternate mechanisms – and accepting that the relationship 
is not straightforward and unambiguous – is key to more open-minded, unbiased, and innovative research 
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APPENDIX 1: SEMI-STRUCTURED INTERVIEW GUIDE 
Indented questions represent PROMPTS for previous non-indented questions. 
Introduction: 
“My name is Iliya Gutin, and I am a PhD student in sociology at UNC-Chapel Hill. I am interested in 
how obesity is defined and measured as well as how it is diagnosed and treated in clinical settings. The 
goal of this interview is to gain insight from obesity experts, such as yourself, to help inform how obesity 
is used and discussed in health research and practice.” 
Background information: 
“Could you tell me your formal title? 
“What are your medical/research specialization and/or areas of interest? 
“How many years of experience do you have?” 
“What is the proportion of time you are engaged in clinical practice?” 
“How did you initially develop an interest in obesity, and/or childhood obesity in particular?” 
 “Did you receive any specialized training in obesity-related medicine and research?” 
 “Could you briefly describe this training?” 
Defining and measuring obesity: 
“How do you define obesity?” 
“What are some of the characteristics/features that come to mind?” 
“Does this definition vary based on context?” For example: 
“Among fellow clinicians?” 
“With patients and their families?” 
  “Do you take a child’s age/gender/race into consideration?” 
“Outside of a clinical context entirely?” 
“Have you observed changes in the definition and understanding of obesity over time?” 
“Has the way you define obesity changed throughout your career?” 
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 “What has motivated these changes?” 
“Do you consider obesity to be a disease?” 
 If YES: “What about obesity makes it a disease?” 
 If NO: “Why not, or what other category does it fall into?” 
“Do you believe a majority of health professionals consider obesity to be a disease?” 
“Do you believe it is important or necessary to call obesity a disease?” 
“How does this differ compared to other medical terms and classifications?” 
“Does this influence how you interact with patients?” 
“Do you think patients view obesity as a ‘disease’?” 
Diagnosing obesity: 
 “How do you measure obesity in a clinical setting?” 
 “Relatedly, how do you arrive at a diagnosis of obesity, especially among children?” 
“How do you think about weight as a measure of obesity, and health in general?” 
“Do you believe that children and adults can be “healthy at any size””? 
“Do you ever use this concept in your practice?” 
“Given more time and resources, would you use different diagnostic criteria?” 
“How do you communicate this diagnosis to your patients and their families?” 
 “What are the types of reactions you usually encounter?” 
 “Do you ever question the decision to make a diagnosis of obesity?” 
  “Have you ever felt it was ‘wrong’ to diagnose obesity in a patient?” 
“Have you ever ignored a patient’s BMI/weight status?” 
Treating obesity: 
“How do you discuss ‘treatment’ options for weight and/or obesity?” 
“Is this usually general advice, or does this vary from patient to patient?” 
“What counts as a successful outcome?” 
“What are the kinds of outcomes or changes in health are you looking for?” 
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“How important is weight/BMI?” 
“How do you perceive your role as a doctor in helping to reduce obesity?” 
 “What are the major obstacles to your success?” 
 “What are the major obstacles to your patients’ success?” 
“Where does obesity usually fit in among patients’ health concerns?” 
Other (time permitting, or incorporated throughout): 
 “Do you think most medical practitioners need obesity-specific training?” 
“How do you view the role of personal responsibility in weight and health?” 
“What do you think is the single most important factor in obesity prevention efforts?” 




APPENDIX 2: CHAPTER 3 SUPPLEMENTAL TABLES 



















Body Size and History        
 Obesity 0.60% 
 77.2%  3.90%  83.5% 
 Ever obese 4.20% 
 100%  11.2%  98.6% 
 
Obesity 10 years 
ago 
0.00%  42.4%  0.00%  61.2% 
 Obesity at age 25 0.30% 
 19.10%  0.00%  22.4% 
 Waist-to-hip 30.3% 
 85.9%  93.2%  97.6% 
 Waist-to-height 35.2% 
 99.4%  92.1%  99.7% 
Cardiovascular        
 Pulse 0.70% 
 1.10%  1.20%  3.30% 
 Hypertension (M) 30.1% 
 63.1%  68.2%  79.9% 
 Hypertension (Dx) 7.30% 
 33.6%  31.5%  66.9% 
Dyslipidemia        
 High Chol. (M) 33.0% 
 54.0%  69.7%  55.1% 
 High Chol. (Dx) 11.1% 
 27.9%  38.8%  50.8% 
 High Trigly. 5.70% 
 40.7%  49.8%  65.9% 
 High Apob 9.40% 
 41.1%  61.1%  42.6% 
 Low HDL 6.30% 
 27.1%  26.3%  41.0% 
Hyperglycemia        
 High HbA1c 4.10% 
 10.6%  20.4%  79.0% 
 High Glucose 19.5% 
 36.0%  50.8%  85.6% 
 High Insulin 0.50% 
 5.40%  30.9%  38.9% 
 Diabetes (Dx) 0.70% 
 0.40%  5.20%  45.0% 
Other   
     
 High CRP 12.8% 
 45.7%  30.9%  65.0% 
 High Alb.-to-Creat. 0.20% 
 0.40%  1.00%  6.20% 
                  
         
Notes:         
National Health and Nutrition Examination Survey, 1988-2014, Ages 30-74. 
Estimates account for NCHS-provided survey weights. 
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Table A.2 Adjusted All-cause Mortality Risk Across Latent Classes 
          
     
Odds 
Ratio 
 95% CI 
5-Class Solution (ref. "Ideal")     
 
 "Fat but Fit"   1.25  1.05  1.49 
 Mixed Health w/ 
Obesity 
 1.37  1.19  1.58 
 Mixed Health w/o Obesity 1.23  1.09  1.39 
 High Risk   2.04  1.77  2.35 
Education (ref. BA or higher)      
 Less than HS  1.46  1.23  1.73 
 HS or equal  1.36  1.18  1.56 
 Some college  1.38  1.16  1.64 
Survey Cycle (ref. 1988-1994)      
 1999-2000   0.56  0.49  0.63 
 2001-2002   0.40  0.36  0.45 
 2003-2004   0.31  0.27  0.36 
 2005-2006   0.30  0.25  0.36 
 2007-2008   0.23  0.20  0.28 
 2009-2010   0.23  0.18  0.29 
 2011-2012   0.26  0.19  0.34 
 2013-2014   0.62  0.54  0.70 
Age    1.05  1.02  1.08 
Age-squared   1.00  1.00  1.00 
Female   0.79  0.73  0.84 
Race/ethnicity (ref. NH White)      
 NH Black   1.13  1.03  1.24 
 MX-American  1.12  1.00  1.25 
 Other   0.87  0.74  1.03 
Foreign-born   0.89  0.78  1.02 
Income-to-needs ratio (ref. 0-0.99)     
 1.00-1.99   1.85  1.62  2.10 
 2.00-3.99   1.47  1.29  1.68 
 4.00+   1.11  0.98  1.25 
Health insurance  0.88  0.77  1.00 
Smoking status (ref. Never)      
 Former   1.28  1.16  1.41 
 Current   2.09  1.93  2.26 
          
  Sample size     40,095 
  Number of deaths   7,106 
          
Notes:         
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National Health and Nutrition Examination Survey, 1988-2014,  
Ages 30-75. 
Deaths restricted to ages 30-85. 
Estimates account for NCHS-provided survey weights. 







Table A.3 Fully-adjusted Cause-specific Mortality Risk Across Latent Classes  







Heart Disease, Diabetes, 
or Cancer 
     
Odds 
Ratio 












 95% CI 
                        
5-Class Solution  
(ref. "Ideal") 
                   
 "Fat but Fit"   1.28  0.53 3.10  1.48  0.85 2.59  1.03  0.66 1.60  1.09  0.88 1.34 
 Mixed Health  
w/ Obesity 
 4.45  2.18 9.08  2.84  1.57 5.15  2.02  1.42 2.90  1.37  1.15 1.62 
 Mixed Health 
 w/o Obesity 
2.83  1.42 5.62  1.83  1.09 3.09  1.60  1.13 2.28  1.21  1.05 1.40 
 High Risk   20.5  10.2 41.2  5.41  3.05 9.60  3.45  2.23 5.32  2.06  1.68 2.53 
                        




  1,017  1,014  1,395  3,502 
                        
Notes:                       
National Health and Nutrition Examination Survey, 1988-2014, Ages 30-75. 
Deaths restricted to ages 30-85. 
Estimates account for NCHS-provided survey weights. 
Estimates based on multiple imputation to account for missing data. 




Table A.4 Average Marginal Effects for All Covariates 
       
   "Ideal"  
    95% C.I.  
Education (ref. BA or higher)    
 Less than HS -15.5% -18.1% -12.9%  
 HS or equal -12.3% -14.3% -10.2%  
 Some college -11.1% -13.8% -8.29%  
Survey Cycle (ref. 1988-1994)    
 1999-2000 -2.70% -5.07% -0.34%  
 2001-2002 -5.73% -8.52% -2.94%  
 2003-2004 -8.14% -10.88% -5.39%  
 2005-2006 -7.91% -10.58% -5.23%  
 2007-2008 -7.68% -9.96% -5.40%  
 2009-2010 -8.52% -10.9% -6.14%  
 2011-2012 -8.25% -11.2% -5.32%  
 2013-2014 -2.45% -5.43% 0.53%  
Age  -1.13% -1.22% -1.05%  
Female  13.1% 11.7% 14.5%  
Race/ethnicity (ref. NH White)    
 NH Black -1.90% -3.48% -0.31%  
 MX-American -9.55% -11.4% -7.67%  
 Other  -4.15% -6.67% -1.64%  
Foreign-born 5.83% 3.93% 7.72%  
Income-to-needs ratio (ref. 0-0.99)   
 1.00-1.99  -5.90% -8.57% -3.23%  
 2.00-3.99  -3.21% -5.45% -0.97%  
 4.00+  -2.30% -4.01% -0.59%  
Health insurance -0.86% -3.48% 1.76%  
Smoking status (ref. Never)    
 Former  -0.34% -2.16% 1.49%  
 Current  3.82% 2.04% 5.61%  
       
   "Fat but Fit"  
    95% C.I.  
Education (ref. BA or higher)    
 Less than HS 2.69% 0.85% 4.52%  
 HS or equal 2.19% 0.81% 3.57%  
 Some college 4.14% 2.68% 5.60%  
Survey Cycle (ref. 1988-1994)    
 1999-2000 5.85% 4.03% 7.67%  
 2001-2002 7.76% 5.04% 10.48%  
 2003-2004 4.61% 2.54% 6.67%  
 2005-2006 4.38% 2.21% 6.56%  
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 2007-2008 6.60% 4.37% 8.83%  
 2009-2010 8.58% 7.02% 10.1%  
 2011-2012 7.56% 5.20% 9.91%  
 2013-2014 5.17% 3.98% 6.35%  
Age  -0.29% -0.33% -0.24%  
Female  3.24% 2.29% 4.18%  
Race/ethnicity (ref. NH White)    
 NH Black 4.74% 3.50% 5.98%  
 MX-American 2.93% 1.21% 4.65%  
 Other  2.04% -0.24% 4.33%  
Foreign-born -6.97% -8.91% -5.03%  
Income-to-needs ratio (ref. 0-0.99)   
 1.00-1.99  2.77% 1.04% 4.51%  
 2.00-3.99  2.31% 0.51% 4.10%  
 4.00+  1.50% 0.21% 2.80%  
Health insurance -0.74% -2.34% 0.87%  
Smoking status (ref. Never)    
 Former  0.07% -1.20% 1.35%  
 Current  -3.52% -4.80% -2.24%  
       
   Mixed Health w/ Obesity  
    95% C.I.  
Education (ref. BA or higher)    
 Less than HS 4.29% 2.11% 6.48%  
 HS or equal 4.57% 2.79% 6.35%  
 Some college 4.16% 2.32% 5.99%  
Survey Cycle (ref. 1988-1994)    
 1999-2000 1.73% -0.21% 3.68%  
 2001-2002 1.60% -0.61% 3.81%  
 2003-2004 5.62% 4.10% 7.15%  
 2005-2006 3.53% 1.98% 5.08%  
 2007-2008 2.81% 0.95% 4.68%  
 2009-2010 1.09% -0.76% 2.94%  
 2011-2012 3.62% 2.13% 5.12%  
 2013-2014 2.14% 0.59% 3.68%  
Age  0.14% 0.11% 0.17%  
Female  -2.79% -3.86% -1.72%  
Race/ethnicity (ref. NH White)    
 NH Black -2.64% -3.63% -1.65%  
 MX-American 1.85% 0.27% 3.44%  
 Other  -3.26% -5.31% -1.20%  
Foreign-born -3.45% -5.41% -1.50%  
Income-to-needs ratio (ref. 0-0.99)   
 1.00-1.99  2.10% 0.20% 4.00%  
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 2.00-3.99  2.11% 0.23% 4.00%  
 4.00+  1.41% -0.03% 2.85%  
Health insurance -0.90% -2.64% 0.84%  
Smoking status (ref. Never)    
 Former  0.69% -0.71% 2.10%  
 Current  -2.39% -3.71% -1.07%  
       
   Mixed Health w/o Obesity  
    95% C.I.  
Education (ref. BA or higher)    
 Less than HS 1.77% -0.99% 4.54%  
 HS or equal 0.87% -1.63% 3.37%  
 Some college -0.29% -2.66% 2.09%  
Survey Cycle (ref. 1988-1994)    
 1999-2000 -6.46% -8.81% -4.11%  
 2001-2002 -6.00% -9.47% -2.54%  
 2003-2004 -5.95% -8.48% -3.41%  
 2005-2006 -5.69% -8.18% -3.20%  
 2007-2008 -7.54% -9.78% -5.31%  
 2009-2010 -7.79% -10.7% -4.93%  
 2011-2012 -10.7% -13.1% -8.29%  
 2013-2014 -5.86% -7.73% -3.99%  
Age  0.93% 0.86% 1.00%  
Female  -12.6% -13.9% -11.3%  
Race/ethnicity (ref. NH White)    
 NH Black -6.58% -8.11% -5.05%  
 MX-American -0.45% -2.40% 1.51%  
 Other  2.89% -0.21% 5.98%  
Foreign-born 8.55% 6.37% 10.74%  
Income-to-needs ratio (ref. 0-0.99)   
 1.00-1.99  -3.72% -6.58% -0.86%  
 2.00-3.99  -4.97% -7.51% -2.44%  
 4.00+  -2.09% -3.86% -0.31%  
Health insurance 0.12% -2.35% 2.58%  
Smoking status (ref. Never)    
 Former  -1.80% -3.30% -0.30%  
 Current  4.39% 2.49% 6.29%  
       
   High Risk  
    95% C.I.  
Education (ref. BA or higher)    
 Less than HS 6.71% 5.27% 8.15%  
 HS or equal 4.64% 3.34% 5.93%  
 Some college 3.04% 2.11% 3.96%  
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Survey Cycle (ref. 1988-1994)    
 1999-2000 1.58% 0.13% 3.03%  
 2001-2002 2.38% 0.88% 3.87%  
 2003-2004 3.85% 2.35% 5.35%  
 2005-2006 5.68% 3.79% 7.57%  
 2007-2008 5.81% 4.29% 7.32%  
 2009-2010 6.65% 4.56% 8.74%  
 2011-2012 7.76% 6.53% 9.00%  
 2013-2014 1.00% 0.44% 2.43%  
Age  0.35% 0.32% 0.38%  
Female  -0.97% 1.67% -0.27%  
Race/ethnicity (ref. NH White)    
 NH Black 6.38% 5.26% 7.50%  
 MX-American 5.21% 3.73% 6.70%  
 Other  2.48% 0.65% 4.32%  
Foreign-born -3.95% 5.39% -2.52%  
Income-to-needs ratio (ref. 0-0.99)   
 1.00-1.99  4.75% 3.32% 6.18%  
 2.00-3.99  3.76% 2.63% 4.89%  
 4.00+  1.48% 0.32% 2.63%  
Health insurance 2.38% 1.04% 3.73%  
Smoking status (ref. Never)    
 Former  1.37% 0.40% 2.33%  
 Current  -2.31% -3.33% -1.28%  
              
       
Notes:       
National Health and Nutrition Examination Survey,  
1988-2014, Ages 30-74. 
Estimates account for NCHS-provided survey weights.  
Estimates based on multiple imputation to account for missing data. 
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Table A.5 Average Marginal Effects for Educational Attainment Across Latent Classes 
   "Ideal" 
   Unadjusted 
 Adjusted 
   
 95% C.I.   95% C.I. 
Education (ref. BA or higher)       
 Less than HS -20.4% -22.9% -17.9%  -15.9% -18.5% -13.4% 
 HS or equal -12.7% -14.8% -10.6%  -12.5% -14.5% -10.4% 
 Some college -11.6% -14.6% -8.67%  -11.1% -13.8% -8.37% 
          
   Mixed Health w/ Obesity 
   Unadjusted 
 Adjusted 
   
 95% C.I.   95% C.I. 
Education (ref. BA or higher)       
 Less than HS 3.90% 1.66% 6.15%  5.85% 3.02% 8.68% 
 HS or equal 5.33% 3.24% 7.42%  5.69% 3.44% 7.95% 
 Some college 8.68% 6.45% 10.9%  6.95% 4.72% 9.17% 
          
   Mixed Health w/o Obesity 
   Unadjusted 
 Adjusted 
   
 95% C.I.   95% C.I. 
Education (ref. BA or higher)       
 Less than HS 5.13% 2.59% 7.67%  2.28% -0.39% 4.96% 
 HS or equal 1.44% -0.90% 3.78%  1.31% -1.07% 3.69% 
 Some college -1.98% -4.48% 0.52%  -0.06% -2.42% 2.30% 
          
   High Risk 
   Unadjusted 
 Adjusted 
   
 95% C.I.   95% C.I. 
Education (ref. BA or higher)       
 Less than HS 11.4% 9.93% 12.8%  7.82% 6.05% 9.59% 
 HS or equal 5.94% 4.47% 7.40%  5.46% 3.86% 7.05% 
 Some college 4.95% 3.86% 6.03%  4.19% 3.00% 5.39% 
                    
          
Notes:          
National Health and Nutrition Examination Survey, 1988-2014, Ages 30-75. 
Estimates account for NCHS-provided survey weights. 
Estimates based on multiple imputation to account for missing data. 
Adjusted for educational attainment, age, survey year, gender, race/ethnicity, nativity, income-to-needs 
ratio, health insurance, and smoking status. 
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Table A.6 Average Marginal Effects for All Covariates 
       
   "Ideal"  
    95% C.I.  
Education (ref. BA or higher)    
 Less than HS 15.9% -18.5% -13.4%  
 HS or equal 12.5% -14.5% -10.4%  
 Some college 11.1% -13.8% -8.37%  
Survey Cycle (ref. 1988-1994)    
 1999-2000 2.53% -5.03% -0.03%  
 2001-2002 6.03% -8.62% -3.45%  
 2003-2004 8.26% -10.9% -5.59%  
 2005-2006 7.60% -9.95% -5.24%  
 2007-2008 7.73% -9.92% -5.55%  
 2009-2010 8.24% -10.6% -5.86%  
 2011-2012 -7.50% -10.5% -4.52%  
 2013-2014 2.51% -5.68% 0.66%  
Age  1.17% -1.26% -1.09%  
Female  13.8% 12.4% 15.2%  
Race/ethnicity (ref. NH White)    
 NH Black 1.58% -3.13% -0.03%  
 MX-American 8.93% -10.8% -7.01%  
 Other  3.94% -6.43% -1.45%  
Foreign-born  5.76% 3.83% 7.69%  
Income-to-needs ratio (ref. 0-0.99)    
 1.00-1.99  -6.11% -8.79% -3.43%  
 2.00-3.99  2.99% -5.29% -0.68%  
 4.00+  2.35% -4.01% -0.69%  
Health insurance 0.95% -3.52% 1.62%  
Smoking status (ref. Never)    
 Former  0.11% -1.94% 1.72%  
 Current  3.78% 1.86% 5.70%  
       
   Mixed Health w/ Obesity  
    95% C.I.  
Education (ref. BA or higher)    
 Less than HS 5.85% 3.02% 8.68%  
 HS or equal 5.69% 3.44% 7.95%  
 Some college 6.95% 4.72% 9.17%  
Survey Cycle (ref. 1988-1994)    
 1999-2000 8.32% 5.66% 11.0%  
 2001-2002 11.1% 8.19% 14.0%  
 2003-2004 10.8% 7.70% 13.9%  
 2005-2006 7.37% 5.30% 9.44%  
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 2007-2008 9.09% 6.83% 11.3%  
 2009-2010 9.86% 7.48% 12.2%  
 2011-2012 10.5% 7.74% 13.3%  
 2013-2014 8.81% 6.60% 11.0%  
Age  -0.17% -0.22% -0.12%  
Female  -0.23% -1.43% 0.97%  
Race/ethnicity (ref. NH White)    
 NH Black 2.00% 0.46% 3.53%  
 MX-American 3.05% 0.61% 5.49%  
 Other  -1.95% -4.77% 0.87%  
Foreign-born  -9.99% -12.5% -7.47%  
Income-to-needs ratio (ref. 0-0.99)    
 1.00-1.99  4.61% 2.44% 6.77%  
 2.00-3.99  4.21% 2.10% 6.32%  
 4.00+  2.62% 0.93% 4.31%  
Health insurance -1.97% -4.23% 0.29%  
Smoking status (ref. Never)    
 Former  0.14% -1.58% 1.87%  
 Current  -5.41% -6.92% -3.90%  
       
   Mixed Health w/o Obesity  
    95% C.I.  
Education (ref. BA or higher)    
 Less than HS 2.28% -0.39% 4.96%  
 HS or equal 1.31% -1.07% 3.69%  
 Some college -0.06% -2.42% 2.30%  
Survey Cycle (ref. 1988-1994)    
 1999-2000 -6.25% -8.74% -3.75%  
 2001-2002 -6.16% -9.49% -2.82%  
 2003-2004 -6.02% -8.47% -3.57%  
 2005-2006 -5.56% -7.85% -3.27%  
 2007-2008 -7.13% -9.34% -4.92%  
 2009-2010 -8.09% -10.69% -5.50%  
 2011-2012 -10.6% -12.7% -8.39%  
 2013-2014 -6.22% -8.14% -4.30%  
Age  0.92% 0.85% 0.99%  
Female  -12.0% -13.4% -10.7%  
Race/ethnicity (ref. NH White)    
 NH Black -6.80% -8.28% -5.31%  
 MX-American -0.83% -2.92% 1.25%  
 Other  2.33% -0.88% 5.53%  
Foreign-born  8.91% 6.66% 11.2%  
Income-to-needs ratio (ref. 0-0.99)    
 1.00-1.99  -3.79% -6.55% -1.04%  
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 2.00-3.99  -5.20% -7.69% -2.70%  
 4.00+  -2.22% -4.01% -0.43%  
Health insurance 0.86% -1.51% 3.23%  
Smoking status (ref. Never)    
 Former  -1.88% -3.41% -0.35%  
 Current  4.43% 2.48% 6.37%  
       
   High Risk  
    95% C.I.  
Education (ref. BA or higher)    
 Less than HS 7.82% 6.05% 9.59%  
 HS or equal 5.46% 3.86% 7.05%  
 Some college 4.19% 3.00% 5.39%  
Survey Cycle (ref. 1988-1994)    
 1999-2000 0.46% -1.40% 2.32%  
 2001-2002 1.11% -0.61% 2.83%  
 2003-2004 3.45% 1.59% 5.32%  
 2005-2006 5.78% 3.71% 7.86%  
 2007-2008 5.78% 4.18% 7.37%  
 2009-2010 6.47% 4.03% 8.90%  
 2011-2012 7.53% 5.94% 9.12%  
 2013-2014 -0.08% -1.77% 1.62%  
Age  0.42% 0.38% 0.46%  
Female  -1.55% -2.37% -0.73%  
Race/ethnicity (ref. NH White)    
 NH Black 6.38% 5.12% 7.63%  
 MX-American 6.72% 5.02% 8.41%  
 Other  3.56% 1.35% 5.77%  
Foreign-born  -4.68% -6.27% -3.08%  
Income-to-needs ratio (ref. 0-0.99)    
 1.00-1.99  5.30% 3.60% 6.99%  
 2.00-3.99  3.97% 2.56% 5.39%  
 4.00+  1.96% 0.60% 3.31%  
Health insurance 2.06% 0.59% 3.52%  
Smoking status (ref. Never)    
 Former  1.84% 0.65% 3.04%  
 Current  -2.79% -3.80% -1.79%  
              
       
Notes:       
National Health and Nutrition Examination Survey,  
1988-2014, Ages 30-74. 
Estimates account for NCHS-provided survey weights. 




Table A.7 Percent Contribution of Latent Classes to Educational Disparities in All-Cause Mortality 
        
     Percent Mediated 
     Unadjusted  Adjusted 
Education (ref. BA or higher)            
 Less than HS (ref. “Ideal”)   17.6 
 15.3 
  Mixed Health w/ Obesity 3.13  3.94 
  Mixed Health w/o Obesity 3.99  1.74 
  "High Risk"  10.5 
 9.63 
        
 HS or equal (ref. “Ideal”)   16.0 
 14.0 
  Mixed Health w/ Obesity 4.95  4.87 
  Mixed Health w/o Obesity 1.79  1.43 
  "High Risk"  9.28 
 7.66 
        
 Some college (ref. “Ideal”)   21.1 
 11.3 
  Mixed Health w/ Obesity 11.4 
 6.02 
  Mixed Health w/o Obesity -0.84 
 0.93 
  "High Risk"  10.5 
 4.33 
                
Notes:        
National Health and Nutrition Examination Survey, 1988-2014, Ages 30-75. 
Deaths restricted to ages 30-85. 
Estimates account for NCHS-provided survey weights. 
Adjusted for age, age-squared, survey year, gender, race/ethnicity, nativity, income-to-







Table A.8 Percent Contribution of Latent Classes to Educational Disparities in Cause-specific Mortality 
            
     Percent Mediated 












Education (ref. BA or higher)                    
 Less than HS (ref. “Ideal”)   37.2 
 28.2  25.6  17.5 
  Mixed Health w/ Obesity 8.65  8.49  6.91  3.87 
  Mixed Health w/o Obesity 5.81  3.93  3.88  2.25 
  "High Risk"  22.7 
 15.8  14.8  11.4 
   
         
 HS or equal (ref. “Ideal”)   32.8 
 22.1  27.3  14.8 
  Mixed Health w/ Obesity 10.46  8.84  9.91  4.52 
  Mixed Health w/o Obesity 4.67  2.73  3.70  1.75 
  "High Risk"  17.66 
 10.6  13.7  8.57 
   
         
 Some college (ref. “Ideal”)   44.4 
 46.5  18.1  11.2 
  Mixed Health w/ Obesity 22.1 
 27.2  9.92  5.41 
  Mixed Health w/o Obesity 5.18 
 4.40  1.94  1.10 
  "High Risk"  17.1 
 14.9  6.27  4.70 
                        
Notes:            
National Health and Nutrition Examination Survey, 1988-2014, Ages 30-75. 
Deaths restricted to ages 30-85. 
Estimates account for NCHS-provided survey weights. 










APPENDIX 3: CHAPTER 4 SUPPLEMENTAL TABLES 
Table A.9 Descriptive Statistics for Perceived Weight, Body Mass Index, and Sociodemographic Covariates and Health Outcomes 
               
    Overall  Female  Male 
               
    Mean/Prop.  
Std. 
Dev. 
 Mean/Prop.  
Std. 
Dev. 
 Mean/Prop.  
Std. 
Dev. 
               
Perceived Weight  
   
 
   
 
   
 Wave I  3.190  0.797  3.334  0.782  3.002  0.776 
 Wave II  3.196  0.760  3.330  0.750  3.019  0.737 
 Wave III  3.354  0.800  3.495  0.784  3.162  0.782 
 Wave IV  3.649  0.831  3.788  0.818  3.461  0.811                
Body Mass Index (BMI)             
 Wave I  22.536  4.471  22.317  4.419  22.816  4.521 
 Wave II  23.058  5.074  22.981  5.200  23.157  4.904 
 Wave III  26.678  6.411  26.677  6.959  26.678  5.583 
 Wave IV  29.175  7.607  29.224  8.208  29.109  6.705                
Sociodemographic             
 Age at Wave I  15.580  1.738  15.511  1.738  15.671  1.733 
 Female  0.567  0.496  -  -  -  - 
 Race/Ethnicity             
  NH-White  0.600  0.490  0.584  0.493  0.622  0.485 
  NH-Black  0.202  0.401  0.225  0.417  0.173  0.378 
  Hispanic   0.123  0.329  0.124  0.330  0.122  0.327 
  NH-Other  0.074  0.263  0.068  0.251  0.083  0.276 
 College-educated Parent  0.347  0.476  0.340  0.473  0.356  0.479 
 Wave III In-College +  0.517  0.500  0.537  0.499  0.490  0.500 
 Wave IV B.A. Degree +  0.358  0.480  0.388  0.487  0.319  0.466 
 Wave V B.A. Degree +  0.407  0.491  0.445  0.497  0.357  0.480                








 BMI  30.703  7.848  30.873  8.444  30.440  6.814 
 Syst. BP (1)  124.345  16.302  120.417  15.631  130.215  15.501 
 Syst. BP (2)  122.923  15.622  119.140  14.880  128.568  14.985 
 Syst. BP (3)  122.200  15.287  118.526  14.636  127.685  14.579 
 Diast. BP (1)  80.185  11.467  78.021  11.149  83.419  11.170 
 Diast. BP (2)  79.662  11.149  77.468  10.805  82.935  10.850 
 Diast. BP (3)  79.261  11.024  77.042  10.692  82.573  10.676 
 
Measured 
Hypertension/Rx  0.308  0.462  0.249  0.432  0.396  0.489 
 C-reactive Protein  4.026  6.133  4.789  6.879  2.888  4.580 
 Felt Depressed Freq.  1.391  0.680  1.425  0.704  1.346  0.647 
 Felt Blues Freq.  1.358  0.691  1.380  0.704  1.330  0.673 
 Felt Sad Freq.  1.575  0.669  1.634  0.686  1.497  0.637 
 Depression Dx  0.246  0.430  0.301  0.459  0.173  0.378 
 Anxiety Dx  0.220  0.415  0.274  0.446  0.149  0.356 
 Sleep Trouble Freq.  1.722  1.329  1.853  1.330  1.551  1.309 
                              
               
N(Overall)=12,300; N(Female)=6,974, N(Male)=5,326. 
Results based on casewise maximum likelihood (also called FIML) estimation to account for missing data, with robust  







Table A.10 Comparison of Longitudinal Models for Subjective Weight Across Different Specifications 
                 
Very Under/Slightly Under/About Right vs. Slightly Over vs. Very Over (Continuous) 
Model     χ2   DF   BIC   CFI   TLI   1-RMSEA   Notes 
                 
Autoregressive  1.045  1  -8.372  1.000  1.000  0.998  None                  
Fixed Effects  416.035  3  387.783  0.940  0.879  0.843  Negative variances                  































Regressions constrained to be equal 
Under vs. About Right vs. Over (Continuous) 
Model     χ2   DF   BIC   CFI   TLI   1-RMSEA   Notes 
                 
Autoregressive  0.403  1  -9.014  1.000  1.000  1.000  None                  
Fixed Effects  713.982  3  685.730  0.888  0.776  0.805  Negative variances                  































Regressions constrained to be equal 
 
 
Under/About Right vs. Over 
Model     χ2   DF   BIC   CFI   TLI   1-RMSEA   Notes 
                 
Autoregressive  0.730  1  -8.687  1.000  1.000  1.000  None 
                 
Fixed Effects  619.866  3  591.614  0.901  0.802  0.820  None                  






































Regressions constrained to be equal 
Very Under vs. Slightly Under vs. About Right vs. Slightly Over vs. Very Over (Ordinal) 
Model     χ2   DF   BIC   CFI   TLI   1-RMSEA   Notes 
                 
Autoregressive  2.907  1  -6.510  1.000  1.000  0.988  None 
                 
Fixed Effects  951.528  3  923.276  0.985  0.969  0.840  Negative variances                  































Regressions constrained to be equal 
Very Under/Slightly Under/About Right vs. Slightly Over vs. Very Over (Ordinal) 
Model     χ2   DF   BIC   CFI   TLI   1-RMSEA   Notes 
                 
Autoregressive  0.099  1  -9.318  1.000  1.000  1.000  None 
                 
Fixed Effects  481.692  3  453.440  0.990  0.981  0.886  Negative variances                  































Regressions constrained to be equal 
Under vs. About Right vs. Over (Ordinal) 
Model     χ2   DF   BIC   CFI   TLI   1-RMSEA   Notes 
                 
Autoregressive  0.149  1  -9.268  1.000  1.000  1.000  None                  
Fixed Effects  639.834  3  611.582  0.985  0.970  0.869  Negative variances 






































Regressions constrained to be equal 
                                  
                 
N=12,300. 
Results based on casewise maximum likelihood (also called FIML) estimation to account for missing data,  
with robust (Huber-White) standard errors for continuous models and diagonal weighted least squares standard errors for ordinal models. 
Variance on first and last two observed measures of perceived weight constrained to be equal, respectively. 
First two thresholds for categorical specifications fixed at 1 and 2, respectively. 
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Table A.11 Unweighted Coefficient Estimates for Best-fitting Longitudinal Model of Subjective Weight 
(SUBJ.) and Objective Weight (OBJ.) 
          
Parameters     Estimate   
Std. 
Err. 
  P-value 
          
Regressions       
 Wave IV OBJ. ←      
 
 Wave III OBJ. 1.117 
 0.029  0.000 
 
 Wave III SUBJ. -0.671 
 0.236  0.004 
 Wave III OBJ. ←                         
 
 Wave II OBJ. 1.064 
 0.021  0.000 
 
 Wave II SUBJ. 0.412 
 0.136  0.002 
 Wave II OBJ. ←                 
        
 
 Wave I OBJ. 1.073 
 0.024  0.000 
 
 Wave I SUBJ. 0.093 
 0.122  0.448 
 Wave IV SUBJ. ←      
 
 Wave III SUBJ. 0.898 
 0.042  0.000 
 
 Wave III OBJ. -0.089 
 0.008  0.000 
 
 Wave IV OBJ. 0.084 
 0.006  0.000 
 Wave III SUBJ. ←                   
 
 Wave II SUBJ. 0.543 
 0.024  0.000 
 
 Wave II OBJ. -0.068 
 0.005  0.000 
 
 Wave III OBJ. 0.096 
 0.003  0.000 
 Wave II SUBJ. ←                   
 
 Wave I SUBJ. 0.798 
 0.032  0.000 
 
 Wave I OBJ. -0.072 
 0.014  0.000 
 
 Wave II OBJ. 0.082 
 0.012  0.000 
 Wave I SUBJ. ←                   
 
 Wave I OBJ. 0.114 
 0.002  0.000 
          
Intercepts   
     
 Wave I OBJ. 22.614  0.041  0.000 
 Wave II OBJ. -1.337  0.241  0.000 
 Wave III OBJ. 0.764  0.267  0.000 
 Wave IV OBJ. 1.450  0.303  0.000 
 Wave I SUBJ. 0.616  0.050  0.000 
 Wave II SUBJ. 0.391  0.044  0.000 
 Wave III SUBJ. 0.606  0.039  0.000 
 Wave IV SUBJ. 0.572  0.055  0.000 
          
Variances   
     
 Wave I BMI 1.852  0.173  0.000 
 Wave II BMI 1.852  0.173  0.000 
 Wave III BMI 3.641  0.367  0.000 
 Wave IV BMI 3.641  0.367  0.000 
 Wave I PW 0.160  0.008  0.000 
 Wave II PW 0.160  0.008  0.000 
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 Wave III PW 0.209  0.010  0.000 
 Wave IV PW 0.209  0.010  0.000 
 Wave I OBJ. 18.623  0.458  0.000 
 Wave II OBJ. 2.270  0.312  0.000 
 Wave III OBJ. 8.965  0.349  0.000 
 Wave IV OBJ. 11.216  0.758  0.000 
 Wave I SUBJ. 0.233  0.011  0.000 
 Wave II SUBJ. 0.038  0.011  0.001 
 Wave III SUBJ. 0.079  0.007  0.000 
 Wave IV SUBJ. 0.065  0.014  0.000 
          
R-Square   
     
 Wave I BMI 0.910     
 Wave II BMI 0.929     
 Wave III BMI 0.913     
 Wave IV BMI 0.937     
 Wave I PW 0.747     
 Wave II PW 0.723     
 Wave III PW 0.673     
 Wave IV PW 0.696     
 Wave II OBJ. 0.906     
 Wave III OBJ. 0.767     
 Wave IV OBJ. 0.793     
 Wave I SUBJ. 0.508     
 Wave II SUBJ. 0.909     
 Wave III SUBJ. 0.816     
 Wave IV SUBJ. 0.863     
                    
          
N=12,300. 
Results based on casewise maximum likelihood (also called FIML) 








Table A.12 Coefficient Estimates for Best-fitting Longitudinal Model of Subjective Weight (SUBJ.) and Objective Weight (OBJ.); Female vs. 
Male 
                    
     Female  Male 


















                    
Regressions                 










 Wave III OBJ. 0.985 
 0.072  0.000  0.834  1.099  0.133  0.000  0.918 
 
 Wave III SUBJ. 0.075 
 0.081  0.359  0.056  -0.063  0.122  0.604  -0.057 
 Wave III OBJ. ←                           
                           
 
 Wave II OBJ. 0.868 
 0.054  0.000  0.648  0.769  0.065  0.000  0.641 
 
 Wave II SUBJ. 0.303 
 0.041  0.000  0.277  0.219  0.040  0.000  0.248 
 Wave II OBJ. ←                 
          
                 
          
 
 Wave I OBJ. 1.080 
 0.081  0.000  0.894  0.967  0.088  0.000  0.862 
 
 Wave I SUBJ. 0.030 
 0.040  0.454  0.037  0.070  0.044  0.115  0.097 
 Wave IV SUBJ. ←        
       
 
 
 Wave III SUBJ. 0.926 
 0.137  0.000  0.889  1.047  0.181  0.000  1.014 
 
 Wave III OBJ. -0.753 
 0.147  0.000  -0.815  -1.054  0.293  0.000  -0.937 
 
 Wave IV OBJ. 0.671 
 0.078  0.000  0.857  0.854  0.157  0.000  0.909 
 Wave III SUBJ. ←                     
                     
 
 Wave II SUBJ. 0.368 
 0.044  0.000  0.379  0.317  0.051  0.000  0.329 
 
 Wave II OBJ. -0.460 
 0.070  0.000  -0.386  -0.303  0.084  0.000  -0.232 
 
 Wave III OBJ. 0.819 
 0.058  0.000  0.922  0.936  0.075  0.000  0.860 
 Wave II SUBJ. ←                     
                     
 
 Wave I SUBJ. 0.863 
 0.086  0.000  0.885  0.791  0.075  0.000  0.813 
 
 Wave I OBJ. -0.381 
 0.312  0.222  -0.257  -0.304  0.312  0.330  -0.199 
 
 Wave II OBJ. 0.437 
 0.220  0.047  0.356  0.451  0.273  0.099  0.332 
 Wave I SUBJ. ←                     
                     
 
 Wave I OBJ. 0.993 
 0.066  0.000  0.653  1.113  0.067  0.000  0.710 
                    
   
      
 









 Wave I OBJ. 2.250  0.016  0.000   
 2.258  0.015  0.000                       
Intercepts   
      
 
       
 
 Wave II OBJ. -0.213  0.077  0.006   
 -0.082  0.102  0.423   
 Wave III OBJ. -0.370  0.076  0.000   
 0.216  0.065  0.001   
 Wave IV OBJ. 0.038  0.132  0.771   
 0.173  0.097  0.073   
 Wave I SUBJ. 1.120  0.154  0.000   
 0.494  0.154  0.001   
 Wave II SUBJ. 0.323  0.110  0.009   
 0.285  0.110  0.010   
 Wave III SUBJ. 1.179  0.077  0.000   
 0.401  0.077  0.000   
 Wave IV SUBJ. 0.575  0.141  0.009   
 0.489  0.141  0.001                       
Variances   
      
 
       
 
 Wave I OBJ. 0.191  0.014  0.000    0.192 
 0.016  0.000                       
Residual Variances        
       
 
 Wave I BMI 0.049  0.008  0.000    0.061 
 0.008  0.000   
 Wave II BMI 0.049  0.008  0.000    0.061 
 0.008  0.000   
 Wave III BMI 0.106  0.011  0.000    0.110 
 0.009  0.000   
 Wave IV BMI 0.106  0.011  0.000    0.110 
 0.009  0.000   
 Wave I PW 0.175  0.018  0.000   
 0.140  0.022  0.000   
 Wave II PW 0.175  0.018  0.000   
 0.140  0.022  0.020   
 Wave III PW 0.219  0.021  0.000   
 0.204  0.019  0.000   
 Wave IV PW 0.219  0.021  0.000   
 0.204  0.019  0.622   
 Wave II OBJ. 0.043  0.016  0.007   
 0.031  0.014  0.000   
 Wave III OBJ. 0.131  0.010  0.000   
 0.103  0.009  0.000   
 Wave IV OBJ. 0.154  0.018  0.000   
 0.125  0.022  0.000   
 Wave I SUBJ. 0.253  0.030  0.000   
 0.234  0.027  0.000   
 Wave II SUBJ. 0.041  0.032  0.200   
 0.071  0.031  0.001   
 Wave III SUBJ. 0.059  0.014  0.000   
 0.055  0.012  0.000   
 Wave IV SUBJ. 0.048  0.035  0.168   
 0.017  0.034  0.000                       
R-Square   
      
 
       
 
 Wave I BMI 0.796       
 0.759       
 Wave II BMI 0.851       







 Wave III BMI 0.825       
 0.760       
 Wave IV BMI 0.868       
 0.820       
 Wave I PW 0.716       
 0.771       
 Wave II PW 0.705       
 0.761       
 Wave III PW 0.643       
 0.669       
 Wave IV PW 0.661       
 0.683       
 Wave II OBJ. 0.845       
 0.872       
 Wave III OBJ. 0.737       
 0.703       
 Wave IV OBJ. 0.779       
 0.750       
 Wave I SUBJ. 0.427       
 0.504       
 Wave II SUBJ. 0.903       
 0.841       
 Wave III SUBJ. 0.850       
 0.866       
 Wave IV SUBJ. 0.888       
 0.962       
                                        
                    
N=7,105. 
Results based on casewise maximum likelihood (also called FIML) estimation to account for missing data,  
with robust (Huber-White) standard errors. 
Model fit statistics: χ2 = 24.508, DF = 16, BIC = -117.389, CFI = 0.999, TLI = 0.997, 1-RMSEA = 0.988. 
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Table A.13 Coefficient Estimates for Health Outcomes Regressed on Subjective Weight (SUBJ.) and 
Objective Weight (OBJ.), Adjusted for Age, Gender, Race/Ethnicity, and Education 
            
Parameters     Estimate   
Std. 
Err. 
  P-value   
Stdz. 
Est. 
            
Health Outcome Regressions        
 Wave V BMI ←        
 
 Wave IV OBJ. 0.945  0.068  0.000  0.835 
 
 Wave IV SUBJ. -0.047  0.078  0.546  -0.038 
 
 Age   -0.020  0.014  0.164   
 
 Female  0.057  0.048  0.239   
 
 NH-Black 0.115  0.057  0.043   
 
 Hispanic 0.095  0.079  0.227   
 
 NH-Other 0.035  0.104  0.734   
 
 Wave V BA+ -0.185  0.076  0.015   
 SBP ←   
     
  
 
 Wave IV OBJ. 0.656  0.162  0.000  0.352 
 
 Wave IV SUBJ. -0.035  0.190  0.855  -0.017 
 
 Age   0.024  0.021  0.242   
 
 Female  -0.926  0.102  0.000   
 
 NH-Black 0.420  0.093  0.000   
 
 Hispanic -0.196  0.145  0.175   
 
 NH-Other -0.030  0.170  0.859   
 
 Wave V BA+ -0.172  0.123  0.161   








 Wave IV OBJ. 0.411  0.137  0.003  0.291 
 
 Wave IV SUBJ. -0.031  0.163  0.851  -0.020 
 
 Age   0.035  0.016  0.034   
 
 Female  -0.525  0.085  0.000   
 
 NH-Black 0.281  0.073  0.000   
 
 Hispanic -0.239  0.122  0.049   
 
 NH-Other 0.162  0.150  0.281   
 
 Wave V BA+ -0.167  0.097  0.086   
 
Measured Hypertension/Rx ← 
    
  
 
 Wave IV OBJ. 0.345  0.130  0.008  0.835 
 
 Wave IV SUBJ. 0.268  0.157  0.088  -0.038 
 
 Age   0.018  0.019  0.364   
 
 Female  -0.541  0.093  0.000   
 
 NH-Black 0.304  0.093  0.001   
 
 Hispanic -0.357  0.156  0.022   
 
 NH-Other 0.219  0.215  0.309   
 
 Wave V BA+ -0.156  0.143  0.278   
  
CRP ←   





 Wave IV OBJ. 0.378  0.040  0.000  0.438 
 
 Wave IV SUBJ. -0.145  0.048  0.003  -0.153 
 
 Age   -0.028  0.010  0.003   
 
 Female  0.286  0.042  0.000   
 
 NH-Black 0.048  0.043  0.262   
 
 Hispanic -0.025  0.057  0.667   
 
 NH-Other 0.138  0.068  0.042   
 
 Wave V BA+ -0.143  0.079  0.069   
 Latent Depression ←        
 
 Wave IV OBJ. -0.097  0.051  0.059  -0.112 
 
 Wave IV SUBJ. 0.120  0.058  0.040  0.126 
 
 Age   -0.005  0.007  0.487   
 
 Female  0.038  0.038  0.324   
 
 NH-Black 0.036  0.037  0.328   
 
 Hispanic -0.069  0.053  0.192   
 
 NH-Other -0.109  0.047  0.020   
 
 Wave V BA+ -0.036  0.049  0.462   
 
Depression Dx ← 
     
  
 
 Wave IV OBJ. -0.183  0.109  0.092  -0.130 
 
 Wave IV SUBJ. 0.307  0.129  0.017  0.200 
 
 Age   -0.016  0.018  0.359   
 
 Female  0.354  0.082  0.000   
 
 NH-Black -0.321  0.082  0.000   
 
 Hispanic -0.347  0.095  0.000   
 
 NH-Other -0.438  0.130  0.001   
 
 Wave V BA+ 0.037  0.091  0.681   
 Anxiety Dx ←        
 
 Wave IV OBJ. -0.304  0.111  0.006  -0.215 
 
 Wave IV SUBJ. 0.364  0.134  0.007  0.235 
 
 Age   -0.023  0.019  0.226   
 
 Female  0.323  0.068  0.000   
 
 NH-Black -0.426  0.086  0.000   
 
 Hispanic -0.351  0.118  0.003   
 
 NH-Other -0.564  0.154  0.000   
 
 Wave V BA+ -0.165  0.092  0.072   
 Trouble Sleeping ←        
 
 Wave IV OBJ. 0.027  0.086  0.758  0.015 
 
 Wave IV SUBJ. 0.012  0.101  0.902  0.006 
 
 Age   0.009  0.018  0.616   
 
 Female  0.370  0.060  0.000   
 
 NH-Black -0.194  0.071  0.007   
 
 Hispanic -0.288  0.119  0.015   
 
 NH-Other -0.150  0.158  0.343   
 
 Wave V BA+ 0.156  0.108  0.151               
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SWS and BMI Regressions        
 Wave IV OBJ. ←        
 
 Wave III OBJ. 1.051 
 0.064  0.000  0.868 
 
 Wave III SUBJ. 0.037 
 0.071  0.606  0.032 
 
 Age   -0.019  0.008  0.014   
 
 Female  0.018  0.039  0.638   
 
 NH-Black 0.046  0.037  0.214   
 
 Hispanic 0.037  0.036  0.300   
 
 NH-Other -0.088  0.068  0.197   
 
 Wave IV BA+ -0.039  0.059  0.510   
 Wave III OBJ. ←        
 
 Wave II OBJ. 0.750 
 0.039  0.000  0.619 
 
 Wave II SUBJ. 0.265 
 0.027  0.000  0.290 
 
 Age   0.006  0.007  0.412   
 
 Female  -0.091  0.026  0.000   
 
 NH-Black 0.070  0.025  0.005   
 
 Hispanic 0.047  0.031  0.133   
 
 NH-Other 0.005  0.035  0.886   
 
 Wave III In College + -0.026  0.029  0.379   




 Wave I OBJ. 0.925 
 0.069  0.000  0.791 
 
 Wave I SUBJ. 0.091 
 0.033  0.006  0.123 
 
 Age   -0.001  0.006  0.885   
 
 Female  -0.025  0.019  0.179   
 
 NH-Black 0.025  0.016  0.132   
 
 Hispanic -0.017  0.023  0.458   
 
 NH-Other -0.049  0.044  0.270   
 
 Parent BA+ -0.049  0.026  0.061   




 Age   0.029  0.006  0.000   
 
 Female  -0.013  0.020  0.496   
 
 NH-Black 0.090  0.028  0.001   
 
 Hispanic 0.063  0.039  0.106   
 
 NH-Other 0.057  0.051  0.264   
 
 Parent BA+ -0.058  0.025  0.021   
 Wave IV SUBJ. ←        
 
 Wave III SUBJ. 0.922 
 0.087  0.000  0.886 
 
 Wave III OBJ. -0.896 
 0.129  0.000  -0.811 
 
 Wave IV OBJ. 0.799 
 0.077  0.000  0.876 
 
 Age   0.006  0.009  0.486   
 
 Female  -0.021  0.049  0.667   
 
 NH-Black -0.052  0.047  0.272   
 
 Hispanic -0.085  0.047  0.070   
 
 NH-Other 0.022  0.058  0.701   
 
 Wave IV BA+ -0.096  0.047  0.040   
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 Wave III SUBJ. ←        
 
 Wave II SUBJ. 0.344 
 0.028  0.000  0.355 
 
 Wave II OBJ. -0.406 
 0.068  0.000  -0.316 
 
 Wave III OBJ. 0.937 
 0.070  0.000  0.882 
 
 Age   0.005  0.008  0.527   
 
 Female  0.267  0.029  0.000   
 
 NH-Black -0.122  0.037  0.001   
 
 Hispanic 0.066  0.041  0.107   
 
 NH-Other 0.026  0.048  0.585   
 
 Wave III In College + 0.013  0.026  0.626   
 Wave II SUBJ. ←        
 
 Wave I SUBJ. 0.902 
 0.040  0.000  0.921 
 
 Wave I OBJ. -0.262 
 0.123  0.033  -0.169 
 
 Wave II OBJ. 0.286 
 0.095  0.003  0.216 
 
 Age   0.017  0.007  0.017   
 
 Female  0.036  0.025  0.147   
 
 NH-Black 0.021  0.035  0.548   
 
 Hispanic 0.002  0.037  0.947   
 
 NH-Other 0.135  0.047  0.004   
 
 Parent BA+ 0.007  0.027  0.791   
 Wave I SUBJ. ←        
 
 Wave I OBJ. 1.068 
 0.059  0.000  0.674 
 
 Age   -0.043  0.007  0.000   
 
 Female  0.371  0.028  0.000   
 
 NH-Black -0.172  0.033  0.000   
 
 Hispanic -0.055  0.045  0.224   
 
 NH-Other -0.222  0.060  0.000   
 
 Parent BA+ 0.005  0.027  0.861   
                        
            
N=6,247. 
Observed BMI, observed SBP and DBP, and observed CRP  
divided by 10 to reduce variance and help with model convergence. 
Latent variable regressions, covariances, means and intercepts, variances,  
and R-squared values omitted for parsimony. 
Results based on casewise maximum likelihood (also called FIML) estimation to 
account for missing data among endogenous variables, with diagonal weighted least 
squares standard errors due to binary outcome variables. 
Weighted estimates account for person-level longitudinal survey weights (WI-V), 
school-level clustering, and regional strata. 
Model fit statistics: χ2 =  361.617, DF = 274, SBIC = -2033.104, CFI = 0.994,  







Table A.14 Coefficient Estimates for Health Outcomes Regressed on Subjective Weight (SUBJ.) and Objective Weight (OBJ.), Adjusted for Age, 
Race/Ethnicity, and Education; Female vs. Male 
                    
     Female  Male 


















                    
Health Outcome Regressions                




 Wave IV OBJ. 0.968  0.085  0.000  0.875 
 0.907  0.116  0.000  0.799 
 
 Wave IV SUBJ. -0.135  0.113  0.231  -0.093 
 0.013  0.121  0.917  0.011 
 
 Age   -0.022  0.019  0.239   
 -0.021  0.018  0.236   
 
 NH-Black 0.145  0.066  0.028   
 0.065  0.078  0.405   
 
 Hispanic 0.073  0.108  0.497   
 0.113  0.128  0.378   
 
 NH-Other 0.103  0.218  0.635   
 -0.014  0.103  0.889   
 
 Wave V BA+ -0.321  0.095  0.001   
 0.001  0.143  0.997   
 SBP ←   
     
  
        
 
 Wave IV OBJ. 0.511  0.177  0.004  0.329 
 1.016  0.274  0.000  0.508 
 
 Wave IV SUBJ. -0.054  0.234  0.819  -0.026 
 -0.231  0.276  0.404  -0.117 
 
 Age   0.004  0.021  0.852   
 0.044  0.036  0.224   
 
 NH-Black 0.452  0.111  0.000   
 0.384  0.156  0.014   
 
 Hispanic -0.251  0.201  0.212   
 -0.188  0.232  0.417   
 
 NH-Other -0.127  0.293  0.664   
 0.036  0.236  0.879   
 
 Wave V BA+ -0.192  0.154  0.211   
 -0.145  0.235  0.538   







        
 
 Wave IV OBJ. 0.158  0.127  0.213  0.132 
 0.792  0.233  0.001  0.506 
 
 Wave IV SUBJ. 0.210  0.170  0.215  0.135 
 -0.346  0.230  0.133  -0.224 
 
 Age   0.018  0.019  0.331   
 0.047  0.026  0.077   
 
 NH-Black 0.372  0.083  0.000   
 0.169  0.113  0.135   
 
 Hispanic -0.348  0.154  0.023   
 -0.161  0.201  0.424   
 
 NH-Other -0.074  0.235  0.754   
 0.380  0.221  0.086   
 
 Wave V BA+ -0.192  0.110  0.079   
 -0.117  0.187  0.531   
 
Measured Hypertension/Rx ← 
    
  








 Wave IV OBJ. 0.310  0.156  0.047  0.246 
 0.482  0.215  0.025  0.313 
 
 Wave IV SUBJ. 0.260  0.205  0.206  0.158 
 0.194  0.236  0.411  0.128 
 
 Age   0.012  0.029  0.671   
 0.020  0.029  0.504   
 
 NH-Black 0.290  0.130  0.026   
 0.305  0.137  0.026   
 
 Hispanic -0.406  0.221  0.066   
 -0.338  0.208  0.104   
 
 NH-Other 0.379  0.365  0.300   
 0.024  0.258  0.926   
 
 Wave V BA+ -0.020  0.160  0.900   
 -0.370  0.221  0.095   
 CRP ←   
     
  
        
 
 Wave IV OBJ. 0.308  0.050  0.000  0.336 
 0.445  0.062  0.000  0.632 
 
 Wave IV SUBJ. -0.027  0.071  0.701  -0.023 
 -0.244  0.061  0.000  -0.350 
 
 Age   -0.036  0.018  0.050   
 -0.019  0.010  0.070   
 
 NH-Black 0.061  0.056  0.278   
 0.036  0.058  0.542   
 
 Hispanic 0.015  0.102  0.879   
 -0.060  0.059  0.303   
 
 NH-Other 0.009  0.260  0.972   
 0.281  0.052  0.000   
 
 Wave V BA+ -0.247  0.130  0.058   
 0.054  0.088  0.534   
 Latent Depression ←        
        
 
 Wave IV OBJ. -0.116  0.062  0.063  -0.144 
 -0.067  0.081  0.410  -0.072 
 
 Wave IV SUBJ. 0.219  0.082  0.008  0.209 
 0.021  0.082  0.802  0.022 
 
 Age   -0.021  0.011  0.052   
 0.007  0.012  0.575   
 
 NH-Black 0.043  0.052  0.406   
 -0.008  0.048  0.861   
 
 Hispanic -0.001  0.065  0.990   
 -0.139  0.082  0.091   
 
 NH-Other -0.052  0.073  0.471   
 -0.143  0.074  0.053   
 
 Wave V BA+ -0.084  0.056  0.136   
 0.024  0.084  0.777   
 
Depression Dx ← 
     
  
        
 
 Wave IV OBJ. -0.115  0.125  0.357  -0.092 
 -0.340  0.209  0.104  -0.223 
 
 Wave IV SUBJ. 0.392  0.173  0.023  0.239 
 0.279  0.197  0.157  0.185 
 
 Age   -0.059  0.023  0.011   
 0.030  0.028  0.283   
 
 NH-Black -0.396  0.097  0.000   
 -0.288  0.137  0.035   
 
 Hispanic -0.256  0.118  0.030   
 -0.499  0.165  0.002   
 
 NH-Other -0.556  0.209  0.008   
 -0.237  0.155  0.125   
 
 Wave V BA+ 0.006  0.116  0.957   
 0.074  0.168  0.661   
 Anxiety Dx ←        








 Wave IV OBJ. -0.286  0.127  0.024  -0.225 
 -0.464  0.212  0.028  -0.303 
 
 Wave IV SUBJ. 0.487  0.184  0.008  0.293 
 0.369  0.212  0.081  0.244 
 
 Age   -0.052  0.025  0.037   
 0.006  0.027  0.827   
 
 NH-Black -0.451  0.101  0.000   
 -0.413  0.142  0.004   
 
 Hispanic -0.343  0.121  0.005   
 -0.358  0.191  0.062   
 
 NH-Other -0.529  0.207  0.011   
 -0.563  0.209  0.007   
 
 Wave V BA+ -0.220  0.104  0.034   
 -0.077  0.171  0.651   
 Trouble Sleeping ←        
        
 
 Wave IV OBJ. 0.057  0.113  0.613  0.035 
 0.071  0.143  0.622  0.036 
 
 Wave IV SUBJ. 0.097  0.149  0.517  0.045 
 -0.139  0.147  0.344  -0.072 
 
 Age   0.010  0.025  0.679   
 0.005  0.024  0.845   
 
 NH-Black -0.305  0.103  0.003   
 -0.137  0.098  0.163   
 
 Hispanic -0.177  0.142  0.214   
 -0.402  0.158  0.011   
 
 NH-Other -0.026  0.188  0.891   
 -0.261  0.222  0.240   
 
 Wave V BA+ -0.007  0.144  0.964   
 0.375  0.162  0.020   
                    
SWS and BMI Regressions         
       
 Wave IV OBJ. ←         
       
 
 Wave III OBJ. 0.903 
 0.076  0.000  0.744  1.319 
 0.144  0.000  1.091 
 
 Wave III SUBJ. 0.185 
 0.095  0.052  0.137  -0.194 
 0.128  0.128  -0.186 
 
 Age   0.001  0.010  0.918   
 -0.047  0.012  0.000   
 
 NH-Black 0.121  0.042  0.004   
 -0.009  0.057  0.869   
 
 Hispanic 0.029  0.051  0.577   
 0.068  0.069  0.323   
 
 NH-Other -0.110  0.098  0.261   
 -0.085  0.078  0.278   
 
 Wave IV BA+ -0.079  0.061  0.197   
 0.004  0.137  0.979   
 Wave III OBJ. ←         
       
 
 Wave II OBJ. 0.814 
 0.048  0.000  0.625  0.622 
 0.075  0.000  0.561 
 
 Wave II SUBJ. 0.290 
 0.036  0.000  0.280  0.285 
 0.048  0.000  0.337 
 
 Age   -0.011  0.011  0.288   
 0.025  0.009  0.003   
 
 NH-Black 0.067  0.041  0.102   
 0.044  0.039  0.259   
 
 Hispanic 0.026  0.045  0.565   
 0.058  0.051  0.252   
 
 NH-Other -0.006  0.058  0.923   
 0.042  0.051  0.414   
 
 Wave III In College + -0.018  0.039  0.645   







 Wave II OBJ. ←    
  
   
       
 
 Wave I OBJ. 0.968 
 0.080  0.000  0.799  0.819 
 0.108  0.000  0.729 
 
 Wave I SUBJ. 0.078 
 0.038  0.038  0.100  0.144 
 0.054  0.008  0.193 
 
 Age   -0.010  0.007  0.173   
 0.012  0.011  0.250   
 
 NH-Black 0.053  0.029  0.063   
 -0.004  0.029  0.883   
 
 Hispanic -0.018  0.029  0.550   
 -0.015  0.039  0.693   
 
 NH-Other -0.112  0.071  0.113   
 0.041  0.057  0.473   
 
 Parent BA+ -0.015  0.035  0.666   
 -0.070  0.038  0.066   
 Wave I OBJ. ←    
  
   
       
 
 Age   0.022  0.009  0.013   
 0.035  0.008  0.000   
 
 NH-Black 0.223  0.030  0.000   
 -0.042  0.046  0.365   
 
 Hispanic 0.095  0.046  0.039   
 0.031  0.054  0.562   
 
 NH-Other 0.028  0.063  0.652   
 0.092  0.060  0.123   
 
 Parent BA+ -0.081  0.027  0.003   
 -0.025  0.033  0.452   
 Wave IV SUBJ. ←         
       
 
 Wave III SUBJ. 0.958 
 0.098  0.000  0.925  1.027 
 0.228  0.000  0.968 
 
 Wave III OBJ. -0.758 
 0.106  0.000  -0.816  -1.369 
 0.444  0.002  -1.118 
 
 Wave IV OBJ. 0.644 
 0.080  0.000  0.841  1.107 
 0.247  0.000  1.094 
 
 Age   0.007  0.013  0.597   
 0.034  0.021  0.099   
 
 NH-Black 0.065  0.056  0.242   
 -0.141  0.086  0.101   
 
 Hispanic 0.039  0.065  0.544   
 -0.150  0.110  0.171   
 
 NH-Other 0.038  0.065  0.560   
 0.031  0.088  0.727   
 
 Wave IV BA+ 0.133  0.054  0.014   
 0.004  0.134  0.975   
 Wave III SUBJ. ←         
       
 
 Wave II SUBJ. 0.341 
 0.034  0.000  0.366  0.269 
 0.055  0.000  0.275 
 
 Wave II OBJ. -0.422 
 0.087  0.000  -0.360  -0.336 
 0.097  0.001  -0.263 
 
 Wave III OBJ. 0.853 
 0.084  0.000  0.949  1.083 
 0.117  0.000  0.939 
 
 Age   0.015  0.011  0.191   
 -0.013  0.011  0.229   
 
 NH-Black -0.137  0.045  0.002   
 -0.076  0.058  0.189   
 
 Hispanic 0.034  0.058  0.561   
 0.097  0.080  0.224   
 
 NH-Other 0.006  0.059  0.922   
 0.007  0.068  0.922   
 
 Wave III In College + 0.037  0.034  0.274   







 Wave II SUBJ. ←         
       
 
 Wave I SUBJ. 0.900 
 0.057  0.000  0.916  0.862 
 0.069  0.000  0.886 
 
 Wave I OBJ. -0.210 
 0.142  0.138  -0.138  -0.157 
 0.167  0.348  -0.107 
 
 Wave II OBJ. 0.228 
 0.108  0.035  0.182  0.237 
 0.146  0.104  0.181 
 
 Age   0.015  0.009  0.097   
 0.014  0.011  0.206   
 
 NH-Black 0.037  0.041  0.366   
 0.011  0.053  0.841   
 
 Hispanic -0.011  0.050  0.824   
 0.012  0.049  0.799   
 
 NH-Other 0.012  0.062  0.848   
 0.244  0.072  0.001   
 
 Parent BA+ 0.002  0.040  0.968   
 -0.007  0.040  0.865   
 Wave I SUBJ. ←         
       
 
 Wave I OBJ. 1.028 
 0.063  0.000  0.664  1.094 
 0.085  0.000  0.724 
 
 Age   -0.001  0.011  0.957   
 -0.081  0.010  0.000   
 
 NH-Black -0.258  0.043  0.000   
 -0.086  0.051  0.092   
 
 Hispanic -0.045  0.053  0.395   
 -0.055  0.059  0.348   
 
 NH-Other -0.180  0.087  0.039   
 -0.297  0.080  0.000   
 
 Parent BA+ -0.016  0.042  0.702   
 0.011  0.039  0.768   
                                        
                    
N(Female)=4,152; N(Male)=2,606. 
Observed BMI, observed SBP and DBP, and observed CRP divided by 10 to reduce variance and help with model convergence. 
Latent variable regressions, covariances, intercepts, variances, and R-squared values omitted for parsimony. 
Results based on casewise maximum likelihood (also called FIML) estimation to account for missing data among endogenous variables,  
with diagonal weighted least squares standard errors due to binary outcome variables. 
Weighted estimates account for person-level longitudinal survey weights (WI-V), school-level clustering, and regional strata. 
Model fit statistics for Male respondents: χ2 = 295.971, DF = 268, SBIC = -1812.002, CFI = 0.996, TLI = 0.993, 1-RMSEA = 0.994. 
Model fit statistics for Female respondents: χ2 = 369.979, DF = 268, SBIC = -1827.625, CFI = 0.990, TLI = 0.983, 1-RMSEA = 0.990. 
 
